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Exogenously generated electrophiles are capable of alkylating DNA.  If not 
repaired, the resulting DNA adducts can lead to mutations and either cancer or cell 
death.  Electrophilic ortho-quinone methides (o-QM) are reactive intermediates that 
alkylate DNA and are generated during xenobiotic metabolism of a variety of 
compounds including environmental toxins and therapeutic agents.  Identifying the 
full alkylation profile of o-QM towards DNA would allow for the genotoxicity of o-
QM precursors to be better understood.  
From model studies based on nucleosides, o-QMs react most readily, but 
reversibly with the strong nucleophiles 2′-deoxycytidine (dC) N3, 2′-deoxyguanosine 
(dG) N7, and 2′-deoxyadenosine (dA) N1 and less efficiently, but irreversibly with 
the weak nucleophiles dG N1, dG N2, and dA N6.  The reverse reactions complicate 
analysis of their products in DNA, which requires enzymatic digestion and 
chromatographic separation.  Selective oxidation by 
  
bis[(trifluoroacetoxy)iodo]benzene (BTI) can transform the reversible o-QM-DNA 
adducts into irreversible derivatives capable of surviving such analysis.  To facilitate 
this analysis, a series of oxidized o-QM-dN adducts were synthesized as analytical 
standards. 
 Initial oxidative trapping studies with an unsubstituted o-QM and dC 
demonstrated the necessity of an alkyl substituent para to the phenolic oxygen to 
block over-oxidation.  A novel o-QM included a methyl group para to the phenolic 
oxygen that successfully blocked the over-oxidation allowing for generation of a 
stable MeQM-dC N3 oxidized product.  Further oxidative trapping studies with 
MeQM and dG resulted in the formation of three stable MeQM-dG oxidized products 
(guanine N7, dG N1, and dG N2).   
Initial studies with duplex DNA optimized the enzymatic digestion and 
confirmed that the assay conditions were compatible with oxidative trapping.  The 
low yielding MeQM alkylation of duplex DNA needs to be scaled up prior to the 
oxidative trapping studies. 
  Alternative studies quantified the release of MeQM from DNA with the use 
of β-mercaptoethanol as a nucleophilic trap.  These studies revealed single stranded 
DNA as a superior carrier of MeQM than duplex DNA and, therefore, a better target 
DNA for the oxidative trapping studies due to increased yield of MeQM adducts.  
With the increased MeQM-DNA yield, the intrinsic selectivity and reactivity of 
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 A number of drugs and environmental toxins are metabolized in our cells 
resulting in compounds that can react with and cause damage to many different 
cellular components, including DNA.  The type, amount, and location of the DNA 
damage, known as lesions, determines the biological response which may consist of 
repair or cell death.  If the biological response is insufficient to correct the DNA 
lesions, mutations may occur possibly leading to cancer or cell death.  Many anti-
cancer drugs also work by damaging DNA.  Understanding the biological response to 
a specific DNA damaging compound would allow for the assessment of that 
compounds toxicity.  To accomplish this goal, the DNA lesions formed by a specific 
compound must first be identified.  This would allow for the relationship between a 
lesion and a specific biological response to be established.  
 One type of DNA damaging compound is quinone methide (QM).  The QM 
functional group is found upon metabolism of a number of anti-cancer compounds, 
the most well known is mitomycin C.  QMs are also found in cells upon metabolism 
of certain environmental chemicals, such as the food preservative BHT.  QMs have 
the unusual ability to form both irreversible and reversible products with DNA.  The 
reversible products exist long enough to elicit a biological response, but not long 
enough for standard analysis.  To effectively assess the toxicity of QMs, the reactivity 
and selectivity of a simple QM towards DNA is a necessity and requires a method of 
trapping the reversible products.  In this way, the product profile can be “frozen” at 
any given time and will not change during the long process of breaking down DNA.  




products into irreversible products through an oxidation mechanism.  Most 
importantly, BTI performs this transformation quickly, completely, and in the near 
physiological conditions used for the QM reaction of DNA.  These points are 
important as they will allow for the analysis of the QM reaction of DNA at short (< 
24 hr), but biologically relevant times leading to a much better understanding of its 
reactivity and selectivity than previous studies have allowed. 
To help with the eventual analysis of the reaction between QM and DNA, a 
number of analytical standards were synthesized from nucleosides.  This was 
accomplished by first reacting individual nucleosides with QM to form the QM-
nucleoside product and second the product was oxidized with BTI to form the 
analytical standard.  Initially, the first nucleoside to be studied was 2′-deoxycytidine 
(dC) because it forms only one, slowly reversible, product with QM.  During these 
studies, the simplest QM was observed to form a complex, and unexpected, product 
after reaction with BTI.  A new QM, which featured the addition of a methyl group to 
limit the reactivity of QM with BTI, was developed to avoid the formation of the 
unexpected complex product.  The new QM (MeQM) successfully reacted with dC 
and formed the expected product upon reaction with BTI. 
After the MeQM-dC product was synthesized and its structure determined, the 
three products between MeQM and the nucleoside 2′-deoxyguanosine (dG) were 
synthesized.  Additionally, MeQM forms two products with the nucleoside 2′-
deoxyadenosine, and these products were studied by my undergraduate mentee Omer 




QM and it was not studied.  In total, six analytical standards were made for use with 
the analysis of the reaction between MeQM and DNA. 
With the help of the six analytical standards, the reaction between MeQM and 
DNA was investigated.  However, not enough MeQM reacted with the DNA and 
therefore future work will increase the amount of MeQM that reacts with DNA.  
Once the reaction between MeQM and DNA can be studied, information on the 
associated lesions (such as their type, amount, and location) can be used to determine 
why QMs elicit specific biological responses and how to assess the toxicity of QM 
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µL – microliter 
mg – milligram 
mL - milliliter 
mmol – millimoles 
M – molar 
MOPS - 3-(N-morpholino)propanesulfonic acid 
nmol - nanomoles 
NMR – nuclear magnetic resonance 
NER – nucleotide excision repair 
nts – nucleotides 
1D – one dimensional 
o – ortho 
N2OPdG -  N2-oxopropenyl-deoxyguanosine 
p – para 
MMR - post-replication mismatch repair system 
1-PrC – 1-propylcytosine 
QM – quinone methide 
QMP – quinone methide precursor 
tr – retention time 
salDNA – salmon sperm DNA 




NaHCO3 – sodium bicarbonate 
MS/MS – tandem mass spectrometry 
TBDMS – tert-butyldimethylsilyl 
TBDMS-Cl – tert-butyldimethylsilylchloride 
THF – tetrahydofuran 
TLC – thin layer chromatography 
TEA – triethylamine 
TEAA – triethylammonium acetate 
TFA – trifluoroacetic acid 
PPh3 – triphenyl phosphine 
Tris-HCl - tris(hydroxymethyl)aminomethane hydrochloride 
2D – two dimensional 
UHPLC – ultra high performance liquid chromatography 
UV-Vis – ultraviolet-visible spectroscopy 





Chapter 1: Introduction 
 
1.1.  DNA Alkylation. 
Nucleophilic sites on DNA have the potential to react with a variety of 
endogenously and exogenously generated electrophiles to form DNA adducts.1-3 
Endogenously generated DNA adducts, such as 5-methylcytosine (5MeC), are crucial 
to normal development in mammals by regulating a number of cellular processes.4-6 
However, there appears to be a low level of mutagenic DNA adducts formed 
nonenzymatically by S-adenosylmethionine (SAM), showing that not all endogenous 
DNA alkylation is beneficial.1 Exogenously generated DNA adducts, formed from 
environmental chemicals, mainly result in DNA damage.  Exogenous DNA alkylating 
agents that target rapidly replicating cells have found success as cancer 
chemotherapeutic drugs by damaging the DNA of cancer cells.7-9 Unfortunately, 
exogenous DNA alkylating agents that damage genomic DNA may result in 
mutations if not repaired.   
Regardless of how the DNA adduct is formed, each unique adduct invokes a 
specific cellular response.  O6-Methylguanine (O6MeG), for example, is a major DNA 
adduct formed by alkylating agents from both endogenous and exogenous 
sources.3,10,11 The repair protein O6-methylguanine-DNA methyltransferase (MGMT) 
directly reverses the methylation by transferring the O6-methyl group to a cysteine 
residue on itself.  If this repair mechanism is not successful, the adduct may cause a 




the DNA sequence.12,13 The O6MeG:T mismatch can be lethal also due to futile 
cycling by the post-replication mismatch repair (MMR) system.12  
Another common DNA adduct is N7-methylguanine (7MeG).  The N7 
position of 2′-deoxyguanosine (dG N7) is the most nucleophilic site within the DNA 
bases, making it highly reactive with electrophiles.14 For example, 82% of the 
methylation of duplex DNA by methyl methanesulfonate (MMS) occurs at dG N7.15 
While alkylation of dG N7 may be frequent, the 7MeG adduct appears to be neither 
mutagenic nor cytotoxic.3 A number of 7MeG degradation products exhibit 
mutagenicity and cytoxicity.  Alkylation at dG N7 places a positive charge on the N7 
nitrogen (1.2), destabilizing the N-glycosidic bond and leading to spontaneous 
depurination.  The resulting abasic site (1.3) may lead to a DNA strand break and is 
toxic (Scheme 1.1).16 
Scheme 1.1. Proposed mechanism for the depurination of N7-alkyl dG residues.  R+ 





Another toxic 7MeG degradation product is 2,6-diamino-4-hydroxy-5N-
methylformamidopyrimidine (FAPy-7MeG, 1.11).  FAPy-7MeG is formed from 
7MeG upon opening of the imidazolium ring by hydrolysis (Scheme 1.2).  Although 
only weakly mutagenic, FAPy-7MeG does block DNA chain elongation, therefore 
affecting DNA synthesis.17,18 Furthermore, the glycosidic bond in FAPy-7MeG is 
chemically stable under physiological conditions, unlike 7MeG.16 The removal of 
these adducts requires active repair, such as base excision repair (BER) which can 
lead to the formation of toxic abasic sites (1.3).3  
Scheme 1.2. Ring opening in 7-methylguanine (1.9) to yield the FAPy-7MeG (1.11) 
adduct.  Adapted from Gates et al.16 
 
 
1.2.  The Importance of Detecting Labile DNA Adducts. 
Much of the study on DNA alkylation is focused on the irreversible process 
rather than the reversible process.  Irreversible adducts lend themselves to simple 
manipulation as the adducts can survive lengthy (>22 hr) assays such as enzymatic 
digestion and work-up prior to tandem liquid chromatography-mass spectrometry 
(LC/MS).19,20 A much less studied area of DNA alkylation is the formation of 
reversible, or labile, DNA adducts.  As these reversible DNA adducts may have 




diminished or go unnoticed altogether.  However, the lifetime of the reversible adduct 
may be sufficient to elicit a cellular response, provoking DNA damage repair 
pathways.  The reversible DNA adducts can then release from the excised DNA and 
reassociate with the original DNA.  This repeated regeneration of the active 
alkylating agent effectively extends the lifetime of these DNA alkylating agents in 
vivo. For this scenario, a lower amount of reversible alkylating agent would, 
therefore, be needed to achieve the same result as a higher amount of irreversible 
alkylating agent, which would be beneficial for therapeutic uses, but harmful with 
environmental toxins. 
Unfortunately, the reversible nature of these alkylating agents makes their 
detection and analysis difficult.  The ability to detect reversible DNA adducts would 
allow for an assessment of the genotoxicity of such an alkylating agent.  Access to the 
full profile of adducts formed by an alkylating agent would also be instrumental in a 
proposed mechanism of its toxicity.20,21 This additional information could influence 
the toxicology rating of chemicals or help to design more selective DNA targeting 
therapeutics.  It is, therefore, imperative that a method, or methods, to detect labile 
DNA adducts be developed. 
 
1.3.  Extensively Studied Labile DNA Alkylating Agents. 
A number of known DNA alkylating agents are confirmed to form labile DNA 
adducts.  One of these DNA alkylating agents, malondialdehyde (MDA, 1.12), is an 




foodstuffs.22,23 MDA can act as both a strong electrophile and as a strong nucleophile 
when it forms its enol tautomer, β-hydroxyacrolein (1.13) (Scheme 1.3).22  
Scheme 1.3.  Malondialdehyde (1.12) can tautomerize to β-hydroxyacrolein (1.13). 
 
MDA forms mutagenic DNA adducts with dA and 2′-deoxycytidine (dC), but 
mostly with dG.22 The major adduct formed with dG is 3-(2′-deoxy-β-D-erythro-
pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one (M1dG, 1.14) (Scheme 1.4).24 At 
neutral pH, M1dG has been shown to be reactive towards nucleophiles,25 and basic 
conditions can cause hydrolytic ring-opening to form N2-oxopropenyl-
deoxyguanosine (N2OPdG, 1.15), which is reactive also with nucleophiles (Scheme 
1.4).26 Further studies determined that M1dG is converted to N2OPdG in duplex DNA 
when positioned complimentary to cytosine which suggests a cytosine catalyzed ring-
opening.27 Furthermore, the N2OPdG does not covalently react with the catalytic 
cytosine, as confirmed by NMR data.  This allows N2OPdG to react with another 
nucleophile, including reforming the original ring (Scheme 1.4).27 This result 
highlights the reversible linkage that allows MDA to exist effectively in two unique 







Scheme 1.4. M1dG (1.14) and N2OPdG (1.15) can interconvert under aqueous 
conditions. 
 
Acrolein (1.16) is another thoroughly studied DNA alkylating agent.  Acrolein 
is also a bis-electrophile that is formed endogenously from oxidation of 
polyunsaturated fatty acids and is present exogenously in cigarette smoke and 
automobile exhaust.28 In vitro studies reveal a number of adducts form between 
acrolein and each nucleoside.19,28-30 However, many of these adducts are 
monofunctional and irreversible.  Unlike the monofunctional adducts, the major 
crosslinking adduct, 8-hydroxy-1,N2-propano-2′-deoxyguanosine (8-HO-PdG, 1.18), 
exhibits lability to form the N2-(3-oxopropyl) adduct (1.17) (Scheme 1.5).28,31 This 
allows 8-HO-PdG to reversibly form interchain crosslinks if the complementary 
strand contains the sequence 5′-CpG opposite of the adduct (Scheme 1.5).31 This 
cross-link occurs at 1 – 2% of the levels of the monofunctional adduct (1.17), which 
approaches the limit of detection using current analytical methods such as LC-
MS/MS (~1 adduct per 108 DNA bases, when 50 µg of DNA is assayed).28 Even at 
this low level of formation, these crosslinks may be lethal to bacterial, yeast, and 
repair-deficient mammalian cells.32,33 The reversible nature of the acrolein dG N2 
crosslinks complicates their identification and analysis in vivo.  Therefore, most 





Scheme 1.5. Initial alkylation of dG by acrolein (1.16) followed by the reversible 
interchain cross-link with an opposing dG (1.19 – 1.21).  Adapted from Kozekov et 
al.31 
 
While malondialdehyde and acrolein are endogenous alkylating agents, the 
natural product ecteinascidin 743 (Et 743, 1.22) represents an exogenous alkylating 
agent (Scheme 1.6).  Et 743 is registered under the trade name Yondelis and is 
currently undergoing clinical trials for treatment of a variety of tumors.34,35 Et 743 
selectively binds to the minor groove of duplex DNA and reversibly alkylates the 
same position on dG as acrolein (Scheme 1.7).36,37 Et 743 alkylates DNA with 




hydrogen-bonding patterns.36,37 Further studies have determined that the rate of 
reversal is dependant on the nucleotide on the 3′ side of the covalent attachment due 
to the formation of this hydrogen-bonding network between Et 743 and the 3′ 
nucleotide while the rate of alkylation is independent of the target sequence.37 Once 
free from the DNA, Et 743 is free to alkylate any target sequence.  The result is a 
gradual accumulation of the thermodynamically favorable adduct leading to the 
observed preference for a specific target sequence.    






Scheme 1.7. Proposed mechanism of the reversible alkylation of dG by Et 743 (1.22).  
The scheme shows only the portion of Et 743 highlighted in red from Scheme 1.6.  
Adapted from Zewail-Foote et al.37 
 
 
1.4.  DNA Alkylation by Quinone Methides. 
Another family of reversible DNA alkylating agents is the quinone methides 
(QM).  QMs can exist as para (p-QM, 1.27) or ortho (o-QM, 1.28) isomers.  QMs are 
highly reactive, electrophilic species that serve as Michael acceptors with 
nucleophilic reaction at the exocyclic methylene group (Scheme 1.8).  Restoration of 
aromaticity occurs upon reaction and is the major driving force behind the reactivity 
of QMs.  The reactivity of QMs have been compared to highly stabilized 





Scheme 1.8. Structures of p-QM (1.27) and o-QM (1.28).  The mechanism of 
nucleophilic addition to o-QM and the restoration of aromaticity is shown. 
 
 One exogenous source of QMs is the antitumor drug mitomycin C (Scheme 
1.9).40 Mitomycin C is enzymatically reduced in vivo to form the vinylogous QM 
1.31.  Initial alkylation results in a monoadduct at the dG N2 position in DNA (1.32).  
Upon loss of the carbamate, alkylation occurs at a second dG N2 position to form the 
cytotoxic crosslink 1.35 (Scheme 1.9).40,41  
Scheme 1.9. Proposed mechanism for the alkylation and cross-link formation of 
DNA by mitomycin C (1.30).  Adapted from Tomasz40 and Noll et al.41 
 
The reductive activation of mitomycin C is key to its antitumor properties.  




mitomycin C, many solid tumors are oxygen deprived and readily activate mitomycin 
C.  Under these reductive conditions, mitomycin C selectively alkylates dG in the 
minor groove.  Unlike the reversible alkylating agents discussed earlier, mitomycin C 
is an irreversible alkylating agent.  It has proven to be an effective anticancer drug 
and an excellent example of the alkylating power of QMs.  
A second exogenous source of QMs is the food preservative 2,6-di-tert-butyl-
4-methylphenol (BHT, 1.36).  BHT is oxidized in vivo by cytochrome P450 to initially 
form the p-QM 2,6-di-tert-butyl-4-methylenecyclohexa-2,5-dienone (BHT-QM, 
1.37).  Alternatively, hydroxylation of a tert-butyl group followed by oxidation 
affords the p-QM 6-tert-butyl-2-(2′-hydroxy-1′,1′-dimethylethyl)-4-
methylenecyclohexa-2,5-dienone (BHTOH-QM, 1.39) (Scheme 1.10).42 These two p-
QMs (1.37 and 1.39) can alkylate every DNA base along with a number of other 
intercellular nucleophiles such as glutathione and amino acids in proteins.43,44 






While most of these adducts are irreversible, the dG N7 and dC N3 adducts 
prove to be labile.43 The dG N7 adduct decomposes through the common 
depurination mechanism of N7-alkylguanine residues to form the guanine N7 
adduct.16 Interestingly, the dC N3 adduct reforms the active QM along with 
unmodified dC through a reverse reaction.43 This property would allow BHT-QM to 
alkylate another nucleophile present in solution and contribute to the in vivo toxicity 
observed in rat and mouse models.42,43,45 
The reactivity of most QMs makes them too unstable to store, and QM study 
requires a stable precursor that can be activated when needed.  Mitomycin C and 
BHT are enzymatically activated in vivo to form the transient QM intermediates.  For 
in vitro studies on BHT, the QM was formed through chemical oxidation with 
Ag2O.43 QMs have been also formed from various precursors through oxidation with 
NaIO4,46 photochemistry47-50 and heat.51,52 Another chemical means of activation that 
was discovered by the Marino laboratory53 and further developed by the Rokita 
laboratory54 utilizes fluoride to cleave a silyl group protecting the phenolic oxygen, 
which subsequently expels a leaving group (either bromide or acetate) to form the 
desired o-QM (Scheme 1.11).  The silyl protected o-QM (BrQMP, 1.40) proved also 
to be stable upon storage at 0 °C either pure or dissolved in an aprotic solvent and 




Scheme 1.11. Proposed mechanism for the fluoride activation of BrQMP (1.40) to o-
QM (1.28). 
 
Initial studies with the simplest o-QM model, 1.28, determined that adducts 
were formed with dC,55 dG,56 and dA,57 but not with 2′-deoxythymidine (dT).  
Additional studies between 1.28 and deoxynucleosides revealed selectivity towards 
the stronger nitrogen nucleophiles dC N3, dG N7, and dA N1 (Scheme 1.12, labeled 
in blue).58 These adducts form reversibly through a kinetically controlled process.59 
This reversibility was shown to also lead to a time dependant shift from these 
kinetically controlled products to the irreversible, thermodynamically controlled, 




Scheme 1.12. Structures of the o-QM-dN adducts.  Reversible adducts are labeled in 
blue and irreversible adducts are labeled in red.  Adapted from Weinert.60 
 
The result of these competing processes is an initial high yield of adducts with 
the stronger nucleophiles that gradually shifts to a low yield of adducts with the 
weaker nucleophiles that persist indefinitely.  Additionaly, ubiquitous water acts as an 
irreversible trap of o-QM.58 The repeated capture and release of the o-QM by the 
stronger nucleophiles effectively extends the lifetime of this transient electrophile.61 




QM from cellular repair processes such as base excision repair (BER) and nucleotide 
excision repair (NER) leading to increased effectiveness as a therapeutic agent, as 
seen with the previously discussed Et 743.37  
 
1.5.  Requirements for a QM-DNA Trapping System. 
As discussed above, there are a number of positive effects stemming from the 
reversibility of the kinetic QM-dN adducts, most notably the extension of the 
effective lifetime of o-QM.  Unfortunately, the reversibility of these QM-dN adducts 
is detrimental also to their detection in duplex DNA.  Only the thermodynamic QM-
dN adducts persist through standard enzymatic digestion and chromatographic 
analysis of the alkylated DNA.43,62,63 The time dependent shift from kinetic to 
thermodynamic products effectively obscures the alkylation profile of o-QM towards 
DNA at short (<4 hr) times, giving an incomplete and inaccurate alkylation profile.  
For example, early studies of the model o-QM 1.28 revealed selectivity for the 
weakly nucleophilic positions dA N6 and dG N2 after a 24 hour reaction with duplex 
DNA.62 Later studies determined that the more nucleophilic position of dA at N1 was 
initially alkylated, but the labile adduct is no longer present after the lengthy reaction 
and work-up due to constant regeneration and gradual trapping to form the 
irreversible dA N6 adduct.57 Isotope labeling with 15N further confirmed a dissociative 
mechanism of reversible alkylation and contradicted the possibility of an 
intramolecular rearrangement (Dimroth rearrangement) leading to formation of the 




 Development of a method to suppress o-QM release from its reversible 
adducts is necessary for satisfactory analysis of the intrinsic selectivity and efficiency 
of o-QM alkylation of DNA.  Classical approaches such as an acid or alkaline quench 
prior to enzymatic digestion57,64-66 fail with the o-QM adducts as they would 
destabilize the labile adducts.57 Mass spectrometry (MS) can be an effective way to 
analyze DNA alkylation, but frequently fails to observe labile adducts, especially at 
the dG N7 position.67 A further complication is that multiple o-QM adducts at a 
particular nucleoside have the same mass.  For example, the QM-dA N1 and QM-dA 
N6 adducts appear as two unique compounds by HPLC, but have identical masses by 
MS.  Therefore MS would be unable to provide important information about the 
position of the covalent linkage. 
A chemical trap that converts the reversible o-QM-dN adducts to irreversible 
derivatives would be very useful in their analysis as it would eliminate the previously 
mentioned issues with labile adducts.  Namely, the alkylation profile would not 
change from the beginning of the alkylation work-up through the ultimate HPLC 
analysis.  There are a number of requirements for a successful trapping method.  One 
requirement is that the trap must be effective under physiological conditions 
(aqueous, pH 7, 37 °C) to ensure that the target DNA is still properly annealed as B-
DNA, the dominant form found in cells.  The trap must not interfere with the ultimate 
chromatographic analysis of the digested DNA and it must also react quickly, 
quantitatively, and selectively with the o-QM phenol to accurately quench the labile 
QM-DNA adducts at the desired time point.  By not reacting with the DNA itself, the 




oxidation by-products formed.  An effective chemical trap should focus on the o-QM 
phenol to prevent donation of the oxygen lone pair back into the nucleoside, therefore 
preventing regeneration of the active o-QM (Scheme 1.13). 
Scheme 1.13. Proposed mechanism for the reverse reaction of an o-QM-dN adduct 
(1.42) (dN = dC, 1.43, in this example). 
 
 From the requirements outlined above, a number of chemical traps can be 
considered.  Although silylation and acetylation may occur quickly with the o-QM 
phenol, reaction may also occur at the phosphate oxygens leading to multiple side-
products and possibly incomplete trapping.  Alkylation of the o-QM phenol is also 
possible but suffers from the same shortcomings as silylation and acetylation while 
also possibly forming side-products with other nitrogen nucleophiles found in DNA 
further confusing the origin of each adduct.  Reduction of the o-QM phenol was also 
not pursued due to the reactive nature of common transition metal reducing agents 
towards DNA. 
 
1.6.  Oxidation of the QM Phenol as an Effective Trap. 
Oxidative de-aromatization of the o-QM phenol has the potential to satisfy 




methods of oxidative de-aromatization would be applicable to the o-QM-DNA 
system.  Singlet oxygen is frequently used for oxidative de-aromatization in synthetic 
procedures but would fail in this system due to its oxidation of guanine residues.68,69 
Potassium nitrosodisulfonate (Fremy’s salt) is a reagent that could selectively 
oxidatively de-aromatize the o-QM phenol.60,70 Initial studies with a ten-fold excess 
of Fremy’s salt observed the oxidation of 2-hydroxymethylphenol (QM-H2O, 1.49) to 
2-hydroxymethylbenzoquinone (1.50) by HPLC analysis (Scheme 1.14).60 UV-Vis 
and high-resolution mass spectrometry confirmed the assignment of the new 
compound.  Unfortunately, oxidation with Fremy’s salt proved to be low yielding, 
even with a twenty-fold excess of oxidant.60 The inability to fully convert a 
substituted phenol to the corresponding benzoquinone would only complicate the 
analysis of o-QM-DNA adducts and studies with Fremy’s salt were abandoned. 
Scheme 1.14. Generic oxidative de-aromatization of 2-hydroxymethylphenol (1.49) 
to 2-hydroxymethylbenzoquinone (1.50). 
 
 Hypervalent iodine species, in particular bis[(trifluoroacetoxy)iodo]benzene 
(BTI, 1.52, also known less commonly in the literature as PIFA which stands for 
phenyliodosyl bis(trifluoroacetate)71) selectively and efficiently de-aromatizes 
phenols under aqueous conditions (Scheme 1.15).72-75 BTI satisfies the requirements 
for the chemical trap due to its mild reactivity, selectivity for phenol moieties, fast 




begins with a nucleophilic addition of the phenolic oxygen to the BTI iodine, leading 
to the expulsion of one equivalent of trifluoroacetate (Scheme 1.15).  Next, 
nucleophilic addition of water to the activated phenol occurs expelling iodobenzene 
and another equivalent of trifluoroacetate and forming the intermediate ketone 1.54.  
A base then removes the acidic proton (para to the newly formed ketone) allowing 
rearomatization to occur.  A second equivalent of BTI can then repeat the reaction 
leading to the formation of 1,4-benzoquinone (1.57).72,73 
Scheme 1.15. Proposed mechanism for BTI (1.52) oxidation of phenol (1.51) to 1,4-
benzoquinone (1.57).  Adapted from Tamura et al.72 and Barret et al.73 
 
 The proof of concept experiment that involved the oxidation of 2-
hydroxymethylphenol (1.49) to 2-hydroxymethylbenzoquinone (1.50) by Fremy’s salt 
was repeated (Scheme 1.14).  The oxidation was successful using a four-fold excess 
of BTI.60 The product was formed in near quantitative yield, as determined by HPLC, 




 Selective oxidative de-aromatization of the o-QM phenol by BTI appears to 
be a viable method for trapping the labile o-QM-DNA adducts.  This will allow, for 
the first time, the intrinsic selectivity of o-QM alkylation of DNA to be determined.  
The goal of this dissertation is to synthesize and characterize the oxidation products 
of each individual o-QM-dN adduct and then use these products as analytical 
standards to determine the o-QM alkylation profile of DNA at short time points.  
Using the information obtained from these studies regarding the type, location, and 
amount of o-QM adducts that are formed with DNA, a relationship between the 













Oxidative de-aromatization of the phenolic products formed between an 
ortho-quinone methide (o-QM) and DNA has the potential to quench the reversible 
alkylation and allow the QM-DNA adducts to survive enzymatic digestion and 
subsequent HPLC analysis.  As discussed in Chapter 1, oxidative de-aromatization 
with bis[(trifluoroacetoxy)iodo]benzene (BTI) meets the criteria outlined for 
successful trapping of the adducts (Scheme 1.15).  Specifically, BTI reacts quickly, 
quantitatively, and selectively with the QM phenol under physiological conditions. 
 2′-Deoxycytidine (dC) was chosen to test whether oxidation of an o-QM-
deoxynucleoside (o-QM-dN) adduct forms a stable and identifiable compound with 
the ability to remain stable during DNA digestion conditions.  Alkylation of dC by 
QM was previously shown to form a single adduct, QM-dC N3 (1.42).55 Since dG56 
and dA57 form multiple adducts with QM and dT does not react with QM,58 dC would 
result in the least convoluted product profile and would be the simplest dN to test 




Scheme 2.1. Formation of o-QM (1.28) and subsequent alkylation of dC (1.48) 
resulting in QM-dC N3 (1.42). 
 
The previously studied QM (1.28) was chosen as the first model o-QM since it 
is the simplest o-QM and its dC adduct shows only modest reversibility under 
aqueous conditions.58 The dC adduct is also one of the highest yielding o-QM-dN 
adducts formed by the reaction with QM 1.28.  
Initial studies were successful in isolating, but not characterizing, the product 
of oxidation of QM-dC N3.60 Synthesis of QM-dC N3 in a solution of 70:30 
DMF:H2O at pH 7 was successful.55 QM-dC N3 was then oxidized in situ by a four-
fold excess of BTI in CH3CN.  HPLC purification resulted in the isolation of a major 
product.  NMR spectra (1H and 13C) of the product were inconsistent with the 
expected compound 2.1 (Scheme 2.2).  While it was determined by 1H and 13C NMR 
that the dC ribose and pyrimidine fragments were intact, the presumed benzoquinone 
protons were shifted downfield (8 - 9.5 ppm) without the anticipated 1H-1H coupling.  
The benzylic carbon and protons were also absent from the 1H and 13C spectra.  The 
most significant evidence for formation of a compound other than 2.1 was the 
observation of only 14 of the expected 16 carbons in the 13C spectra.  While 




spectrum hindered the complete structural characterization of the unknown product.  
The goal of this chapter was to reproduce the synthesis of the unknown QM-dC N3 
oxidation product and elucidate the structure.  A second goal was the synthesis of a 
novel quinone methide precursor that would have the same alkylation selectivity as 
1.40 but would be oxidized by BTI to produce an expected product.  Most of the 
following research has been published as McCrane et al.76  
Scheme 2.2. Oxidation of QM-dC N3 (1.42) and the expected product 2.1. 
 
 
2.2. Results and Discussion. 
2.2.1. Oxidation of QM-dC N3. 
 The first step in preparing enough of the oxidized QM-dC N3 adduct for 
structure elucidation involved repeating the previously used method.60 The QM 
precursor, o-(tert-butyldimethylsilyl)-2-(bromomethyl)phenol (BrQMP, 1.40), used 
with this method was synthesized according to a literature procedure, and the QM-dC 
N3 adduct was then generated in situ following literature procedure.55,58 After the 20 
minute alkylation, the QM-dC N3 adduct was oxidized in situ by a four-fold excess of 




products the reaction was fractionated by reverse phase HPLC.  The major product 
matched the retention time and λmax (219 nm, 271 nm, 335 nm) of the previously 
unidentified compound.  The compound was collected and lyophilized to dryness to 
yield a white solid that rapidly turned brown.  The isolated compound remained stable 
(90%) over 6 days in aqueous acetonitrile.  Initial characterization by 1H and 13C 
NMR matched the previously unidentified compound, proving that the formation of 
this oxidized product of QM-dC N3 is reproducible.   
 Multiple HPLC runs were needed to obtain the mg quantities of oxidized QM-
dC N3 adduct necessary for further analysis by NMR.  Signals (1H and 13C) based on 
literature values77 for both the pyrimidine and ribose groups were observed, and their 
assignments were confirmed by 1H-13C HSQC and 1H-13C HMBC analysis 
(Appendix A.5 – A.8).  The unsaturated nature of the o-QM remnant was apparent 
from the remaining 13C signals that all ranged between 116.6 ppm and 187.6 ppm 
(Figure 2.1).  The large 2-bond coupling (2JCH = 43 Hz) observed for the cross peak 
between C11 (124.4 ppm) and H12 (9.44 ppm) in the 1H-13C HMBC spectrum is 





Figure 2.1. 1H-13C HMBC of 2.2 in DMSO-d6 at 600 MHz. 
 
Connectivities between C7 through C12 were established by a combination of 
1H-13C HSQC, 1H-13C HMBC, and 1H-15N HMBC analysis (Appendix A.7 – A.9).  
Specifically, it was determined that C7, C10, and C12 were bonded to hydrogen from 
the 1H-13C HSQC.  The quaternary carbons C8 and C11 were placed in between the 
carbons C7, C10, and C12 based on 1H-13C HMBC correlations and to account for the 
lack of 1H-1H coupling.  The attachment of C10 to C8 and not C7 was accomplished 
with data from 1H-13C HSQC and 1H-15N HMBC experiments, which show that N9 
has a correlation to H10 and N3 does not.  The remaining order of carbon atoms was 
determined with 1H-13C HSQC and 1H-13C HMBC experiments.  The only 
unaccounted linkage was the atom attached to C11.  A proton or carbon was ruled out 
due to each atom in the 1H and 13C spectra having been assigned.  It was unlikely that 
the unknown functional group was -OH (from H2O), -NH2 (from dC), or -I (from 
BTI) due to the chemical shift of C11 (124.4 ppm).  Computational estimates 




groups would be 163 ppm, 157 ppm, and 96 ppm respectively.  A bromine (from 
BrQMP) attached to C11 corresponds well to the experimentally determined chemical 
shift of C11 (computational = 126 ppm vs. experimental = 124.4 ppm).   
 Initial analysis of the product by electrospray ionization mass spectrometry 
(ESI+-MS) at the University of Maryland Department of Chemistry and Biochemistry 
Mass Spectrometry Facility was unable to produce a consistent mass.  Through 
collaboration with the FDA, mass spectrometry on the product was finally 
accomplished with the help of their much more sensitive equipment.  This added 
sensitivity allowed for the NMR sample (in DMSO-d6) to be diluted by 1000-fold in a 
solution of 25% CH3CN and 75% H2O with 0.1% acetic acid prior to infusion.  The 
resolution of the FDA equipment was also improved as the parent mass signal had a 
mass accuracy of 13 ppm compared to >20 ppm at the department facility.  Loss of 
the two carbons was confirmed by ESI+-MS, and the parent ion (m/z 384 .0141 
(M+H)+) revealed the presence of one bromine by its distinct isotope ratio (Appendix 
A.10).  MS/MS experiments generated the characteristic deglycosylation (m/z 
267.9716 (M – drb + H)+) and debromination (m/z 304.9544 (M – Br)+) products to 
support the structural assignment based on extensive NMR data (Appendix A.11 – 
A.12). 
 The entire conjugated system of the QM-dC N3 oxidized adduct is illustrated 
in a favorable thermodynamic configuration for simplicity and has not been 
confirmed experimentally (Figure 2.1).  While over-oxidation is proposed to be a 
driving force in the formation of the unexpected product, a mechanism by which this 




still under consideration.  Therefore, its use for quantifying QM alkylation adds an 
unneeded complication.  Without knowing the mechanism for the oxidation of the 
QM phenol, it would be impossible to know which variables in the QM alkylation of 
DNA would affect the product formation.  For example, if the bromine in the product 
comes from a reincorporation of the bromine from the precursor then product 
formation is most likely concentration dependant on the precursor and may not be 
successful at the lower concentrations used with DNA.  
 
2.2.2. Synthesis of a Novel o-Quinone Methide Precursor to Block Over-
Oxidation. 
The possible over-oxidation and rearrangement that plagued the QM precursor 
1.40 was addressed through the application of a novel QM precursor that generated 
products containing an alkyl group para to the phenolic oxygen.72-74 An alkyl group 
at the para position should block deprotonation that leads to re-aromatization of the 
QM phenol (Scheme 1.15).  The oxidation would terminate at a para-quinol instead 
of allowing a second equivalent of BTI to associate with the re-aromatized QM 
phenol and eventually lead to the formation of a 1,4-benzoquinone. 
The simplest alkyl containing precursor 2-bromomethyl-4-methyl-O-(tert-
butyldimethylsilyl)phenol (2.6) was prepared from 5-methylsalicylaldehyde in three 
steps (Scheme 2.3).  5-Methylsalicylaldehyde (2.3) was protected with 
tertbutyldimethylsilyl (TBDMS) to form 2-(tert-butyldimethylsilyl)oxy-5-
methylbenzaldehyde (2.4).  The aldehyde was subsequently reduced to a primary 




butyldimethylsilyl)phenol (2.5).  Finally, the primary alcohol was used directly and 
substituted with bromine using PBr3 to form the desired QM precursor 2-
bromomethyl-4-methyl-O-(tert-butyldimethylsilyl)phenol (4-MeBrQMP, 2.6).79 
Bromination with PBr3 was superior to the previous method of CBr4/PPh3 
bromination by providing a simpler work-up and purification by forming fewer by-
products such as bromoform.  Furthermore, the new method resulted in a ten-fold 
faster reaction (1.5 hr vs. 19 hr).  
Scheme 2.3. Synthesis of 4-MeBrQMP (2.6). 
 
 Deprotection of 2.6 with fluoride results in the formation of 4-methyl-6-
methylene-cyclohexa-2,4-dienone (MeQM, 2.7).  The presence of the methyl 
substituent was not expected to alter the alkylation preference of the QM.  A related 
set of substituents had not significantly altered the alkylation profile of QMs towards 
dNs.60,80 The electron-donating properties of the methyl group stabilize the electron 
deficient MeQM intermediate resulting in faster generation and increased lability of 
the resulting adducts formed by MeQM vs. those of QM.60,80 By blocking re-
aromatization during the oxidation of phenol by BTI, the methyl-substituted model 
was expected to block the over-oxidation observed with the unsubstituted QM (1.49 
to 1.50, Scheme 1.15).72-74 However, the new MeQM posed a greater challenge for 




2.2.3.  Alkylation of dC with MeQM. 
Prior to the start of the oxidation studies, the alkylation profile of the novel 
precursor (2.6) was determined to confirm that it is the same as the unsubstituted QM 
(1.28) and can therefore be used as a model o-QM.  Alkylation of dC by MeQM 
results in the formation of a single adduct, MeQM-dC N3 (2.8).  The MeQM-dC N3 
adduct was prepared in situ by deprotection of 4-MeBrQMP (2.6) with aqueous KF in 
the presence of dC, under similar conditions as previously discussed for the formation 
of QM-dC (1.42) (Scheme 2.4).  The major product was purified by reverse phase 
HPLC and its structure confirmed to be 2.8 by 1H NMR, 13C NMR, and UV-Vis data 
(Appendix A.13 – A.14).  MeQM attachment at dC N3 was also confirmed by 
comparison with literature values of 1.42.55 Evidence that MeQM alkylates dC at the 
N3 position comes from the similar chemical shifts of the benzylic protons, that vary 
by less than 0.1 ppm, (4.96 ppm for 1.42,55 4.89 ppm for 2.8).  Similarly the λmax 
values vary by only 1 nm (278 nm for 1.42,55 279 nm for 2.8).  The absorbance data is 





Scheme 2.4. Formation of MeQM (2.7) and subsequent alkylation of dC (1.48) 
resulting in MeQM-dC N3 (2.8). 
 
2.2.4.  Initial Attempts at MeQM-dC N3 Oxidation. 
 
Preliminary attempts to isolate and characterize the MeQM-dC N3 oxidized 
adduct were unsuccessful.  The initial oxidation of MeQM-dC N3 used the same 
reaction conditions as the formation of QM-dC N3 oxidized adduct (2.2) (Scheme 
2.5).  However, HPLC analysis failed to reveal a major product, but mostly 
unresolved, low intensity peaks.  The next attempt utilized a longer oxidation (1 hr vs. 
20 min) to confirm that the failed HPLC analysis wasn’t the result of incomplete 
oxidation.  An alternative work-up replaced the NaHCO3 addition with an equal 
volume of H2O to limit the number of reactive species present.  The HPLC method 
was also changed from using H2O to 10 mM triethylammonium acetate (TEAA) 
buffer at pH 4 as the aqueous phase.  An acidic aqueous phase has been shown to be 
effective in the fractionation of other substituted QM-dN adducts.80 These conditions 
resulted in the detection of a new product by HPLC (tr = 46 min) with a unique UV-
Vis absorbance (λmax = 238 nm, 289 nm, 348 nm) (Appendix A.2).  Upon 




mass (m/z 364.15 (M + H)+) or any relevant fragment.  These results suggest that the 
isolated compound decomposes or transforms to a different compound after HPLC 
purification. 
Scheme 2.5. Oxidation of MeQM-dC N3 (2.8) with BTI and the expected product 
2.9. 
 
 The eluting buffer was altered in both the pH and concentration of the TEAA 
buffer to determine if it contributed to the decomposition of the isolated compound.  
The pH of the collected solution was also adjusted to values between 5.9 and 9.1 prior 
to lyophilization.  Decomposition was observed by HPLC and 1H NMR in the form of 
multiple compounds being eluted and a very congested NMR spectra (Table 2.1).  
While decomposition became less significant as the pH was adjusted from acidic 
towards neutral, it was never halted.  Analysis by 1H and 13C NMR revealed the 
consistent presence of TEAA, which may contribute to the decomposition of the 










Table 2.1. The effect of pH on the stability of the major product of MeQM-dC N3 
oxidation during purification. 
Step When pH is 







Purification 10 mM TEAA, pH 4 4.0 
None (reinjected 





Purification 10 mM TEAA, pH 4 4.0 lyophilization Decomposition 
Prior to HPLC 
Purification 100 mM TEAA, pH 4 4.0 lyophilization Decomposition 
After HPLC 
Purification HPLC grade TEA 5.9 - 9.1 lyophilization Decomposition
2 
During HPLC 
Purification 5 mM TEAA, pH 5 5.6 lyophilization Decomposition 
During and After 
HPLC Purification 
5 mM TEAA, pH 5 
then HPLC Grade 
TEA 
6.2 lyophilization Decomposition 
After HPLC 




1Decomposition checked by HPLC.  2Decomposition also analyzed by 1H and 13C 
NMR. 
 
 A small (360 mg silica) reverse phase column potentially allows for the HPLC 
solvent to be exchanged for a less reactive, TEAA-free solvent.  The column used 
was a Waters Sep-Pak® Plus C18 cartridge.  The Sep-Pak could be used to exchange 
the TEAA buffer for a less reactive, non-nucleophilic solvent by loading the isolated 
compound onto the column and eluting with the solvent of choice.  Four different 
procedures were attempted (Table 2.2).  MeQM (2.7) was reacted with dC and then 
subsequently oxidized with BTI to form the desired compound.  The crude reaction 
was then purified by reverse phase HPLC allowing for collection of the desired 
compound in 20 mL of a solution of 85% 10 mM TEAA (pH 4) and 15% CH3CN.  A 




the Sep-Pak showed the least decomposition when analyzed by HPLC.  To acquire 
enough compound for NMR analysis, this procedure was repeated four times and the 
isolated solid was combined in DMSO-d6.  Unfortunately, greater decomposition (in 
the form of a complex spectra) was observed by 1H NMR than the preliminary results 
suggested (Appendix A.4).  The Sep-Pak studies were thus abandoned for a new 
approach to successfully isolate the MeQM-dC N3 oxidation product. 
Table 2.2. Parameters for the Sep-Pak assisted solvent exchange of the major product 
of MeQM-dC N3 oxidation.   
Sample                
pre-treatment 
Column               







Lyophilization         
(1 hr) 
nanopure H2O           
(5 mL) 
Nanopure H2O      
(3 × 1 mL) 
CH3CN 
(2 × 5 mL) 
Streaming N2 
(5.5 hr) Decomp. 
Dilution with    
10 mL H2O 
nanopure H2O         
(5 mL) 
Nanopure H2O       
(3 × 1 mL) 
CH3CN 
(2 × 5 mL) 
Streaming N2 
(5.5 hr) Decomp. 
Dilution with       
5 mL H2O 
0.1 % TEA in H2O 
(3 mL) 
0.1 % TEA in 





Dilution with       
5 mL H2O 
nanopure H2O          
(5 mL) 
Nanopure H2O        
(3 × 2 mL) 
65:35, 1 mM 
phosphate 
buffer pH 7: 
CH3CN 





1Decomposition checked by HPLC.  2Decomposition also analyzed by 1H NMR.  
Less decomposition refers to fewer non-product peaks observed by HPLC. 
 
 
As it became obvious that the major product of MeQM-dC N3 oxidation was 
too unstable to be isolated, a new direction was needed to characterize the MeQM 
alkylation and subsequent oxidative trapping of the cytosine base.  A simple approach 
would be to remove the ribose ring of deoxycytidine and replace it with a methyl 
group to form 1-methylcytosine (1-MeC, 2.12a) (Scheme 2.6).  This substitution 
would simplify the aliphatic region of the 1H NMR spectra and should increase the 
solubility of the subsequent MeQM adduct in organic solvents.  The increase in 




and possibly make purification and isolation of the MeQM-dC N3 oxidized adduct 
simpler by avoiding reverse phase HPLC. 
Scheme 2.6. Synthesis of 1-methylcytosine (2.12a) and 1-propylcytosine (2.12b).  
Adapted from Hosmane et al.82 and Helfer et al.83 Yields are for 1-methylcytosine.  
 
 
The synthesis of 1-MeC and 1-propylcytosine (1-PrC) were undertaken 
simultaneously, following literature procedures (Scheme 2.6).82,83 The synthesis of 1-
PrC was attempted to further increase the solubility of the MeQM adduct in organic 
solvents.  As the synthesis of 1-MeC was completed first, it became the focus of the 
dC substitution studies.   
Once the synthesis of 1-MeC was completed, alkylation with MeQM was 
confirmed (Scheme 2.7).  Phosphate buffer (pH 7), 4-MeBrQMP, 1-MeC, and KF 
were combined, at the same ratios as for the formation of MeQM-dC N3, and held at 
37 °C for 30 minutes.  The reaction mixture was filtered (0.2 µm) and fractionated 
using reverse phase HPLC with a semi-prep column (5 mL/min).  The major product 
(tr = 35 min) exhibited a λmax at 223 nm and 279 nm, equivalent to the MeQM-dC N3 
adduct.  This is consistent with formation of the MeQM-MeC N3 adduct as the 




further confirmed by ESI+-MS (observed m/z 246.10 (M + H)+ vs. calculated m/z 
246.12 (M + H)+).  The only other significant product formed was identified (by tr 
and UV-Vis) as the MeQM-H2O adduct. 
Scheme 2.7. Formation of MeQM (2.7) and subsequent alkylation of 1-MeC (2.12a) 
resulting in MeQM-MeC N3 (2.13). 
 
Prior to attempting the oxidative trapping, the ability to extract MeQM-MeC 
N3 from the eluting solvent (85% 10 mM TEAA pH 4, 15% CH3CN) into an organic 
solvent was studied.  In small-scale (1 mL) experiments monitored with UV-Vis, 
extraction with Et2O was completely unsuccessful, while CH2Cl2 proved successful.  
MeQM-MeC N3 was again formed and purified by HPLC.  The collected sample was 
extracted with CH2Cl2 (3 × 20 mL), dried over MgSO4, and the solvent removed 
under reduced pressure.  The resulting material was dissolved in 200 µL CH3CN: 
H2O (1:1) prior to analysis by HPLC.  MeQM-MeC N3 was observed as the major 
peak (by tr and UV-Vis) and proved to be stable enough to undergo the extraction 
procedure, adding to the confidence that the oxidized adduct will also survive the 
extraction procedure. 
After the successful alkylation of 1-MeC by MeQM, the next step was to trap 




experiments used the same procedure as that used for MeQM-dC N3 oxidized adduct.  
The starting adduct (MeQM-MeC N3) was fully consumed, but no major product was 
observed by HPLC, or any product matching the UV-Vis absorbance signature as the 
previously discussed unstable oxidation product of MeQM-dC N3.  
Scheme 2.8. Oxidation of MeQM-MeC N3 (2.13) with BTI and the expected product 
2.14. 
 
To test if the oxidized adduct was formed, but not observed due to inherent 
stability issues or compatibility issues with the HPLC eluting buffer or the silica 
itself, the above oxidation was repeated and analyzed by ESI+-MS prior to the work-
up.  The mass corresponding to the proposed MeQM-MeC N3 oxidized adduct (2.14) 
was detected (m/z 262.09 (M + H+)) in the crude reaction along with 1-MeC (m/z 
126.04 (M + H)+).  The remainder of the crude reaction was analyzed by HPLC, but 
no major product was observed with a UV-Vis absorbance at 348 nm corresponding 
to both the MeQM-MeC N3 oxidized adduct and the previously discussed MeQM-dC 
N3 oxidized adduct. 
The MeQM-MeC N3 adduct was purified by HPLC and extracted with 
CH2Cl2 in an effort to separate the alkylation and oxidation reactions.  This 
successfully removed the excess 1-MeC and KF, along with the by-products 
TBDMS-F and Br-, and eliminated these species as potential reactants within the 




absorbance.  The presence of MeQM-H2O was due to the release of MeQM from the 
MeQM-MeC N3 adduct and not from the initial formation of MeQM-H2O.  Once the 
CH2Cl2 was removed, MeQM-MeC N3 was redissolved with a mixture of solvents 
ideal for BTI oxidation (300 µL CH3CN, 100 µL H2O).  An equal volume of BTI 
(200 mM in CH3CN) was added to the solution and kept at room temperature for 1 
hour.  The solution was filtered (0.2 µm) prior to HPLC analysis.  Once again, the 
starting material was completely consumed, but there was no compound matching the 
UV-Vis absorbance signature (λmax = 238 nm, 289 nm, 348 nm) of the previously 
discussed MeQM-dC N3 oxidized adduct.  Substituting phosphate buffer (pH 7) for 
the water in the oxidation did not change the HPLC profile of the reaction. 
While these results were discouraging, the procedures still relied on HPLC as 
the final purification step of the oxidized adduct.  If the MeQM-MeC N3 oxidized 
adduct did decompose on reverse phase silica, HPLC would need to be avoided as 
any purification after the introduction of BTI to the reaction.  Extraction of the 
MeQM-MeC N3 oxidized adduct with CH2Cl2 would leverage the increased 
solubility of the 1-MeC in organic solvents.  The MeQM-MeC N3 oxidized adduct 
was formed as described above, but after a 1 hr oxidation using the same conditions 
the reaction was washed with saturated diethyl ether.  This wash should remove 
oxidation by-products such as iodobenzene while hopefully leaving the MeQM-MeC 
N3 oxidized adduct in the aqueous phase, as MeQM-MeC N3 was previously shown 
to prefer aqueous conditions to diethyl ether.  The aqueous layer was extracted with 
CH2Cl2 (3 × 1 mL), dried over MgSO4, and the solvent removed under reduced 




NMR revealed a complex spectra that was either the result of a mixture of compounds 
or product decomposition.  Incidentally, a new mass (m/z 244.15 (M + H+)) was 
observed here, but not in the crude reaction.  At the time it was not identified, but 
later was proposed to be a spiro product analogous to the eventual MeQM-dC N3 
oxidized adduct (2.15).  While the MeQM-MeC N3 oxidized adduct seemed unstable 
to the HPLC conditions, it would not be pure enough to be characterized by NMR 
without a final purification procedure.  Additionaly, the lengthy oxidation (1 hr) may 
also have aided in driving the reaction from a stable MeQM adduct towards an 
unstable oxidized MeQM adduct. 
 
2.2.5.  Oxidation of MeQM-dC N3. 
 With the 1-MeC studies at an apparent standstill, focus shifted back to the dC 
studies.  As described above, purification conditions of the MeQM-dC N3 oxidation 
were thought to be possibly to blame for the failure to isolate the major product.  
Therefore, with the focus shifted back to oxidation of MeQM-dC N3, the HPLC 
elution buffer was changed to find a new buffer that the MeQM-dC N3 oxidized 
adduct was stable in.  Triethylamine based buffers were avoided due to their 
persistence during lyophilization and the possibility that triethylamine acetate may be 
involved in the decomposition of the MeQM-dC N3 oxidized adduct.  Ammonium 
formate, at pH 6.9, is a common volatile buffer for fractionating nucleoside adducts 
and is less nucleophilic than triethylamine acetate.  It was chosen as the first elution 
buffer to be tested, at 10 mM to match the previous concentration of TEAA.  




phenol in the presence of dC.  The model oxidation consisted of dC (25 mM), phenol 
(25 mM), and lastly BTI (100 mM) combined in a solution of 5:3 CH3CN:H2O.  
Upon addition of BTI, the clear solution instantly turned purple-brown and gradually 
changed to yellow-brown over 5 minutes.  After a 30 minute incubation at room 
temperature, the reaction was analyzed, without work-up, by HPLC using CH3CN as 
the organic phase and 10 mM ammonium formate pH 6.9 as the aqueous phase with a 
semi-prep column (5 mL/min).  The dC was unaffected by the oxidation while the 
phenol was completely consumed and the BTI oxidation by-product iodobenzene was 
present.  The oxidation of phenol in the presence of dC was repeated with the reaction 
time decreased from 30 minutes to 1 minute.  Even with an oxidation of 1 minute, the 
phenol was completely consumed. 
 The new reaction and purification conditions, consisting of ammonium 
formate (10 mM, pH 6.9) as the eluting buffer and a reduced BTI oxidation time of 20 
minutes from 1 hour, were successfully applied to the isolation of the MeQM-dC N3 
oxidized adduct.  Fractionation by reverse phase HPLC revealed the previously 
observed unstable compound at tr = 38 minutes (λmax = 239, 284, 348 nm) along with 
an increased yield for the compound (2.15) at tr = 27 minutes (λmax = 235, 283, 340 
nm).  Preliminary analysis with 1H NMR revealed that the compound eluting at 27 
minutes is stable upon isolation and is likely the elusive oxidized MeQM-dC N3 
adduct (Scheme 2.9).  Furthermore, the isolated compound is stable (>85%, 24 hrs) in 
an aqueous solution (9 mM ammonium formate pH 6.8, 12% CH3CN) at 




Scheme 2.9. Oxidative trapping of MeQM-dC N3 (2.8) with BTI.  Oxidation product 
2.15 was isolated and characterized while 2.9 was not observed. 
 
 Preliminary characterization by 1H NMR confirmed that over-oxidation, as 
seen in 2.2, was effectively blocked by the para methyl group.  Initial evidence 
consisted of coupling between adjacent vinyl protons of 2.15 and no observable 1H 
signals downfield of 8 ppm (Figure 2.2).  ESI+-MS further confirmed that oxidation 
of MeQM-dC N3 did not result in the loss of two carbon atoms or the incorporation 
of a bromine atom.  ESI+-MS also gave the first indication, from a (M + H)+ of m/z 
346.18, that the oxidized product 2.15 (calculated m/z 346.14 (M + H)+) had formed 





Figure 2.2. 1H NMR of 2.15 in DMSO-d6 at 400 MHz.  All signals observed 
downfield of 5 ppm are shown. 
 Signals (1H and 13C) for both the pyrimidine and ribose groups were once 
again observed based on literature values,77 and their assignments were confirmed by 
1H-13C HSQC and 1H-13C HMBC analysis (Appendix A.18 and A.19).  Data from 
these 2D spectra were also used to establish the connectivities of the oxidized 
MeQM-dC N3 adduct (2.15).  A key atom in the structure elucidation of the oxidized 
MeQM-dC N3 adduct is carbon 8 (C8).  C8 was identified by its correlations to the 
protons attached to C7.  The 13C chemical shift of C8 (73.1 ppm) was most consistent 
with the sp3 hybridization of the proposed spiro carbon of compound 2.15 (Scheme 
2.9).  The observed chemical shift is quite different from that predicted for the 
corresponding sp2 carbon (C8) in 2.9 (ca. 133 ppm).68 The comparison was with the 
compound 4-hydroxy-2,4-dimethyl-2,5-cyclohexadien-1-one (2.16).  This compound 
was chosen as a para-quinol model compound, as this was the expected 




Scheme 2.10. Two possible products from the BTI oxidation of MeQM-dC N3 (2.9 
and 2.15).  A model compound used for comparison with the para-quinol moiety is 
also shown (2.16).68 
 
 Another key correlation was observed between the para-methyl protons (H14) 
and the adjacent vinyl proton (H13) by 1H-1H COSY NMR (Appendix A.17), as 
expected for 2.15 due to the conjugation between these protons.  This correlation 
would not be present for 2.9 or observed in 2.16 due to the lack of this conjugation.68 
The final key correlations center on C7 and the two attached protons (H7A and H7B).  
Restricted rotation of C7 is apparent from the diastereotopic relationship of the 
attached protons and their proximity to the carbonyl oxygen of C9 that alternatively 
extends in front or behind C8 (Figure 2.3).  A pair of doublets in the 1H NMR is 
created from this configuration.  The spectrum is further complicated by the 
diastereomeric mixture of 2.15 (2.15a and 2.15b) formed by the oxidation of MeQM-





Figure 2.3. 1H-13C HMBC of 2.15 in DMSO-d6 at 400 MHz. 
 The oxidized MeQM-dC N3 adduct 2.15 is proposed to be formed through an 
intramolecular attack of the exo-imine to a position ortho to the phenolic oxygen in 
competition with an intermolecular attack of water to a position para to the phenolic 
oxygen.  While many literature examples show only intermolecular attack of water,72-
74,84 examples show when a nitrogen or oxygen nucleophile is present at an ideal 
position which would form a 5 or 6 member ring it will outcompete water due, in 





2.3.  Summary. 
Oxidative de-aromatization by BTI of the labile adduct formed between 
MeQM and dC results in the formation of a stable and identifiable compound.  The 
oxidative trapping by BTI meets the criteria outlined for application to MeQM-DNA 
adducts.  Specifically, BTI reacts quickly, quantitatively, and selectively with the QM 
phenol under physiological conditions.  The oxidative trap based on BTI will, for the 
first time, allow for the determination of the intrinsic selectivity and efficiency of o-
QM alkylation of DNA. 
Initial studies with QM-dC N3 highlight the necessity of an alkyl substituent 
para to the phenolic oxygen to block over-oxidation and subsequent rearrangement 
and reincorporation of bromine to the final product.  The novel precursor 4-
MeBrQMP (2.6) will therefore be applied to oxidative trapping studies with dG and 
dA.  The oxidized products of MeQM-dG and MeQM-dA will be characterized in a 
similar manner as the MeQM-dC N3 oxidized adduct.  This will allow for their use as 
analytical standards in the HPLC analysis of MeQM alkylation of DNA.    
 
2.4.  Materials and Methods. 
Starting materials, reagents, and solvents were obtained commercially and 
used without further purification.  [Bis(trifluoroacetoxy)iodo]benzene (BTI) was 
purchased from Acros and CH3CN (HPLC grade) was purchased from Fisher 
Scientific.  Water was purified to a resistivity of 18.2 MΩ-cm.  The silyl-protected 




experiments were performed on Bruker 400, 500, and 600 MHz spectrometers using 
deuterated solvents.  The residual non-deuterated solvent peaks were used as internal 
standards.  Chemical shifts (δ) and coupling constants (J) are reported in parts per 
million (ppm) and Hertz (Hz), respectively.  HPLC analysis employed a reverse-
phase, Alltech C18 Econosphere semi-preparative column (10 mm × 250 mm) for 
isolation of the nucleoside products and Varian C18 Microsorb column (4.6 mm × 
250 mm) for analytical studies.  Mass spectrometry analysis was performed at UMD 
on a JEOL AccuToF-CS ESI-MS in ESI+ ionization mode.  Mass spectrometry 
analysis was also performed at FDA on a Waters Corporation Q-TOF Premier 
(Quadrupole-TOF-MS) in ESI+ ionization mode and a Thermo-Electron Corporation 
“Exactive” FT-ICR-MS in ESI+ ionization mode. 
 
Formation and oxidation of the dC N3 adduct (1.42) generated by the ortho 
quinone methide (1.28).  Alkylation was initiated by addition of aqueous KF (32 µL, 
3.13 M) to a mixture of dC in DMF (70 µL, 143 mM), the QM precursor 1.40 in 
DMF (70 µL, 143 mM), and potassium phosphate (28 µL, 50 mM, pH 7). The 
reaction was stirred at 37 °C for 20 minutes to form the dC N3 adduct (1.42) in situ 
before subsequent oxidation by addition of an equal volume of BTI in CH3CN (0.10 
M, 4 equivalents compared to 1.40).  The resulting mixture was stirred at room 
temperature for 20 min and then raised from pH 5 to pH 7 by addition of saturated 
NaHCO3 and washed with diethyl ether to remove iodobenzene.  The aqueous phase 
was filtered through a 0.2 µm syringe filter and fractionated by preparative reverse-




aqueous CH3CN over a subsequent 30 minutes, 5 mL/min).  The oxidized dC adduct 
2.2 was collected (tr = 30 minutes) and lyophilized to yield a brown solid.  A reliable 
yield could not be measured due to the small amounts of product isolated from each 
HPLC separation.  1H NMR (600 MHz, DMSO-d6): δ 2.23 (m, 2H), 3.62 (m, 2H), 
3.87 (m, 1H), 4.30 (m, 1H), 5.15 (br, 1H), 5.34 (br, 1H), 6.39 (t, J=6.6 Hz, 1H), 6.78 
(d, J=8.0 Hz, 1H), 7.85 (d, J=8.0 Hz, 1H), 8.39 (s, 1H), 8.63 (s, 1H), 9.44 (s, 1H).  
13C NMR (600 MHz, DMSO-d6): δ 40.2, 61.1, 70.2, 85.6, 87.9, 98.1, 116.6, 124.4, 
129.9, 138.7, 143.2, 145.4, 145.2, 187.6.  15N NMR (600 MHz, DMSO-d6): δ 149.1, 
193.9, 253.9.  ESI+-MS: m/z 384.0141 (M + H+).  Calcd for C14H15BrN3O5 (M + H+): 
384.0195.  λmax = 219, 271, 335 nm (diode array detector, 20% aq. CH3CN). 
 
2-(tert-Butyldimethylsilyl)oxy-5-methylbenzaldehyde (2.4). 5-
Methylsalicylaldehyde (1.93 g, 14.2 mmol) was dissolved in 50 mL anhydrous DMF.  
tert-Butyldimethylsilyl chloride (TBDMS-Cl, 6.63 g, 44.0 mmol) and imidazole (6.63 
g, 97.4 mmol) were added sequentially to the reaction solution while stirring under N2 
at room temperature.  Stirring was continued at room temperature for 26 hours and 
then the reaction was quenched by addition of water (150 mL).  The mixture was 
extracted with CH2Cl2 (4 × 150 mL).  The organic fractions were combined, washed 
with brine (6 × 100 mL), dried over MgSO4 and evaporated under reduced pressure to 
a yellow oil.  Purification of the desired material by silica gel column 
chromatography (hexanes/diethyl ether, 80:20) yielded a very pale yellow oil (2.88 g, 
81 % yield).  1H NMR (500 MHz, d4-methanol) δ 10.36 (s, 1H), 7.53 (d, J=2.0 Hz, 




0.26 (s, 6H).  13C NMR (500 MHz, d4-methanol) δ 191.3, 158.3, 138.1, 132.5, 129.2, 
128.2, 121.7, 26.4, 20.6, 19.4, -4.1.  ESI+-MS: m/z 251.19 (M + H)+.  Calcd for 
C14H23O2Si (M + H)+: 251.15. 
 
2-Hydroxylmethyl-4-methyl-O-(tert-butyldimethylsilyl)phenol (2.5).  Borane/THF 
(1 M, 15 mmol) was slowly added over 5 min to a solution of 2-(tert-
butyldimethylsilyl)oxy-5-methylbenzaldehyde (2.47 g, 9.86 mmol) in 50 mL 
anhydrous THF while stirring under N2 at 0 °C.  The reaction was stirred for an 
additional 2.5 hr at 0 °C under N2 and then quenched slowly by addition of 150 mL 
water.  The resulting mixture was extracted with CH2Cl2 (4 × 150 mL).  The organic 
fractions were combined, washed with water (4 × 100 mL), brine (6 × 100 mL), dried 
over MgSO4 and evaporated under reduced pressure to a very pale yellow oil.  The 
crude product was used directly without purification for the next synthetic procedure.  
 
2-Bromomethyl-4-methyl-O-(tert-butyldimethylsilyl)phenol (2.6).79 A solution of 
PBr3 (0.99 mL, 10 mmol) in anhydrous CH2Cl2 (20 ml) was added dropwise under N2 
at 0 °C to the crude product generated above (2.50 g, ≤ 9.90 mmol) in 10 mL 
anhydrous CH2Cl2.  The reaction was stirred for 1.5 hr at 0 °C under N2 and then 
concentrated under reduced pressure to an orange oil.  The oil was dissolved with 60 
mL ethyl acetate and washed with 50 mL H2O.  The aqueous fraction was extracted 
with an additional 60 mL ethyl acetate, and all the organic fractions were combined, 
washed with H2O (2 × 50 mL), dried with MgSO4 and evaporated under reduced 




chromatography (chromatotron) using hexanes/ethyl acetate (19:1) to yield a clear oil 
(1.74 g, 56 % yield).  1H NMR (400 MHz, d3-acetonitrile) δ 7.16 (d, J=2.1 Hz, 1H), 
7.02 (dd, J=8.2, 2.1 Hz, 1H), 6.78 (d, J=8.2 Hz, 1H), 4.54 (s, 2H), 2.24 (s, 3H), 1.05 
(s, 9H), 0.27 (s, 6H).  13C NMR (500 MHz, d3-acetonitrile) δ 152.6, 132.6, 131.7, 
131.6, 129.2, 119.6, 30.8, 26.3, 20.6, 19.0, -3.9.  ESI+-MS: m/z 235.17 (M - Br)+.  
Calcd for C14H23OSi (M - Br)+: 235.15. 
 
Formation of the dC N3 adduct (2.8) generated by the precursor 2.6 and its 
MeQM intermediate (2.7). Alkylation was initiated by addition of aqueous KF (20 
µL, 2.50 M) to a mixture the MeQM precursor 2.6 in CH3CN (25 µL, 200 mM), dC in 
DMF (45 µL, 112 mM), and potassium phosphate (10 µL, 50.0 mM, pH 7).  The 
reaction was stirred at 37 °C for 20 min and then cooled, filtered and fractionated by 
preparative reverse-phase HPLC using a 3 - 25% gradient of CH3CN in ammonium 
formate pH 6.8 over 76 min (5 mL/min).  The MeQM-dC N3 adduct 2.8 was 
collected (tr = 60 minutes) and lyophilized to yield a white solid.  A reliable yield 
could not be measured due to the small amounts of product isolated from each HPLC 
separation.  1H NMR (500 MHz, DMSO-d6):  δ 2.07 (m, 2H), 2.16 (s, 3H), 3.53 (m, 
2H), 3.76 (m, 1H), 4.22 (m, 1H), 4.89 (d, J=4.7 Hz, 2H), 5.90 (d, J=8.0 Hz, 1H), 6.21 
(t, J=6.9 Hz, 1H), 6.62 (d, J=8.2 Hz, 1H), 6.93 (dd, J=8.2, 2.0 Hz, 1H), 7.22 (d, J=2.0 
Hz, 1H), 7.45 (d, J=8.0 Hz, 1H).  13C NMR (500 MHz, DMSO-d6):  δ 20.2, 39.3, 
41.4, 61.3, 70.4, 84.8, 87.3, 100.0, 117.5, 123.1, 127.1, 130.1, 132.2, 133.5, 150.2, 
154.6, 158.3.  ESI+-MS: m/z 348.25 (M + H+), 232.17 (M - drb + H+).  Calcd for 




219, 279 nm (diode array detector, 20% CH3CN in ammonium formate, 8 mM, pH 
6.8). 
 
Oxidation of the dC N3 adduct 2.8 to form 2.15.  The dC adduct 2.8 was generated 
in situ as described above at 37 °C for 20 minutes and then treated with an equal 
volume of BTI in CH3CN (0.10 M) for 20 min at room temperature.  The mixture was 
then diluted with water (25% v/v) and washed with diethyl ether.  The aqueous phase 
was filtered through a 0.2 µm syringe filter and fractionated by preparative reverse-
phase C18 HPLC using a 3 - 25% gradient of CH3CN in ammonium formate pH 6.8 
over 76 min (5 mL/min).  The product 2.15 was collected (tr = 26 min) and 
lyophilized to yield a yellow solid. A reliable yield could not be measured due to the 
small amounts of product isolated from each HPLC separation.  1H NMR (400 MHz, 
DMSO-d6): δ 1.90 (d, J=1.2 Hz, 3H), 2.04 (m, 2H), 3.53 (m, 2H), 3.70 (d, J=11.2 Hz, 
1H), 3.75 (m, 1H), 3.92 (d, J=11.2 Hz, 1H), 4.22 (m, 1H), 4.99 (br, 1H), 5.24 (br, 
1H), 5.78 (d, J=8.2 Hz, 1H), 5.97 (d, J=9.9 Hz, 1H), 6.06 (bd, J=6.4 Hz, 1H), 6.16 (t, 
J=7.0 Hz, 1H), 7.03 (dd, J=9.9, 2.2 Hz, 1H), 7.50 (d, J=8.2 Hz, 1H). 13C NMR (500 
MHz, DMSO-d6): δ 20.3, 39.5, 51.5, 61.4, 70.5, 73.1, 83.8, 87.1, 96.0, 123.5, 128.8, 
136.6, 137.0, 146.3, 147.5, 154.9, 199.7.  ESI+-MS: m/z 346.18 (M + H+).  Calcd for 
C17H20N3O5 (M + H+): 346.14.  λmax = 235, 283, 340 nm (diode array detector, 12% 




Chapter 3: Formation and Oxidation of MeQM-dG Adducts 
 
3.1.  Introduction. 
Oxidative de-aromatization of the phenolic product formed between MeQM 
and dC has been proven to quench the reversible alkylation and allow the MeQM-dC 
N3 adduct to survive at least 24 hours for enzymatic digestion and HPLC analysis.76 
The usage of BTI allows the oxidative trapping to occur quickly, quantitatively, and 
selectively with the QM phenol under physiological conditions.  These properties are 
necessary considering the ultimate goal of analyzing the alkylation profile of MeQM 
and DNA over short times by quickly trapping the reaction prior to enzymatic 
digestion. 
To properly quantify the HPLC data for the alkylation of DNA by MeQM, 
each of the potential oxidized MeQM-dN adducts must be synthesized and 
characterized for use as analytical standards.  The aforementioned MeQM-dC N3 
oxidation product was synthesized and fully characterized by 1D and 2D NMR, ESI+-
MS, and UV-vis.76 The next nucleoside to be studied was 2′-deoxyguanosine (dG) as 
it contains the most nucleophilic position (dG N7) and produces the largest number of 
adducts at three.   
MeQM is expected to react with dG at the same positions as previously 
observed with the simple o-QM (Scheme 3.1).  Of the three initial alkylation products 
formed between MeQM and dG, the product at dG N7 is the most important as it is 




nucleophilic site of the DNA bases, and as such, is the most reactive site towards 
many electrophiles, the strongly electrophilic o-QMs included.14,58  
Scheme 3.1. Structures of products formed from the alkylation of dG (3.1) by MeQM 
(2.7). 
 
 Along with being the nucleophilic position in DNA, dG N7 is also the most 
accessible of the strong nucleophiles in DNA.  Unlike dC N3 and dA N1, which 
participate in hydrogen bonding in dsDNA, dG N7 is available in the major groove. 
(Figure 3.1).  This availability allows unobstructed access to dG N7 for electrophiles, 





Figure 3.1. Watson-Crick base pairing in DNA with the major and minor grooves 
labeled.  The top pair is T-A and the bottom pair is C-G. 
The alkylation of dG by MeQM was expected to be a greater challenge to the 
oxidative trapping than dC, partly due to the lower solubility of dG in aqueous 
conditions when compared to dC.  Adding to the challenge of dG is that previous 
work determined that the alkylation of dG by a simple o-QM results in the formation 
of four unique adducts (dG N1, dG N2, dG N7, and guanine N7) instead of the single 
adduct formed by dC (dC N3) (Scheme 1.12).56 The formation of multiple adducts 
could complicate the HPLC isolation of individual products due to difficulties in their 




competing processes in the reaction of the dG N7 adduct, reversibility to free o-QM 
and deglycosylation to form the guanine N7 adduct.  These processes limit the yield 
of QM-dG N7 and make it difficult to observe the adduct after DNA alkylation.  
Despite these challenges, each of the oxidation products of MeQM-dG must be 
isolated and fully characterized for use as an analytical standard in the quantification 
of MeQM alkylation of DNA. 
 
3.2.  Results and Discussion. 
3.2.1. Alkylation of dG with MeQM. 
The oxidized MeQM-dC N3 adduct was formed in a one-pot reaction in which 
the MeQM-dC N3 adduct was formed in situ and subsequently treated with four 
equivalents of BTI prior to work-up and HPLC purification.76 These reaction 
conditions were applied to the alkylation of dG by MeQM to rapidly isolate the four 
oxidized MeQM-dG products.  4-MeBrQMP (50.0 mM), dG (22.5 mM), potassium 
phosphate (5 mM, pH 7), and KF (500 mM) were combined in a solution of CH3CN 
(25%), DMF (45%), and H2O (30%).  The reaction was held at 37 °C for 20 minutes 
prior to addition of a four-fold excess of BTI.  This was then removed from heat for 
another 10 minutes followed by a work-up consisting of a saturated diethyl ether 
wash and HPLC analysis.  Unfortunately, the resulting HPLC chromatogram 
contained a number of low intensity peaks and there was no major product identified 
(Figure 3.2).  The reason for this failure is not known, but it may be due to any 
number of reactions between any of the chemical species in solution, leading to 





Figure 3.2. HPLC analysis of a “one-pot” MeQM-dG oxidation.  The MeQM-dG 
adducts were generated in situ prior to oxidation by BTI.  The reaction was analyzed 
with Gradient 1 using the analytical column (1 mL/min). 
  The alkylation of dG with MeQM consisted of combining 4-MeBrQMP (2.6) 
(10 mM), dG (10 mM), and KF (500 mM) in 2:1 DMF:H2O.  This mixture was held 
at 37 °C for 1 hour prior to filtration (0.2 µm) and analysis by HPLC using a semi-
prep column (Figure 3.3).  There were five products observed by HPLC and the 
product at tr = 46 minutes was the major product.  1H NMR confirmed that the 
compound was a MeQM-dG adduct by the presence of protons correlated to dG and 





Figure 3.3. HPLC analysis of the alkylation of dG with MeQM.  The reaction 
combined 10 mM each dG and 4-MeBrQMP in a 2:1 solution of DMF:H2O for 1 hour 
at 37 °C.  HPLC analysis used Gradient 1 with the semi-prep column (5 mL/min).  
Peak identification was confirmed with additional data from future experiments. 
Since the reactivity of MeQM was expected to be similar to the previously 
studied o-QM,58 it was expected that the MeQM-dG N7 adduct would form quickest 
of the adducts.  The above experiment demonstrated that after one hour at 37 °C 
produced primarily the MeQM-dG N1 adduct, which suggested that the MeQM 
reacted faster than the unsubstituted QM.  The MeQM-dG N1 adduct became the 
major product between QM and dG after approximately 8 hours.  A series of 
reactions were carried out at temperatures varying from 0 °C to 37 °C with a reaction 
time at one minute from KF activation of MeQM to HPLC analysis.  These reactions 
consisted of a 1:1:2 mixture of DMF:CH3CN:H2O containing dG (12.5 mM), 4-
MeBrQMP (12.5 mM), potassium phosphate buffer (12.5 mM, pH 7), and KF (625 




MeQM-dG N7.  While the lower temperature managed to slow the rate of adduct 
formation, the rate decreased proportionally for each adduct and did not maximize the 
amount of MeQM-dG N7 formed.  While MeQM reacted at the same positions of dG 
as QM, it appears that the product profile may have changed. 
The reaction conditions were adjusted due to the low overall yield of the 
previous alkylations.  The goal was to increase the yield of each MeQM-dG adduct 
instead of focusing on any individual adduct.  The concentrations of 4-MeBrQMP 
and dG were increased to 50 mM and 22.5 mM, respectively, in a 1.8:1:1.2 mixture of 
DMF:CH3CN:H2O.  The dG concentration was limited by its low solubility in the 
reaction solvents.  The HPLC analysis used an analytical column to obtain better 
resolution than the previously used semi-prep column (Figure 3.4).  There were four 
products isolated by HPLC, but only MeQM-dG N1 had sufficient yield for 1H NMR 
analysis.  The reaction was scaled up 2-fold and the subsequent HPLC purification 
used a semi-prep column to accommodate the larger reaction size.  Unfortunately, the 







Figure 3.4. HPLC analysis of MeQM-dG alkylation with 50 mM 4-MeBrQMP and 
22.5 mM dG in a 1.8:1:1.2 mixture of DMF:CH3CN:H2O.  The reaction was held at 
37 °C for 20 minutes and fractionated using Gradient 1 with an analytical column (1 
mL/min).  Injection volume was 180 µL. 
 
Figure 3.5. HPLC analysis of a 2x scale MeQM-dG alkylation of Figure 3.4.  The 
analysis used Gradient 1 with a semi-prep column (5 mL/min).  Injection volume was 
370 µL.  The scale-up resulted in the co-elution of at least two of the MeQM-dG 




The reaction conditions were again varied in an attempt to form more of the 
other MeQM-dG adducts (dG N2 and dG N7).  New conditions were inspired by 
previously optimized conditions to form QM-dG N2 consisting of a 1:1 mixture of 
DMF:H2O with 4-MeBrQMP (25.0 mM), dG (12.5 mM), and KF (250 mM).56 This 
mixture was held at 37 °C for between 30 minutes and 23 hours before HPLC 
analysis.  The HPLC analysis utilized an analytical column for the improved 
resolution.  The different reaction times were used to find an ideal reaction length for 
the formation of the various adducts (Figure 3.6).  As expected, the yield of MeQM-
dG N7 decreases for reaction times over 30 minutes.  MeQM-guanine N7, however, 
increases in yield for reaction times over 30 minutes.  This relationship is expected as 
MeQM-guanine N7 forms from the deglycosylation of MeQM-dG N7.  MeQM-dG 
N1 and N2 appear to have a constant yield over the range of 30 minutes to 23 hours.  






Figure 3.6. HPLC analysis of the MeQM-dG alkylation that consisted of a 1:1 
mixture of DMF:H2O with 4-MeBrQMP (25.0 mM), dG (12.5 mM), and KF (250 
mM).  The reaction was monitored by analyzing 100 µL aliquots by HPLC at 30 
minutes (A) and 3 hours (B).  The reaction was also monitored by analyzing a 50 µL 
aliquot at 23 hours (C). Gradient 1 was used with an analytical column (1 mL/min). 
Each of the five MeQM adducts observed by HPLC (including MeQM-H2O) 




identification of the adducts was done by comparing tr and UV-Vis data with the 
unsubstituted QM data (Table 3.1).56  
Table 3.1. Comparison of UV-Vis and tr data between MeQM-dG and QM-dG.56 
Adduct 
Experimental 
λmax for MeQM-dG 
(nm) 
Literature 








dG N7 259, 279 260 1 1 
guanine N7 283 280 2 2 
dG N1 255, 271 257, 275 3 3 
dG N2 247, 275 256, 280 4 4 
  
Each of the lyophilized MeQM-dG products were then individually combined 
with 100 µL H2O and 100 µL CH3CN and analyzed by HPLC immediately to assess 
their stability.  There was no observed decomposition of MeQM-dG N1, MeQM-dG 
N2, or MeQM-guanine N7 after the overnight lyophilization.  This is expected as 
these three adducts were determined to be irreversible with the unsubstituted QM.58 
MeQM-dG N7, however, does show a small amount (< 2%) of MeQM-guanine N7, 
but no water adduct.  This indicates that, under lyophilizing conditions, the 
reversibility of MeQM-dG N7 is of small concern while the deglycosylation of 
MeQM-dG N7 does occur, albeit slowly (Appendix B.1).   
 The reaction was repeated several times to obtain enough material for 1H 
NMR analysis of each product (Appendix B.3 – B.6).  The 1H NMR chemical shifts 
were compared with the literature values for the QM-dG adducts in order to confirm 
the MeQM-dG adduct identities (Table 3.2).56 Specifically, the methylene bridge 
protons and the lone proton on guanine (H8) were used as points of direct 




Table 3.2. 1H NMR comparison between MeQM-dG and QM-dG (ppm).  All 
MeQM-dG adducts analyzed in DMSO-d6.  QM-dG N7 was not analyzed by NMR, 
QM-guanine N7 was analyzed in NaOD/D2O, QM-dG N1 and QM-dG N2 were 














dG N7 5.52 n/a 9.18 n/a 
guanine N7 5.30 5.39 7.84 7.64 
dG N1 5.06 5.28 7.96 8.05 
dG N2 4.36 4.58 7.90 7.99 
 
 ESI+-MS was carried out on each of the NMR samples of the MeQM-dG 
adducts.  To facilitate ionization and flow through the tubing, the DMSO-d6 samples 
were diluted to 40% water prior to analysis.  Each of the MeQM-dG adducts was 
observed along with their deglycosylated fragments.  The remaining NMR samples 
were analyzed by HPLC to observe their stability both dry in the freezer and in 
DMSO-d6.  The MeQM-dG N7 adduct decomposed such that only approximately 
50% of the original adduct remained after one day frozen at 0 °C in DMSO-d6 
(Figure 3.7).  Surprisingly, the major decomposition product was MeQM-dG N1 
(~50% of the dG N7 peak area at A260).  This result suggests that the rate of 
reversibility is faster than the rate of deglycosylation, further highlighting the 
importance of trapping the MeQM-dG N7 adduct.  The other decomposition products 
MeQM-H2O (<1% of dG N7) and MeQM-guanine N7 adduct (<7% dG N7) formed 
in very low concentrations.  The MeQM-dG N1 and MeQM-guanine N7 adducts did 
not show any detectable decomposition, confirming that they are irreversible 
products.  The MeQM-dG N2 adduct showed a small amount (<10%) of MeQM-dG 
N1 adduct, which was probably collected during the initial purification of the crude 





Figure 3.7. HPLC analysis of the MeQM-dG N7 NMR sample that was stored in 
DMSO-d6 for 24 hours at -20 °C. 
The alkylation described above would yield a maximum of 3.9 mg MeQM-dG 
adducts (total) per 400 µL reaction.  Due to the high reactivity of MeQM the yield 
does not approach 100%, although the actual yield is difficult to determine due to the 
small amounts of product formed.  This low yield necessitated a scaled up reaction 
capable of delivering mgs of each MeQM-dG adduct in a shorter period of time.     
The solubility of dG was greatly improved by using a 70:30 mixture of 
DMF:H2O to produce a 100 mM stock solution of dG resulting in a final 
concentration of 25.0 mM dG in a reaction solvent consisting of 57.5% H2O and 
42.5% DMF.  This increased the maximum yield of the alkylation reaction 2-fold 
when considering all adducts.  Initial reaction purifications utilized the same HPLC 
gradient as before, Gradient 1 (Table 3.3), and a 200 µL reaction to confirm that the 




the previously observed MeQM adducts was observed by HPLC and identified by tr 
and UV-Vis absorbance.  Once this was accomplished, the same gradient was run on 
the semi-preparative column in anticipation of larger injection volumes.  The same 
reaction was analyzed using five different HPLC gradients, each one improving on 
the separation of MeQM adducts of the previous gradient while decreasing the time 
for each run (Table 3.3).  The optimal gradient was Gradient 6 due to the separation 
of the MeQM-dG adducts from the by-products and the shorter method length 
(Figure 3.9). 
Table 3.3. HPLC gradient optimization for the fractionation of the MeQM-dG 
alkylation.  The aqueous buffer is 10 mM TEAA pH 5.  The flow rate was 5 mL/min 











1 Step 1 3 25 76 0.289 
Step 1 3 10 14 0.500 
Step 2 10 18 40 0.200 2 
Step 3 18 25 14 0.500 
Step 1 3 11.2 16.4 0.500 
3 
Step 2 11.2 16.2 50 0.100 
Step 1 3 12 18 0.500 
4 
Step 2 12 14 40 0.050 
Step 1 3 12 10 0.900 
Step 2 12 12 40 isocratic 5 
Step 3 12 14 10 0.200 
Step 1 3 12 10 0.900 
6 






Figure 3.8. HPLC analysis of MeQM-dG alkylation using a 42.5% DMF percentage.  
The reaction was held at 37 °C for 2 hours and fractionated using Gradient 1 with an 
analytical column (1 mL/min).  Injection volume was 200 µL. 
 
Figure 3.9. HPLC analysis of MeQM-dG alkylation.  The reaction was held at 37 °C 
for 1 hour and fractionated using Gradient 6 with a semi-prep column (5 mL/min).  




With an optimized HPLC gradient, the alkylation reaction was gradually 
scaled up from 200 µL to 1 mL.  The optimized 1 mL alkylation reaction consisted of 
4-MeBrQMP in DMF (250 µL, 100 mM), dG in 70% aqueous DMF (250 µL, 100 
mM), and aqueous KF (500 µL, 500 mM) and was stirred at 37 °C for 1- 5 hr (Figure 
3.10).  The new reaction increased the theoretical yield 2.5-fold to 9.7 mg total 
adducts formed.  It was demonstrated that the alkylation products of MeQM-dG could 
be isolated in mg quantities sufficient for 1H NMR.  The next step was to develop an 
efficient method for forming and isolating the oxidized products of MeQM-dG. 
 
Figure 3.10. HPLC analysis of MeQM-dG alkylation using Gradient 6.  The reaction 
was held at 37 °C for 1 hour and was fractionated using a semi-prep column (5 







3.2.2. Oxidation and Isolation of the MeQM-dG adducts. 
Since MeQM-dG N1 formed in the highest yield (35 – 55% of the total 
MeQM adducts measured by peak area at A260) it was the logical choice to start the 
individual oxidation studies.  The lyophilized MeQM-dG N1 adduct was dissolved in 
125 µL water and 125 µL CH3CN to prepare it for oxidation.  This solution was 
transferred to an Eppendorf tube and 200 µL BTI (200 mM in CH3CN) was added.  
The reaction was mixed and allowed to stand at room temperature for 20 minutes.  
Over the course of the reaction, the solution changed from pale yellow to orange in 
color.  Water (100 µL) was added to the reaction and the mixture was washed with 
water saturated diethyl ether (3 × 0.5 mL).  The aqueous layer was collected and 
filtered (0.2 µm) prior to analysis by HPLC (Figure 3.11).  
 
Figure 3.11. Crude oxidation of MeQM-dG N1 with BTI.  The reaction was held at 
room temperature for 20 minutes prior to HPLC analysis.  Gradient 1 was used with 




 The oxidation of MeQM-dG N1 yielded a very complex mixture.  The major 
products eluting between 20 - 24 minutes, 47 - 50 minutes, and 51 - 53 minutes were 
collected and lyophilized overnight for 1H NMR analysis.  Of these collected 
compounds, only the 2 peaks at 20 - 24 minutes yielded enough material for 1H NMR 
(Figure 3.12).   
 
Figure 3.12. 1H NMR of the product formed by oxidation of MeQM-dG N1 in 
DMSO-d6 at 400 MHz.  Two possible structures are shown as 3.6 and 3.7. 
 The structure for the oxidized product of MeQM-dG N1 was initially 
proposed to be a spiro-compound (3.6) due to the similarities between the 1H NMR of 
this compound and the MeQM-dC oxidized adduct which was determined to be a 
spiro compound.  Similarities include a downfield shift and small splitting (<2 Hz) of 
the 4-Me protons (H17).  The complex splitting of the (presumed) methylene bridge 




adduct.  Additionally, upon HPLC analysis of the NMR sample, two compounds (tr = 
25.5 and 26.5 min) with identical UV-Vis absorbances eluted, which also corresponds 
to the formation of a diastereomeric mixture as seen with the MeQM-dC oxidized 
adduct (Appendix B.2).  The synthesis of more MeQM-dG N1 oxidized adduct was 
necessary to perform additional 1D and 2D NMR to confirm the structure of the 
isolated compound. 
Fortunately, using the optimized alkylation conditions and purification using 
Gradient 6 (Table 3.3) synthesis of MeQM-dG N1 became efficient.  Under these 
conditions MeQM-dG N1 and MeQM-dG N2 elute sequentially with tr 30 and 33 
minutes and are not fully resolved (Figure 3.6).  Instead of attempting to collect the 
adducts separately, they were collected together for oxidation in the same reaction 
vessel which should produce two unique, stable compounds.  Lyophilized samples of 
the MeQM-dG N1 and MeQM-dG N2 were dissolved in a 1:1 solution of potassium 
phosphate (50 mM, pH 7) and CH3CN at an average of 50 µL solvent per vial of 
lyophilized adduct and then subjected to 20 mmol BTI for 5 minutes at room 
temperature.  These oxidation conditions were milder than previously used (40 mmol 
BTI for 20 minutes at room temperature) in an effort to reduce the number of by-
products simplify purification and increase yield.  The initial HPLC purification using 
Gradient 1 with the analytical column resulted in a number of compounds of similar 
UV-Vis spectra (λmax = approximately 243 and 271 nm) eluting from 21 - 36 minutes 





Figure 3.13. HPLC analysis of the crude oxidation of the mixture of MeQM-dG N1 
(3.2) and MeQM-dG N2 (3.3) with BTI.  The reaction was held at room temperature 
for 5 minutes.  Gradient 1 was used with the analytical column (1 mL/min). 
1H NMR of the collected sample suggested a mixture of two unique MeQM-
dG adducts from the presence of two proton signals for each H8, H17, and H10 
(Figure 3.14).  The aromatic region also appeared more complex than what would 
result from a single MeQM-dG adduct.  HPLC analysis of the NMR sample, which 
was first diluted by 50% with H2O, showed two pairs of peaks with much better 
resolution with retention times of approximately 24.5, 26.0, 29.0, and 30.0 minutes 
(Figure 3.15).  As the same column and gradient was used as the previous 
purification (Figure 3.13) this suggests that the initial purification of the oxidation 
reaction slightly overloaded the HPLC column, shifting the retention times of the 
adducts forward.  Each of the four peaks has an identical λmax (243 and 271 nm) 





Figure 3.14. 1H NMR of the material collected between 21 and 36 minutes of HPLC 
analysis of the crude oxidation of the mixture of MeQM-dG N1 (3.2) and MeQM-dG 
N2 (3.3) with BTI (Figure 3.13). 
 
Figure 3.15. HPLC analysis of the 1H NMR sample from Figure 3.14.  The NMR 
sample was diluted with H2O to 50% aqueous DMSO-d6 prior to re-injection into the 




The two pairs of compounds were collected separately, lyophilized overnight, 
and analyzed by 1H NMR.  Preliminary results showed that the first eluting 
compound was the oxidized product of MeQM-dG N1 (3.7) while the second 
compound was the oxidized product of MeQM-dG N2 (3.8).  These characterizations 
were based largely on the chemical shifts of H8 and H10 compared to the non-
oxidized adducts.  The oxidation was repeated until sufficient product was collected 
for 2D NMR. 
Scheme 3.2. Proposed structure of the product (3.7) formed by oxidation of MeQM-
dG N1 (3.2). 
 
The first compound characterized was the oxidized product of MeQM-dG N1 
(3.7) (Scheme 3.2).  NMR signals (1H and 13C) corresponding to the purine and 
ribose moieties of 3.7 were again assigned from literature values for dG and N1 
alkylated dG derivatives56,88,89 and confirmed by 1H-13C HSQC and 1H-13C HMBC 
spectra (Appendix B.7 – B.10).  The compound 4-hydroxy-2,4-dimethyl-2,5-
cyclohexadien-1-one (3.9) was used as a model for the p-quinol moiety (Appendix 
Table B.4).68 Specifically, the 13C chemical shift of the sp2 hybridized C11 (129.5 
ppm) and the sp3 hybridized C15 (66.5 ppm) are in agreement with the corresponding 





Figure 3.16. 1H – 13C HMBC of 3.7 in DMSO-d6 at 600 MHz. 
Alkylation of the N1 position of dG was confirmed by 1H-13C HMBC NMR, 
which detected correlations between the methylene protons (H10) and C2, C6, C11, 
and C16 (Figure 3.16).  Only alkylation of N1 would satisfy these data.  The 
presence of diastereomers observed by HPLC was also seen in the splitting pattern of 
the methylene protons (H10).  The coupling constant (J=15.7 Hz) between the two 
protons is characteristic of geminal coupling, the result of restricted rotation around 
C10.  The splitting pattern is similar to the overlapping doublet of doublets observed 
in the 1H NMR spectra of MeQM-dC N3 oxidized adduct.76 Again, this unique 
splitting pattern is the result of the diastereomeric mixture of compounds along with 
the diastereotopic relationship of the protons (H10).  ESI+-MS provided a m/z 404.13 
(M + H)+ that corresponds with the proposed structure of 3.7 (calculated m/z 404.16 




initially proposed spiro-cyclized product 3.6 (calculated m/z 386.15 (M + H)+) 
observed with the MeQM-dC N3 oxidized adduct.  
Scheme 3.3. Proposed structure of the product (3.8) formed by oxidation of MeQM-
dG N2 (3.3). 
 
The next compound to be characterized was the oxidized product of MeQM-
dG N2 (3.8) (Scheme 3.3).  NMR signals (1H and 13C) corresponding to the purine 
and ribose moieties of 3.8 were again assigned from literature values for dG and N2 
alkylated dG derivatives 56,88 and confirmed by 1H-13C HSQC and 1H-13C HMBC 
spectra (Appendix B.11 – B.14).  The compound 4-hydroxy-2,4-dimethyl-2,5-
cyclohexadien-1-one (3.9) was again used as a model for the p-quinol moiety.68 
Specifically, the 13C chemical shift of the sp2 hybridized C11 (131.7 ppm) and the sp3 
hybridized C15 (66.4 ppm) are in agreement with the corresponding carbons in the 
model compound (133.3 ppm and 67.3 ppm, respectively).  The 1H chemical shifts of 
H13 (6.06 ppm) and H14 (6.96 ppm), along with their coupling constants (J = 10.0 
Hz and J = 10.0 Hz, 2.9 Hz, respectively), also agree reasonably well with the 
corresponding values of the model compound (6.01 ppm, J = 9.9 Hz and 6.81 ppm, J 





Figure 3.17. 1H – 13C HMBC of 3.8 in DMSO-d6 at 600 MHz. 
The connectivity of C10 to the N2 position of dG was confirmed with 1H-13C 
HMBC NMR (Figure 3.17).  Protons H10 display correlations to C2, C11, C12, and 
C16, but not to C6.  A correlation to C6 would be indicative of an alkylation of the 
N1 position of dG.  Protons H10 are not observed as diastereomers despite the 
diastereomeric composition of the NMR sample, as shown by HPLC analysis (Figure 
3.15).  This is perhaps due to less hindered rotation about the C10 - N2 bond that is 
not possible in the other adduct, 3.7.  Protons H10 instead display a splitting pattern 
consistent with one adjacent proton (N-H).  ESI+-MS showed a m/z 404.18 (M + H)+ 




Scheme 3.4. Proposed structure of the product (3.11) formed by oxidation of MeQM-
dG N7 (3.4) and the subsequent deglycosylated product (3.10). 
 
For the remaining two oxidized products of MeQM-dG, dG N7 (3.11) and 
guanine N7 (3.10), the two adducts were collected together since MeQM-guanine N7 
is the result of deglycosylation of MeQM-dG N7.  The co-collection of these two 
products would facilitate the isolation of the lone stable oxidation product, 3.10 
(Scheme 3.4).  The two adducts were collected together after following the 1 mL 
alkylation reaction and purification previously used with MeQM-dG N1 and MeQM-
dG N2 (Table 3.3).  After overnight lyophilization, the two adducts were dissolved in 
a 1:1 solution of potassium phosphate (50 mM, pH 7) and CH3CN at an average of 50 
µL solvent per vial of lyophilized adduct and then subjected to the mild oxidation 
conditions (20 mmol BTI, 5 min, room temperature).  Using gradient 1 with an 
analytical column for increased resolution, a major product was collected with a 
retention time of 9 - 13 minutes (Figure 3.18).  Analysis by 1H NMR suggested the 
presence of both the oxidized products of MeQM-dG N7 (3.4) and MeQM-guanine 
N7 (3.5) due to the observation of two signals for H8, H17, and H10 (Figure 3.19).  
The presence of the deglycosylated adduct (guanine N7) could be inferred by the 
ribose protons that integrated to only one set of signals for H8 and the QM fragment.  




adducts (m/z 404.16 and 288.11 respectively).  Unfortunately, product 3.10 is also the 
major fragmentation product of 3.11 under ESI+ conditions, so further NMR analysis 
was necessary to characterize the products. 
 
Figure 3.18. HPLC analysis of the crude oxidation of the mixture of MeQM-dG N7 
(3.4) and MeQM-guanine N7 (3.5) with BTI.  Reaction with BTI was held at room 
temperature for 5 minutes then worked-up and analyzed using Gradient 1 with the 





Figure 3.19. 1H NMR of the material collected between 9 and 13 minutes of HPLC 
analysis of the crude oxidation of the mixture of MeQM-dG N7 (3.4) and MeQM-
guanine N7 (3.5) with BTI (Figure 3.18). 
Interestingly, two compounds with different retention times (20 and 21 
minutes) and different λmax (239, 280 nm and 235, 277 nm) eluted upon HPLC 
analysis of the NMR sample shown above (Figure 3.20).  These two compounds 
were combined and 1H NMR analysis again showed a mixture of oxidized adducts 
3.10 and 3.11.  This result again suggests that the initial purification of the oxidation 
reaction slightly overloaded the HPLC column, shifting the retention times of the 
adducts forward.  The initial NMR sample that was analyzed contained less material, 
and the adducts eluted at what is assumed to be their normal retention times (20 and 





Figure 3.20. HPLC analysis of the 1H NMR sample from Figure 3.19.  The NMR 
sample was diluted with H2O to 50% aqueous DMSO-d6 prior to re-injection into the 
HPLC.  Gradient 1 was used with the analytical column (1 mL/min). 
The 1 mL scale alkylation reaction previously used with MeQM-dG N1 and 
MeQM-dG N2 was used again to collect 3.4 and 3.5 together after HPLC purification 
using gradient 6 with a semi-prep column (5 mL/min) (Table 3.3).  This will allow 
enough purified 3.10 to be obtained for analysis by 2D NMR.  After lyophilization to 
remove the elution buffer, the adducts were subjected to a 5 minute oxidation 
discussed above.  Purification by HPLC followed, again using gradient 1, and all 
compounds that eluted between 9 - 13 minutes were collected.  After another round of 
lyophilization, the remaining solid was dissolved with 600 µL of a 1:1 DMSO:H2O 
solution and held at 37 °C for 2 - 6 hours to complete the deglycosylation of 3.11 to 
form 3.10.  The solution was purified by HPLC using 200 µL per injection to avoid 




23 minutes, which was collected and lyophilized overnight.  This compound was fully 
characterized using 1H, 13C, 1H-13C HSQC, and 1H-13C HMBC NMR (Appendix 
B.15 – B.18). 
The structure of 3.10 was proposed to be the p-quinol product (Scheme 3.4).  
The lack of 2′-deoxyribose sugar NMR signals indicated that this was not the 
oxidized product of MeQM-dG N7 (3.11).  Assignment of the purine 13C NMR 
signals of C2 (154.4 ppm), C4 (159.7 ppm), C5 (107.9 ppm), and C6 (152.9 ppm) 
were based on literature precedence of 7-methyl guanine.90 The 1H and 13C NMR 
signals for C8 (7.84 and 143.4 ppm) were assigned based on 1H-13C HSQC.  The site 
of alkylation was confirmed by the observed correlation between the methylene 
bridge protons (H10) and carbons C5 and C8 associated with guanine and carbons 
C11, C12, and C16 associated with the former MeQM segment (Figure 3.21).  The 
same correlations were previously observed for the QM-guanine N7 adduct.56 C11 
was identified by its proximity to protons H10, H13, and H16.  Carbon C15 was 
identified by its proximity to protons H13 and H17.  The 13C chemical shift of C11 
(131.3 ppm) was consistent with sp2 hybridization, while the 13C chemical shift of 
C15 (66.3 ppm) was consistent with sp3 hybridization, which agree with 13C chemical 
shifts of the corresponding carbons in the model compound 4-hydroxy-2,4-dimethyl-
2,5-cyclohexadien-1-one (3.9).68 The protons at C10 show splitting consistent with a 
diastereomeric relationship due to the introduction of a chiral center at C15 and 
restricted rotation of the methylene bridge.  The two protons appear as doublets with 
a coupling constant of J=15.7 Hz, consistent with their geminal relationship.  ESI+-




(calculated m/z 288.11 (M + H)+).  Due to the location of nearby nitrogens it is 
mechanistically impractical for MeQM-guanine N7 or MeQM-dG N7 to form the 
spiro-cyclized product upon oxidation by BTI.  The above evidence confirms that the 
p-quinol product is formed and not the spiro-cyclized product observed with the 
oxidized product of MeQM-dC N3.76  
 
Figure 3.21. 1H – 13C HMBC of 3.10 in DMSO-d6 at 600 MHz. 
Each of the MeQM-dG adducts was confirmed to form the p-quinol product 
upon oxidation with BTI.  This result serves to highlight the unique environment 
necessary for the spiro-cyclization to occur, especially since MeQM-dG N1 3.2 and 
MeQM-dG N2 3.3 contain primary and secondary amines in the equivalent position as 
a primary imine in the MeQM-dC N3 adduct (2.8) (Figure 3.22).  The position of 
each nitrogen does not, however, take into account the nucleophilicity of the nitrogen.  




nucleophilic of the three compounds and therefore would be the most likely to form 
the spiro-cyclized product. 
 
Figure 3.22. Structural similarities, labeled in green, between MeQM-dG N1 (3.2), 
MeQM-dG N2 (3.3), and MeQM-dC N3 (2.8).   
 
3.3.  Summary. 
The goal of oxidative de-aromatization by BTI of the adducts formed between 
MeQM and dG has been accomplished.  Oxidation of the four MeQM-dG adducts 
(dG N7, dG N1, dG N2, and guanine N7) yields four unique products.  Due to the 
deglycosylation of MeQM-dG N7 to MeQM-guanine N7, only three of the oxidation 
products were fully characterized by 1D NMR, 2D NMR, and ESI+-MS as these are 
the only oxidized products expected to survive the enzymatic digestion of DNA.  The 
transformation of the QM phenol to a p-quinol was further confirmed by comparison 
to a model compound, 4-hydroxy-2,4-dimethyl-2,5-cyclohexadien-1-one (3.9).68 The 
p-quinol forms through an intermolecular addition of H2O, as opposed to the 
intramolecular addition of the dC exo-imine leading to the spiro-cyclized MeQM-dC 
N3 product.76 These results demonstrate the influence of the reaction environment on 




nucleophilicity of atoms capable of adding to the QM phenol upon its activation by 
BTI. 
 In addition to the synthesis and characterization of the oxidized MeQM-dC 
N3 adduct,76 the synthesis and characterization of the oxidized MeQM-dG adducts 
yielded four of the six analytical standards necessary for the eventual study of MeQM 
alkylation with DNA.  The remaining two analytical standards are the oxidized 
MeQM-dA adducts (dA N1 and dA N6), which will be characterized in a similar 
manner as the oxidized MeQM-dG adducts by my undergraduate mentee Omer Ad. 
 
3.4.  Materials and Methods. 
Formation of the dG N1, dG N2, dG N7, and guanine N7 adducts (3.2, 3.3, 3.4, 
3.5) generated by the precursor 2.6 and its MeQM intermediate 2.7.  Alkylation 
was initiated by addition of aqueous KF (500 µL, 500 mM) to a mixture of the 
MeQM precursor 2.6 in DMF (250 µL, 100 mM) and dG in 70% aqueous DMF (250 
µL, 100 mM).  The reaction was mixed and held at either room temperature (20-25 
°C) or 37 °C for 1 - 5 hr.  The reaction was then cooled and fractionated by semi-
preparative reverse-phase C-18 HPLC using a gradient of 3 - 12% over 10 min 
followed by 12% isocratic over 30 min of CH3CN in triethylammonium acetate (10 
mM, pH 5) at 5 mL/min. 
MeQM-dG N1 (3.2):  1H NMR (400 MHz, DMSO-d6): δ 2.10 (s, 3H), 2.19 (m, 1H), 
2.45 (m, 1H), 3.52 (m, 2H), 3.80 (m, 1H), 4.34 (m, 1H), 5.06 (s, 2H), 6.13 (q, J=6.9 
Hz, 1H), 6.76 (s, 1H), 6.78 (d, J=8.2 Hz, 1H), 6.90 (d, J=8.2 Hz, 1H), 7.96 (s, 1H).  




255, 271 nm (diode array detector, 18% CH3CN in triethylammonium acetate, 8 mM, 
pH 5). 
MeQM-dG N2 (3.3):  1H NMR (400 MHz, DMSO-d6): δ 2.17 (s, 3H), 2.22 (m, 1H), 
2.61 (m, 1H), 3.53 (m, 2H), 3.82 (m, 1H), 4.35 (m, 1H), 4.36 (s, 2H), 6.18 (t, J=6.9 
Hz, 1H), 6.72 (d, J=8.3 Hz, 1H), 6.89 (dd, J=8.3, 1.6 Hz, 1H), 7.03 (d, J=1.6 Hz, 1H), 
7.90 (s, 1H).  ESI+-MS: m/z 388.27 (M + H)+.  Calcd for C18H22N5O5+ (M + H)+: 
388.16.  λmax = 247, 275 nm (diode array detector, 19% CH3CN in triethylammonium 
acetate, 8 mM, pH 5). 
MeQM-dG N7 (3.4):  1H NMR (600 MHz, DMSO-d6): δ 2.17 (s, 3H), 2.33 (m, 1H), 
2.56 (m, 1H), 3.60 (m, 2H), 3.89 (m, 1H), 4.36 (m, 1H), 5.52 (d, J=5.8 Hz, 2H), 5.86 
(s, 2H), 6.21 (t, J=6.2 Hz, 1H), 6.74 (d, J=8.3 Hz, 1H), 6.98 (dd, J=8.3, 1.8 Hz, 1H), 
7.22 (d, J=1.8 Hz, 1H), 9.18 (s, 1H).  λmax = 259, 279 nm (diode array detector, 15% 
CH3CN in triethylammonium acetate, 9 mM, pH 5). 
MeQM-guanine N7 (3.5):  1H NMR (400 MHz, DMSO-d6): δ 2.11 (s, 3H), 5.30 (s, 
2H), 6.72 (d, 1H), 6.80 (d, 1H), 6.90 (dd, 1H), 7.84 (s, 1H).  ESI+-MS: m/z 272.18 (M 
+ H)+.  Calcd for C13H14N5O2+ (M + H)+: 272.11.  λmax = 283 nm (diode array 
detector, 17% CH3CN in triethylammonium acetate, 8 mM, pH 5). 
 
Oxidation of the dG N7 and guanine N7 adducts 3.4 and 3.5 to form 3.10.  The 
adducts 3.4 and 3.5 were combined with 100 µL CH3CN and 100 µL potassium 
phosphate (50 mM, pH 7).  The starting amount of 3.4 and 3.5 were unknown due to 
the small amounts isolated from each HPLC separation.  Instead, an average of 50 µL 




treated with 100 µL BTI (200 mM in CH3CN) for 5 minutes at room temperature.  
The reaction was then diluted with water (100 µL) and washed with diethyl ether (3 × 
500 µL).  The aqueous phase was filtered through a 0.2 µm syringe filter and 
fractionated by analytical reverse-phase C-18 HPLC using a linear gradient of 3 - 
25% CH3CN in ammonium formate (10 mM, pH 6.9) over 76 min (1 mL/min).  The 
product 3.10 was collected (tr = 20 min) and lyophilized to yield a white solid.  A 
reliable yield could not be measured due to the small amounts of product isolated 
from each HPLC separation.  1H NMR (600 MHz, DMSO-d6): δ 1.25 (s, 3H), 4.99 (d, 
J=15.7 Hz, 1H), 5.04 (d, J=15.7 Hz, 1H), 6.06 (d, J=10.1 Hz, 1H), 6.51 (s, 1H), 6.95 
(dd, J=2.8, 10.1 Hz, 1H), 7.84 (s, 1H).  13C NMR (600 MHz, DMSO-d6): δ 27.1, 43.8, 
66.3, 107.9, 125.2, 131.3, 143.4, 150.6, 154.6, 184.1.  ESI+-MS: m/z 288.11 (M + 
H)+.  Calcd for C13H14N5O3+ (M + H)+: 288.11.  λmax = 239, 283 nm (diode array 
detector, 9% CH3CN in ammonium formate, 9 mM, pH 6.9). 
 
Oxidation of the dG N1 and dG N2 adducts 3.2 and 3.3 to form 3.7 and 3.8. 
The oxidation of 3.2 and 3.3 was identical to the above procedure for 3.4 and 3.5.  
The two products 3.7 and 3.8 were collected separately (tr = 25 min and 30 min) and 
lyophilized to yield a yellow solid (3.7) and a white solid (3.8).  A reliable yield could 
not be measured due to the small amounts of product isolated from each HPLC 
separation.  
MeQM-dG N1 Oxidized adduct (3.7):  1H NMR (600 MHz, DMSO-d6): δ 1.25 (s, 
3H), 2.22 (m, 1H), 2.54 (m, 1H), 3.53 (m, 2H), 3.81 (m, 1H), 4.34 (m, 1H), 4.62 (d, 




(t, J=6.9 Hz, 1H), 6.95 (dd, J=2.9, 10.0 Hz, 1H), 7.97 (s, 1H).  13C NMR (600 MHz, 
DMSO-d6): δ 27.4, 39.4, 39.5, 61.7, 66.5, 70.8, 82.2, 87.6, 115.6, 125.5, 129.5, 135.7, 
146.3, 149.4, 153.9, 154.3, 156.2, 184.8. ESI+-MS: m/z 404.13 (M + H)+.  Calcd for 
C18H22N5O6+ (M + H)+: 404.16.  m/z 442.06 (M + K)+.  Calcd for C18H21KN5O6+ (M + 
K)+: 442.11.  λmax = 243, 271 nm (diode array detector, 10% CH3CN in ammonium 
formate, 9 mM, pH 6.9). 
MeQM-dG N2 Oxidized adduct (3.8):  1H NMR (600 MHz, DMSO-d6): δ 1.31 (s, 
3H), 2.19 (m, 1H), 2.58 (m, 1H), 3.50 (m, 2H), 3.80 (m, 1H), 4.11 (d, J=5.3 Hz), 4.32 
(m, 1H), 6.06 (d, J=10.0 Hz, 1H), 6.14 (t, J=6.9 Hz, 1H), 6.80 (m, 1H), 6.96 (dd, 
J=2.9, 10.0 Hz, 1H), 7.91 (d, J=2.5 Hz, 1H).  13C NMR (600 MHz, DMSO-d6): δ 
27.3, 38.9, 39.3, 61.8, 66.4, 70.8, 82.8, 87.6, 117.0, 125.5, 131.7, 135.7, 149.4, 150.3, 
152.4, 154.5, 156.6, 185.1.  ESI+-MS: m/z 404.18 (M + H)+.  Calcd for C18H22N5O6+ 
(M + H)+: 404.16.  λmax = 243, 271 nm (diode array detector, 12% CH3CN in 
ammonium formate, 9 mM, pH 6.9).  
 




Chapter 4: Alkylation of DNA by MeQM and Subsequent 
Enzymatic Digestion 
 
4.1.  Introduction. 
Identification of the complete profile of adducts formed between MeQM and 
DNA is necessary for understanding the selectivity of MeQM towards DNA.  While 
standard analysis of DNA alkylating agents would consist of a lengthy (24 hr) 
enzymatic digestion of alkylated DNA followed by LC/MS, this method fails for 
MeQM for two reasons.  The first reason is that multiple MeQM adducts at a 
particular nucleoside would have the same mass.  Therefore MS would be unable to 
provide important information about the position of the covalent linkage between 
MeQM and DNA.  The second reason is that the alkylation profile of DNA by MeQM 
would change drastically over the course of enzymatic digestion because some of the 
MeQM-DNA adducts are labile.   
 Oxidative de-aromatization of the QM phenol with BTI followed by HPLC 
analysis would solve both of the issues stated above.  The oxidative trapping of 
MeQM-DNA adducts would transform the labile adducts to stable adducts, allowing 
them to survive the enzymatic digestion.  Also, to eliminate the need to isolate and 
characterize the oxidized MeQM-DNA adducts (by LC/MS or NMR), analytical 
standards for each oxidized adduct were synthesized and fully characterized (Figure 




discussed in Chapter 2.76 The synthesis and characterization of oxidized MeQM-dG 
N1 (3.7), MeQM-dG N2 (3.8), and MeQM-guanine N7 (3.10) were discussed in 
Chapter 3.  Synthetic studies and structure elucidation of oxidized MeQM-dA N1 
(4.4) and oxidized MeQM-dA N6 (4.3) were carried out simultaneously by my 
undergraduate mentee Omer Ad.   
 
Figure 4.1. Fully characterized products of the BTI oxidation of MeQM-dC N3 
(2.15), MeQM-dG N1 (3.7), MeQM-dG N2 (3.8), MeQM-guanine N7 (3.10), and 
MeQM-dA N6 (4.3).  The oxidation product of MeQM-dA N1 (4.4) has not been 
confirmed.  
 The MeQM-dA N1 (4.1) and MeQM-dA N6 (4.2) adducts were successfully 
synthesized using procedures optimized for the formation of each adduct.91 As the dA 
N1 position is more reactive than the dA N6 position, the formation of MeQM-dA N1 
was favored at short reaction times (20 minutes) while the formation of MeQM-dA 




was initiated by the addition of KF to a solution of 4-MeBrQMP, dA, and potassium 
phosphate in a 1:1.8:1.2 mixture of CH3CN:DMF:H2O.  The structure of both 
MeQM-dA N1 and MeQM-dA N6 was elucidated with 1H NMR, 13C NMR, and 
ESI+-MS.91 
MeQM-dA N1 and MeQM-dA N6 were oxidized separately, after HPLC 
purification, using the same procedure that was used to form the oxidized MeQM-dG 
adducts.  The structure of oxidized MeQM-dA N6 (4.3) was elucidated with 1D and 
2D NMR along with ESI+-MS and comparison to model compounds N6-Me-dA,92 
N1-Me-dA,93 and 4-hydroxy-2,4-dimethyl-2,5-cyclohexadien-1-one (3.9).68 
Unfortunately, oxidized MeQM-dA N1 (4.4) was not characterized due to instability 
of the product.  This remains the only uncharacterized oxidation product of MeQM 
alkylation of dN and studies are ongoing to remedy this issue.  Until that time, 
oxidation studies with MeQM-DNA that yield a single unknown product can only 
assume and not confirm that the product is the result of oxidation of MeQM-dA N1. 
 The alkylation of dsDNA by a simple o-QM has been previously studied by 
the Rokita laboratory.62 These studies observed predominant formation of QM-dG N2.  
At the time, this preference was explained solely by the ability of the exo-amino 
group of dG to maintain its reactivity from nucleosides to dsDNA.62 It was later 
discovered that the alkylation profile of nucleosides varies greatly over the time 
needed for enzymatic digestion of DNA (24 hours).58 Specifically, the initial 
alkylations occur with the stronger nucleophilic positions (dG N7, dA N1, and dC 
N3), but these adducts are reversible.  Alkylation with the weaker nucleophilic 




irreversible they will accumulate over time.  The result of these processes is a 
significantly different alkylation profile at the beginning of DNA digestion than at the 
end of DNA digestion, when the mixture is analyzed by HPLC.  The oxidative de-
aromatization of QM phenols by BTI discussed earlier has the potential to trap the 
labile MeQM-DNA adducts prior to enzymatic digestion (Scheme 4.1).  This will 
allow, for the first time, quantification of MeQM alkylation of DNA at short, but 
biologically relevant, time points.  
Scheme 4.1. Oxidative de-aromatization can trap labile MeQM-DNA adducts.  The 
trapped MeQM-DNA adducts are stable enough to persist through enzymatic 











4.2.  Results and Discussion. 
4.2.1. Optimization of the Enzymatic Digestion of DNA. 
The early studies of QM alkylation of DNA were based on the following 
experiments involving the formation and subsequent oxidation of MeQM-DNA 
adducts.62 One aspect of the MeQM-DNA experiments to be optimized is the 
enzymatic digestion of DNA.  The complete enzymatic digestion of DNA to the 
nucleoside level is necessary for the subsequent HPLC analysis.  The individual 
nucleosides and nucleoside adducts are well resolved using a gradient of 3 – 11% 
CH3CN in 50 mM TEAA, pH 4 over 24 minutes (1 mL/min) followed by 11 – 25% 
CH3CN in 50 mM TEAA pH 4 over the next 85 minutes (1 mL/min).62 The different 
compounds are well resolved due to the large change in structure of each nucleoside 
adduct by the addition of MeQM.  Undigested DNA containing MeQM adducts, 
however, would elute as an unresolved peak.  This is because even several MeQM 
additions have little influence on a molecule the size of polymeric DNA and differing 
amounts of alkylation would not be distinguished by HPLC. 
The two enzymes involved in the digestion are phosphodiesterase I (from 
Crotalus adamanteus venom) and alkaline phosphatase (from Escherichia coli).  
Phosphodiesterase I is an exonuclease responsible for breaking the 3′ phosphorus-
oxygen bond in DNA stepwise from the 3′ terminus94,95 while alkaline phosphatase 
dephosphorylates the resulting mononucleotides at their 5′ position.  When used 
together, the two enzymes digest DNA to monomeric nucleosides free of phosphate.  
Alkaline phosphatase was stored at a concentration of 0.1 unit/µL in a solution of 50 




Phosphodiesterase I was initially stored at a concentration of 0.001 unit/µL in 100 
mM TEAA pH 10.  For later studies, phosphodiesterase I was stored at a 
concentration of 0.005 unit/µL in a solution of 50 mM Tris-HCL pH 8, 50 µM 
ZnSO4, 10 mM MgCl2, and 50% glycerol.  These storage conditions protect against 
degradation from repeated freezing and thawing while providing Mg2+and Zn2+ 
needed for the catalytic activity of the enzymes.96,97  
The work-up and digestion conditions after alkylation of DNA were based on 
previous work by Gao et al.,98 Lewis et al.,43 and Pande et al.62 Initially for a 200 µL 
scale alkylation, once the alkylation and oxidation reactions are complete, the CH3CN 
was removed under a stream of N2 (15 minutes).  The DNA was precipitated by 
adding EtOH (55 µL, 100 %) and cooling to -20 °C for 30 minutes.  The EtOH was 
evaporated under reduced pressure and the remaining DNA was washed with 
additional EtOH (140 µL, 80 %), frozen with liquid N2, and centrifuged (15 minutes, 
14,800 rpm).  The supernatant was decanted from the Eppendorf tube and the 
remaining solid was dissolved in 100 mM TEAA (100 µL, pH 10) and hydrolyzed by 
alkaline phosphatase (0.2 units per 1 mM nts DNA) and phosphodiesterase I (0.006 
units per 1 mM nts DNA).  The digestion mixture was held at 37 °C for 24 hours, 
followed by neutralization to pH 7 with 1% aqueous acetic acid (5 µL).  The mixture 
was filtered through a 0.2 µm syringe filter (with an addition of 50 µL H2O when 
necessary) and fractionated by analytical reverse-phase C18 chromatography (3% 
CH3CN in 9.7 mM ammonium formate, pH 6.9, to 11% CH3CN in 8.9 mM 
ammonium formate, pH 6.9, over 24 minutes (1 mL/min), followed by 11% CH3CN 




formate, pH 6.9, over the next 85 minutes).  This is the only HPLC gradient used in 
this chapter.  This procedure for enzymatic digestion of DNA is known as Method 1. 
Prior to alkylation and oxidation studies, a number of control experiments 
were necessary to optimize conditions that resulted in the complete enzymatic 
digestion of the target DNA, along with confirming that the alkylation and oxidation 
conditions were compatible with enzymatic digestion.  The initial target DNA was 
calf thymus DNA (ctDNA), a large molecular weight DNA historically used to 
represent a large duplex DNA of random sequence.43,56,62 The findings are 
summarized in Table 4.1.  Experiments 1-4 did not contain 4-MeBrQMP or BTI and 
served as blank controls, containing only ctDNA and potassium phosphate pH 7 in a 
70:30 solution of H2O:CH3CN.  Experiment 1 revealed that 2 mM nucleotides (nts) of 
ctDNA was insufficient to determine digestion by HPLC.  Experiments 2-4 confirmed 
that 10 mM nts ctDNA was sufficient to observe digestion by HPLC.  An effective 
ratio of enzymes to ctDNA was also determined.  In experiment 5, ctDNA was 
alkylated by a ten-fold excess of 4-MeBrQMP activated with KF (525 mM) in 30% 
aqueous CH3CN for 30 minutes prior to enzymatic digestion, to simulate the 
alkylation conditions.  The complete enzymatic digestion of ctDNA was observed by 
HPLC.  In experiment 6, 4-MeBrQMP was omitted, but an excess of BTI (167 mM) 
was added to the ctDNA solution and the mixture was kept at room temperature for 5 
minutes followed by enzymatic digestion, to simulate the oxidation conditions.  




Table 4.1. Enzymatic digestion conditions for the initial ctDNA experiments, 
compared to the literature precedent.62 
Exp [Nucleotides] (mM) 
Alkaline 
Phosphatase  Phosphodiesterase I  
Complete 
Digestion? 
Literature62 20 10 units 0.27 units yes 
1 2 1 unit (10 µL) 0.03 units (30 µL)  Insufficient DNA 
2 - 6 10 2 units (20 µL) 0.06 units (60 µL) yes 
 
While the ctDNA was completely digested in each experiment, including 
experiment 6 containing BTI, one issue needed to be addressed.  This issue was that 
in experiment 6, precipitation occurred upon addition of the BTI.  If the precipitate 
was ctDNA, then it may prove to be difficult to oxidize the MeQM-DNA adducts.  A 
series of trials involving the alkylation conditions and the addition of BTI addressed 
the precipitation issue.  For these trials, three different duplex DNAs were used to 
observe any influence by the oligo length or sequence.  The three duplex DNAs were 
ctDNA, salmon sperm DNA (salDNA) which is another large molecular weight DNA 
historically99,100 used as a large duplex DNA of random sequence, and OD1/OD3 
which was conveniently available as excess material from Dr. Jen Buss from an 
unrelated project (Figure 4.2).  In each case that duplex DNA (ctDNA, salDNA, or 
OD1/OD3) was included in the mixture, a precipitate was formed upon addition of 
BTI.  A large concentration (>31 mM) of K+ also seemed to result in precipitate 
formation upon addition of BTI.  A large concentration (225 mM) of Na+ did not 
result in a precipitate upon addition of BTI.  Fluoride was also added at a 
concentration of 200 mM without precipitate formation upon addition of BTI.  
Washing the reaction with saturated diethyl ether (3 × 200 µL) 5 minutes after BTI 




precipitate was DNA.  These trials lead to general conditions for the alkylation and 
subsequent oxidation of duplex DNA.  These conditions for enzymatic digestion of 
DNA, further known as Method 2, effectively solved the precipitation issue and 
included the use of Na+ counter ions where possible and a saturated diethyl ether 
wash (3 × 200 µL) prior to EtOH precipitation of the DNA. 
 
Figure 4.2. Synthesized complimentary oligonucleotide sequences used as target 
duplex DNA.   
A series of experiments used the improved reaction conditions (Method 2) to 
confirm that the alkylation and oxidation conditions were compatible with enzymatic 
digestion.  For these experiments, ctDNA was replaced by salDNA as the random 
sequence duplex DNA because the remainder of ctDNA in the laboratory was 
dissolved in potassium phosphate buffer and a large quantity of lyophilized salDNA 
was available.  The first experiment was to dissolve the salDNA (8 mM nts) under 
alkylation and oxidation conditions without the presence of 4-MeBrQMP or BTI.  
The reaction was then worked-up and digested according to Method 2 using 2 units 
of alkaline phosphatase (20 µL) and 0.06 units of phosphodiesterase I (60 µL).  This 
resulted in fully digested salDNA with no background compounds eluting after the 
nucleosides (tr > 20 minutes) providing a clean baseline for the detection of 
nucleoside adducts (Figure 4.3).  The nucleosides are identified by comparison of tr 





Figure 4.3. HPLC analysis of the enzymatic digestion of a reaction consisting of 
salDNA (8 mM nts), sodium phosphate (25 mM, pH 7), and NaF (200 mM) in an 
80:20 solution of H2O:CH3CN.  The reaction was worked-up and digested according 
to Method 2 using alkaline phosphatase (2 units, 20 µL) and phosphodiesterase I 
(0.06 units, 60 µL). 
The next experiment aimed to determine if BTI would inhibit the enzymatic 
digestion of salDNA.  Again, salDNA (8 mM nts) was combined with sodium 
phosphate (25 mM, pH 7), and NaF (200 mM) in an 80:20 mixture of H2O:CH3CN 
(200 µL).  BTI (20 µL, 91 mM) was added to the reaction and held for 5 minutes at 
room temperature prior to work-up following Method 2, using 2 units of alkaline 
phosphatase (20 µL) and 0.06 units of phosphodiesterase I (60 µL).  The salDNA was 
completely digested, with no observable background noise or oxidation by-products 





Figure 4.4. HPLC analysis of the enzymatic digestion of a reaction consisting of 
salDNA (8 mM nts), sodium phosphate (25 mM, pH 7), and NaF (200 mM) in an 
80:20 solution of H2O:CH3CN.  BTI (91 mM) was added to the reaction and held for 
5 minutes prior to work-up and digestion according to Method 2 using alkaline 
phosphatase (2 units, 20 µL) and phosphodiesterase I (0.06 units, 60 µL). 
Through the course of these experiments, the phosphodiesterase I purchased 
from Sigma-Aldrich was exhausted and a new supplier (Worthington Biochemical) 
was found to offer significantly more enzyme activity (100 units vs. 0.6 units) for 
approximately the same price, which would be advantageous due to the large amount 
of enzyme needed for future experiments.  Unfortunately, the new phosphodiesterase 
I failed to fully digest salDNA in a series of experiments using previously successful 
reaction conditions.   
 To improve the solubility of the duplex DNAs (ctDNA and salDNA), a new 
duplex DNA was chosen to test the less active phosphodiesterase I.  The new DNA, 




after work-up, unlike ctDNA and salDNA which required more time to completely 
dissolve (Figure 4.2).  OD1/OD3 was also unsuccessfully digested by the 
phosphodiesterase I from Worthington Biochemical in a series of experiments, which 
included increasing the amount of enzyme from 0.06 units to 0.75 units while keeping 
the concentration of DNA at 8 mM nts.   
At this point there appeared to be enough evidence that the phosphodiesterase 
I from Worthington Biochemical was inferior to that from Sigma-Aldrich.  Due to the 
inability of the phosphodiesterase I from Worthington Biochemical to completely 
digest the target DNA, further experiments utilized the more expensive, but effective 
phosphodiesterase I from Sigma-Aldrich.  The large difference in activity of 
phopshodiesterase I from two different suppliers highlights the need to test chemicals 
and enzymes from previously unused suppliers to confirm their effectiveness. 
The activity of phosphodiesterase I from Sigma-Aldrich was tested by 
digesting a reaction that consisted of OD1/OD3 (20 mM nts), sodium phosphate (25 
mM, pH 7), and KF (500 mM) in a 70:30 solution of H2O:CH3CN.  The reaction was 
subjected to work-up and digestion conditions from Method 2 using alkaline 
phosphatase (10 units, 100 µL) and phosphodiesterase I (0.28 units, 56 µL).  This 





Figure 4.5. HPLC analysis of the enzymatic digestion of a reaction consisting of 
OD1/OD3 (20 mM nts), sodium phosphate (25 mM, pH 7), and KF (500 mM) in an 
70:30 solution of H2O:CH3CN.  The reaction was subjected to work-up and digestion 
according to Method 2 using alkaline phosphatase (10 units, 100 µL) and 
phosphodiesterase I (0.28 units, 56 µL). 
Now that the enzymatic digestion of target DNA has been optimized, the 
alkylation of the target DNA by MeQM could be investigated. 
 
4.2.2. Alkylation of DNA by MeQM. 
Early experiments using ctDNA as the target DNA observed no alkylation 
when the reactions were analyzed by HPLC (Table 4.1).  This would make it 
impossible to observe the subsequently formed oxidized MeQM-DNA adducts.  A 
series of experiments replaced DNA in the alkylation reaction with an equimolar 
solution of nucleosides (dC, dG, dA, and dT) to determine the amount of dN and 4-




mM dN, 25 mM sodium phosphate pH 7, 200 mM NaF, and 67 mM 4-MeBrQMP in 
a 80:20 aqueous: CH3CN solution.  The reaction was incubated in a 1.5 mL plastic 
Eppendorf tube for 30 minutes at 37 °C, filtered (0.2 µm), and analyzed by HPLC 
(Figure 4.6).  There was almost no detectable alkylation. 
 
Figure 4.6. HPLC analysis of an alkylation reaction consisting of 2 mM each dN, 25 
mM sodium phosphate (pH 7), 200 mM NaF, and 67 mM 4-MeBrQMP in an 80:20 
solution of H2O:CH3CN.  The reaction was carried out in a 1.5 mL plastic Eppendorf 
tube for 30 minutes at 37 °C. 
 The next reaction increased the concentration of 4-MeBrQMP to 160 mM, but 
these conditions still failed to produce a significant amount of alkylation (measured 
by integration of the peak area at A260, Figure C.1) compared to the baseline (Figure 
4.5).  Further increasing 4-MeBrQMP concentration to 240 mM, substituting KF (500 
mM) for NaF (200 mM) due to the higher solubility of KF in H2O, and increasing the 
CH3CN percentage from 20% to 30% slightly increased the alkylation yield (Figure 




the alkylation yield (Figure C.3), while a larger increase came with switching from 
plastic Eppendorf tubes to 0.3 mL glass Reacti-vials equipped with Teflon stirbars 
(Figure C.4).  This effect is most likely the result of stirring the reaction as opposed 
to allowing the reagents to react through diffusion.  The most promising results came 
when the concentration of nucleosides was increased to 20 mM total dN while 4-
MeBrQMp was kept at 240 mM (Figure 4.7).   
 
Figure 4.7. HPLC analysis of an alkylation reaction consisting of 5 mM each dN, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 240 mM 4-MeBrQMP in a 70:30 
solution of H2O:CH3CN.  The reaction was stirred in a 0.3 mL glass Reacti-vial for 1 
hour at 37 °C. 
The next experiment used the optimum alkylation conditions of dN and 
applied them to the alkylation of salDNA.  Guided by the earlier nucleoside results, a 
200 µL reaction mixture consisting of 20 mM nts salDNA, 25 mM sodium phosphate 
pH 7, 500 mM KF, and 240 mM 4-MeBrQMP in a 70:30 aqueous: CH3CN solution 




addition, an additional 40 µL CH3CN was added after the 1 hour.  The reaction was 
worked-up and digested according to Method 2 using 6 units of alkaline phosphatase 
(60 µL) and 0.18 units of phosphodiesterase I (90 µL).  Despite compensating for the 
2.5 fold increase in salDNA by increasing the amount of enzymes (units) by 3 fold, 
undigested salDNA was present in the analysis (Figure 4.8).  Another problem was 
that little to no alkylation was observed, which may have been due to the high 
concentration of 4-MeBrQMP that did not appear to be fully miscible in the reaction 
mixture.  
 
Figure 4.8. HPLC analysis of an alkylation reaction consisting of 20 mM salDNA, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 240 mM 4-MeBrQMP in a 70:30 
solution of H2O:CH3CN.  The reaction was stirred in a 0.3 mL glass Reacti-vial for 1 
hour at 37 °C prior to an addition of 40 µL CH3CN to simulate the addition of BTI.  
The reaction was worked-up and digested according to Method 2 using alkaline 





To adjust for these two problems, the next experiment increased the amount of 
enzymes 4-fold to 8 units (80 µL) alkaline phosphatase and 0.24 units (120 µL) 
phosphodiesterase I while the concentration of 4-MeBrQMP was decreased from 240 
mM to 100 mM.  The ensuing reaction mixture was fully miscible and resulted in a 
complete digestion of the salDNA, but only trace amounts of alkylation were 
observed (Figure 4.9) when compared to the optimized dN alkylation (Figure 4.7).  
 
Figure 4.9. HPLC analysis of an alkylation reaction consisting of 20 mM salDNA, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 100 mM 4-MeBrQMP in a 70:30 
solution of H2O:CH3CN.  The reaction was stirred in a 0.3 mL glass Reacti-vial for 1 
hour at 37 °C prior to an addition of 40 µL CH3CN to simulate the addition of BTI.  
The reaction was worked-up and digested according to Method 2 using alkaline 
phosphatase (8 units, 80 µL) and phosphodiesterase I (0.24 units, 120 µL). 
A possible complication with a large target DNA, such as ctDNA or salDNA, 
is the potential for it to form complex secondary structures that may suppress 
alkylation by MeQM.  The large target DNA was also difficult to dissolve following 




easily dissolved at the same concentration and was used as the target in future 
experiments of MeQM alkylation.  The exact sequence had no significance, merely 
that there was not an excess of any one base-pair (52.5% G:C) and the melting 
temperature was above 37 °C (calculated at 69 °C by the supplier Integrated DNA 
Technologies) to limit the presence of single stranded DNA.  OD1/OD3 met these 
criteria as the target duplex DNA.  The reaction conditions were the same as used 
above with salDNA.  Specifically, OD1/OD3 (20 mM nts), sodium phosphate (25 
mM, pH 7), KF (500 mM), and 4-MeBrQMP (100 mM) were combined in a solution 
of 70:30 H2O:CH3CN.  The reaction was stirred in a 0.3 mL Reacti-vial for 1 hour 
prior to work-up and digestion using alkaline phosphatase (10 units, 100 µL) and 
phosphodiesterase I (0.28 units, 56 µL) (Method 2).  After enzymatic digestion for 24 
hours, the mixture was analyzed by HPLC (Figure 4.10).  The identification of the 
alkylated products was made with UV-Vis and tr comparisons to the individual 





Figure 4.10. HPLC analysis of an alkylation reaction consisting of 20 mM 
OD1/OD3, 25 mM sodium phosphate (pH 7), 500 mM KF, and 100 mM 4-
MeBrQMP in a 70:30 solution of H2O:CH3CN.  The reaction was stirred in a 0.3 mL 
glass Reacti-vial for 1 hour at 37 °C prior to an addition of 40 µL CH3CN to simulate 
the addition of BTI.  The reaction was worked-up and digested according to Method 






Figure 4.11.  Expansion of Figure 4.10 to better show the products of MeQM 
alkylation of OD1/OD3.  The same reaction without 4-MeBrQMP is shown in Figure 
4.5. 
HPLC analysis of the MeQM alkylation of OD1/OD3 confirmed that there 
was a higher yield of alkylation products formed when compared to salDNA (Figure 
4.9).  Unfortunately, there was still not a significant amount of MeQM alkylation 
products formed.  A low yield of alkylation products would be problematic for the 
planned oxidation and HPLC analysis due to the sensitivity of the HPLC and diode 
array detector.  The MeQM alkylation reaction shown in Figures 4.10 and 4.11 
revealed that the alkylation products are very close to the limit of detection. 
To confirm that the alkylation yield is insufficient for further oxidation 
studies, the reaction above (Figure 4.10) was repeated with an addition of BTI (40 
µL, 167 mM final concentration) after the 1 hour alkylation.  The work-up and 




Unfortunately, HPLC analysis confirmed that the amount of oxidized MeQM-DNA 
adducts produced was insufficient for quantification (Figure 4.12).  At this point, a 
new method of analysis, such as Ultra High Performance Liquid Chromatography 
(UHPLC) or tandem Liquid Chromatography – Mass Spectrometry (LC/MS) may be 
necessary to continue the study of MeQM alkylation of DNA and the subsequent 
oxidative trapping of reversible adducts. 
 
Figure 4.12. HPLC analysis of an alkylation reaction consisting of 20 mM 
OD1/OD3, 25 mM sodium phosphate (pH 7), 500 mM KF, and 100 mM 4-
MeBrQMP in a 70:30 solution of H2O:CH3CN.  The reaction was stirred in a 0.3 mL 
glass Reacti-vial for 1 hour at 37 °C prior to an addition of 40 µL BTI in CH3CN (167 
mM final concentration).  The reaction was stirred for 5 minutes at room temperature 
prior to work-up and digestion according to Method 2 using alkaline phosphatase (10 





4.3.  Summary. 
The enzymatic digestion of DNA has proven to be effective after both 
alkylation and oxidation conditions are applied to a target DNA.  The efficiency of 
alkylation by MeQM of target DNA decreases as the target is changed from 
monomeric nucleosides to a short duplex DNA (OD1/OD3) and decreases further as 
the target DNA is changed to a long duplex DNA (salDNA).  Unfortunately, it has 
become apparent that the sensitivity of UV analysis of HPLC chromatograms is not 
high enough to quantify the formation of product from the MeQM alkylation of 
duplex DNA (salDNA or OD1/OD3).  This leads to an inability to quantify the 
products of oxidation of MeQM alkylated DNA.  Either a new method of detection is 
needed to increase sensitivity or new alkylation conditions are needed to increase the 
amount of MeQM-DNA adducts formed. 
 
4.4.  Materials and Methods. 
Calf thymus DNA (ctDNA) was purchased from Sigma-Aldrich and salmon 
sperm DNA (salDNA, Na+salt, highly polymerized) was purchased from NBCo 
Biochemicals (now MP Bio), both as lyophilized solids.  OD1 and OD3 were 
purchased from Integrated DNA Technologies with “standard desalting” and were not 
further purified prior to use.  To form duplex DNA, OD1 and OD3 were dissolved in 
either potassium or sodium phosphate buffer, mixed, heated to 90 °C for 5 minutes 
and slowly cooled to room temperature over several hours.  Alkaline phosphatase 




venom (P3243) were purchased from Sigma-Aldrich as lyophilized solids and each 
was stored at a concentration of 0.1 unit/µL and 0.005 unit/µL, respectively, in a 
solution of 50 mM Tris-HCl pH 8, 50 µM ZnSO4, 10 mM MgCl2, and 50% glycerol.   
 
DNA work-up and digestion – Method 1.  For a 200 µL scale alkylation, once the 
alkylation and oxidation reactions were complete, the CH3CN was removed under a 
stream of N2 (15 minutes).  The DNA was precipitated by adding EtOH (55 µL, 100 
%) and cooling to -20 °C for 30 minutes.  The EtOH was evaporated under reduced 
pressure and the remaining DNA was washed with additional EtOH (140 µL, 80 %), 
frozen with liquid N2, and centrifuged (15 minutes, 14,800 rpm).  The supernatant 
was decanted from the Eppendorf tube and the remaining solid was dissolved in 100 
µL TEAA (100 mM, pH 10) and hydrolyzed by alkaline phosphatase (0.2 units per 1 
mM nts DNA) and phosphodiesterase I (0.006 units per 1 mM nts DNA).  The 
digestion mixture was held at 37 °C for 24 hours, followed by neutralization by 1% 
aqueous acetic acid (5 µL).  The mixture was filtered through a 0.2 µm syringe filter 
(with an addition of 50 µL H2O when necessary) and fractionated by analytical 
reverse-phase C18 chromatography (3% CH3CN in 9.7 mM ammonium formate, pH 
6.9, to 11% CH3CN in 8.9 mM ammonium formate, pH 6.9, over 24 minutes (1 
mL/min), followed by 11% CH3CN in 8.9 mM ammonium formate, pH 6.9, to 25% 






DNA work-up and digestion – Method 2.  For a 200 µL scale alkylation, once the 
alkylation and oxidation reactions were complete, the reaction mixture was washed 
with saturated diethyl ether (3 × 300 µL).  Ethanol (400 µL, 100%, 0 °C) was added 
to the aqueous phase and the solution was kept at -20 °C for 30 minutes to facilitate 
precipitation of the DNA.  The solution was centrifuged (5 minutes, 14,800 rpm) and 
the supernatant removed by pipette.  The remaining DNA was washed with 80% 
aqueous ethanol (140 µL) and centrifuged (5 minutes, 14,800 rpm).  The supernatant 
was removed by pipette and the remaining solid was dissolved in 100 µL TEAA (100 
mM, pH 10) and 44 µL MgCl2 (66.7 mM, 15 mM final concentration of Mg2+).  The 
DNA was hydrolyzed by 100 µL alkaline phosphatase (10 units for 20 mM nts DNA) 
and 56 µL phosphodiesterase I (0.28 units for 20 mM nts DNA).  The digestion 
mixture was held at 37 °C for 24 hours, followed by neutralization by 1% aqueous 
acetic acid (5 µL).  The mixture was filtered through a 0.2 µm syringe filter and 
fractionated by analytical reverse-phase C18 chromatography (3% CH3CN in 9.7 mM 
ammonium formate, pH 6.9, to 11% CH3CN in 8.9 mM ammonium formate, pH 6.9, 
over 24 minutes (1 mL/min), followed by 11% CH3CN in 8.9 mM ammonium 
formate, pH 6.9, to 25% CH3CN in 7.5 mM ammonium formate, pH 6.9, over the 








Chapter 5: Quantifying Quinone Methide Release from 
DNA with β-Mercaptoethanol 
 
 
5.1.  Introduction. 
Oxidative trapping of o-QM-DNA adducts can provide data on the intrinsic 
selectivity of a model o-QM (MeQM, 2.7) towards the nucleophilic positions on 
nucleosides.  Nucleophilic trapping of the o-QM released from DNA can provide 
complimentary data that allows for the quantification of how much of the o-QM-
DNA alkylation products are reversible.  Specifically, released QM from its adducts 
can be trapped by a nucleophile (such as β-mercaptoethanol, βME) and quantified.  
The kinetics of release can be observed by measuring QM release at various times 
between fluoride initiation of a precursor (to form o-QM) and nucleophile addition (to 
form o-QM-βME product) (Scheme 5.1).  For this project βME was chosen as a 
nucleophile for the trapping of MeQM as it reacts quickly with previous o-QMs and 
has been proven to be an effective trap of o-QM.61,101 Phenylhydrazine is another 
nucleophile previously used to trap the release of QM from QM-dG N7 adducts.58 
Subsequent studies completed prior to my arrival in the Rokita group replaced 
phenylhydrazine as a trapping nucleophile because decomposition of phenylhydrazine 






Scheme 5.1. Reaction scheme for nucleophilic trapping of MeQM (2.7) with βME to 
form MeQM-βME (5.3). 
 
As mentioned above, βME is an effective nucleophilic trap of active o-
QM.61,101 In these previous studies, βME suppressed cross-linking of a bisQM 
precursor with DNA by successfully competing with other nucleophiles such as water 
and dA to react irreversibly with an active bisQM present in solution to form QM-
βME.  This method provided the starting point for an alternative method for 
quantifying the reversibility of QMs.  Previously, transfer of a bisQM between 
complementary oligonucleotides has been used to observe the reversibility of the 
bisQM.61,102 Trapping of the released QM with a low molecular weight nucleophile 
would allow the reaction to be followed by HPLC.  The trapped products can also be 
unambiguously identified with analytical standards by comparing UV-Vis 
absorbencies and retention times.  Furthermore, the trapped products can be 




 The goal for the following studies is to, for the first time, quantify the 
reversible alkylation of DNA by using a model QM (MeQM, 2.7).  The release of 
QM from nucleosides, single stranded DNA (ssDNA), and double stranded DNA 
(dsDNA) was measured through the use of βME as a nucleophilic trap followed by 
HPLC analysis and quantification of the βME and water adducts of MeQM.  The 
expectation is that the βME product will form in high yield initially and gradually 
decrease as the QM is allowed more time to form irreversible adducts with H2O and 
the weaker nucleophiles of DNA (Scheme 5.1). 
 
5.2.  Results and Discussion. 
5.2.1. Synthesis of the Water and β-Mercaptoethanol Adducts of MeQM. 
The first step in this project was to synthesize the MeQM-H2O adduct (2-
(hydroxymethyl)-4-methylphenol, 5.2) and the MeQM-βME adduct (4-methyl-2-[(2-
hydroxyethylthio)methyl]phenol, 5.3) as standards to measure their molar extinction 
coefficients (ε) and obtain their HPLC retention times (tr).   
Synthesis of the MeQM-H2O adduct (5.2) was first attempted by combining 4-
MeBrQMP (2.6) and KF in a 3:2 solution of CH3CN:H2O.  The reaction was allowed 
to stir at room temperature for 26 hours to allow for the full reaction between MeQM 
and H2O.  The compound appeared to be MeQM-H2O from comparison of the HPLC 
tr to previous reactions with 4-MeBrQMP, which always contain a small amount of 
MeQM-H2O as a side product.  Additionally, 1H NMR confirmed the loss of the silyl 




acetate (TEAA) leftover from the HPLC buffer after lyophilization.  ESI+-MS was 
unable identify a parent ion of fragment that corresponded to MeQM-H2O, possibly 
due to TEAA repressing the signal.  Contamination with TEAA would also change 
the measured mass of MeQM-H2O and would introduce error into the molar 
extinction coefficient determination.  To minimize impurities, such as TEAA, a new 
method was needed to obtain pure MeQM-H2O.   
MeQM-H2O was synthesized by reduction of 5-methylsalicylaldehyde (2.3) 
with a 1 M borane/THF solution in high yield (> 95%) (Scheme 5.2).  The new 
synthesis had a shorter reaction time (< 2 hr), was much easier to scale up to gram 
quantities if needed and avoided the use of HPLC purification and 4-MeBrQMP (that 
required 3 steps to synthesize) as a starting material.  Most importantly, the product 
was observed to be pure based on 1H NMR and was characterized by 1H NMR, 13C 
NMR, and ESI+-MS (Appendix D1 – D3). 
Scheme 5.2. Synthesis of MeQM-H2O (5.2) in one step by reduction of 5-
methylsalicylaldehyde (2.3). 
 
The second standard to be synthesized was the MeQM-βME adduct (5.3).  
The first attempt at this synthesis was based on literature precedent.103 In the reaction 
vessel, βME was combined with KF prior to slow addition of 4-MeBrQMP for a 1:1 
reaction solution of DMF:H2O.  After 10 minutes the reaction was worked-up and 




was then increased from 10 minutes to 26 hours and the amount of βME was 
increased 1.5-fold.  The starting material was completely consumed under these later 
conditions and a total of five compounds were isolated by HPLC.  Unfortunately, 
ESI+-MS was unable to identify the expected product, possibly due to TEAA that was 
still present from the final HPLC purification after multiple rounds of lyophilization 
that suppressed the MS signals.  The TEAA would also interfere with the 
determination of the molar extinction coefficient.  Another drawback of this synthetic 
method was again the need to use 4-MeBrQMP.  An alternative synthesis was 
developed to address the drawbacks of the earlier synthetic scheme by starting with a 
simpler, commercially available reagent and avoiding the use of buffered HPLC 
solvents. 
The new synthesis started from 5-methylsalicylaldehyde (2.3) and formed the 
product MeQM-βME (5.3) in two steps (Scheme 5.3).  The silica supported sodium 
hydrogen sulfate catalyst (NaHSO4/SiO2) was prepared from the literature 
procedure.104 The first attempt at dithiolation followed the literature procedure except 
for substituting 5-methylsailicylaldehyde (2.3) for the reported salicylaldehyde.  5-
Methylsalicylaldehyde (2.3) was combined with βME and stirred slowly at room 
temperature while NaHSO4/SiO2 was slowly added.  Immediately, the mixture 
formed a yellow paste that stopped stirring.  Petroleum ether was added to the paste, 
but did not dissolve the mixture.  TLC (3:1, hexanes: ethyl acetate) of the petroleum 
ether phase suggested the presence of only the starting material, 2.3.  The 




Scheme 5.3. Synthesis of MeQM-βME (5.3) from 5-methylsalicylaldehyde (2.3.) 
through a dithioacetal intermediate (5.9).  1,4-CHD: 1,4-cyclohexadiene.  1,2-DCE: 
1,2-dichloroethane.   
 
   
 The second attempt at dithiolation of 2.3 was successful.  The amount of βME 
used was increased by more than 3-fold to alleviate the stirring difficulties involved 
with the paste formation.  5-Methylsalicylaldehyde (2.3) was again combined with 
βME and stirred slowly at room temperature while NaHSO4/SiO2 was slowly added 
to the mixture, stopping to add additional βME when a paste began to form.  
Immediately after the catalyst was completely added petroleum ether was added to 
the reaction, causing a solid to precipitate.  No compounds were observed by TLC 
(3:1, hexanes: ethyl acetate) in the liquid phase.  The petroleum ether was pipetted off 
of the solid and saved.  CHCl3 was added to dissolve the solid and produced a cloudy 
opaque solution.  TLC (3:1, hexanes: ethyl acetate) showed the presence of at least 
one compound at the baseline with no starting material (2.3) present.  The CHCl3 
solution was washed with petroleum ether (including the saved portion) and both 
layers were saved.  Additional CHCl3 was added to the CHCl3 layer and washed with 
H2O, dried with NaSO4, and removed under reduced pressure to yield a clear oil (1.73 
g, 63% crude yield).  The clear oil mostly crystallized upon standing and the 




confirmed to be the expected dithioacetal product 5.9 by 1H NMR (Figure 5.1) and 
ESI+-MS (Appendix D4).   
 
Figure 5.1. 1H NMR of 5.9 in CDCl3 at 400 MHz. 
In the second step of the synthesis the dithioacetal was reduced to a single 
thioether.105 The proposed mechanism by Ikeshita et al.105 of this transformation is 
shown in Scheme 5.4.  The Lewis acid, AlCl3, activates dithioacetal 5.9 and also 
abstracts a hydride from 1,4-cyclohexadiene (1,4-CHD).  The AlCl3 transfers the 
abstracted hydride to the activated dithioacetal, forming product 5.3 and reforming 
the catalyst AlCl3.  The cyclohexadienyl cation reacts with the previously formed 
AlCl3 - thioether to regenerate the catalyst AlCl3 along with benzene and βME, which 




Scheme 5.4. Proposed mechanism for the reduction of dithioacetal 5.9 by 1,4-CHD.  
Adapted from Ikeshita et al.105 
 
Dithioacetal (5.9) and 1,4-CHD were combined with 1,2-dichloroethane (1,2-
DCE, 7 mL) under N2 at room temperature.  While stirring, a suspension of AlCl3 in 
hexanes was slowly added.  Upon addition of AlCl3, the solution changed from 
colorless to a red/orange color.  Within 5 minutes, a precipitate formed and the 
reaction gradually changed to yellow over an hour.  The reaction was followed by 
TLC (2:1, hexanes; ethyl acetate) by removing a 100 µL aliquot and slowly 
quenching it with 200 µL H2O in a 1.5 mL Eppendorf tube.  CHCl3 (100 µL) was 
added to the aliquot containing 1.5 mL Eppendorf, shaken, and the organic layer was 
sampled for TLC.  The first TLC (2 hr 40 min) showed 4 spots, one at the baseline 




first, but when compared to the starting material, 5.9, it was determined that the 
baseline spot was starting material.  Further analyzing the aliquot removed at 4 hours 
40 minutes by 1H NMR (CD3CN) showed some starting material present, but also at 
least one other compound present, creating a complicated spectra.   
After seven hours, 9-fold more of the AlCl3 suspension was added and the 
reaction solution became a cloudy red.  The reaction was stirred overnight under N2 at 
room temperature.  After 22 hours, the solution was cloudy yellow with yellow solid 
on the sides of the round bottom flask.  TLC (2:1, hexanes: ethyl acetate) of the liquid 
phase revealed the same four spots, with the three mobile spots appearing darker.  
Analysis by ESI+-MS of the TLC aliquot was inconclusive while 1H NMR (CD3CN) 
gave a similar spectra as the earlier aliquot.  Analysis of the 1H NMR sample by 
HPLC shows the expected product formed as a minor component of the mixture 
(Figure 5.2).  MeQM-βME was identified by retention time and UV-Vis absorbance 





Figure 5.2. HPLC analysis of the 1H NMR (CD3CN) sample of the MeQM-βME 
reaction at 23 hours.  Fractionation by HPLC uses a linear gradient of 5 – 30% 
CH3CN in ammonium formate (10 mM, pH 6.9) over 45 minutes (1 mL/min). 
An additional 10-fold of the AlCl3 suspension was added to the reaction after 
25.5 hours.  The reaction turned a cloudy dark red/brown and became cloudy brown 
within 45 minutes.  TLC (2:1, hexanes: ethyl acetate) at 27.5 hours revealed the same 
4 spots as the previous TLCs.  At this point, a total of 2 equivalents of AlCl3 have 
been added to the reaction.  After 28 hours, the reaction was slowly quenched with 
H2O and extracted with CHCl3.  The organic phase was washed with brine, dried over 
MgSO4, and removed under reduced pressure to yield a yellow/brown oil.  The oil 
was stored at 0 °C for 6 days, where a color change occurred leaving a brown/black 
oil.  The oil was dissolved with ethyl acetate and purified by chromatotron.  The 
expected product (5.3) was collected with a crude yield of 0.032 g (16 %) and 




 Additional purification by HPLC was undertaken due to the high purity 
necessary for extinction coefficient measurements.  To avoid the presence of buffer 
salts in the lyophilized product, the first HPLC purification used nanopure H2O as the 
aqueous phase, with CH3CN as the organic phase.  The desired product was purified 
using a gradient of 3 - 25% aqueous CH3CN over 76 minutes (1 mL/min).  The 32 mg 
sample was dissolved into 400 µL CH3CN and aliquots of 25 - 50 µL were 
fractionated by HPLC.  After the first run using nanopure H2O as the aqueous phase, 
the remaining runs used 0.1% trifluoroacetic acid as the aqueous phase to sharpen 
some of the compounds that were tailing on the column, while avoiding the use of 
TEAA (Figure 5.3).106 
 
Figure 5.3. HPLC purification of MeQM-βME following a first purification by 
chromatotron.  Crude material (31.6 mg) was dissolved in CH3CN (400 µL) prior to 
the injection of a 50 µL aliquot.  Fractionation by HPLC used a linear gradient of 3 – 




A total of 8 HPLC runs were needed to purify all of the crude oil.  The 
resulting clear oil was combined and analyzed by 1H NMR to confirm pure MeQM-
βME for a yield of 0.013 g (6.7 %) (Appendix D6).  ESI+-MS and 13C NMR were 
also used to fully characterize the product (Appendix D7 – D8).  While the final yield 
of MeQM-βME was low (13 mg), there was enough pure compound to obtain a molar 
extinction coefficient (greater than 10 mg).   
Although the necessary amount of MeQM-βME was obtained from the above 
procedure, some improvements could be made if more MeQM-βME is needed in the 
future.  The slow introduction of 3 equivalents (instead of 2) of AlCl3 to the reaction 
as a solid should improve the yield.  The original use of a suspension of AlCl3 in 
hexanes proved difficult to regulate the amount of AlCl3 added to the reaction.  The 
increase in AlCl3 will also compensate for the possible interaction between AlCl3 and 
the three hydroxy groups present in the starting material 5.9.  The amount of 1,4-
CHD should also be increased from 1 equivalent to 2 equivalents if the new AlCl3 
procedure is ineffective, to increase the amount of hydride source in solution. 
 
5.2.2. Determination of Extinction Coefficients for MeQM-H2O, MeQM-
βME, and Internal Standards. 
The molar extinction coefficients of MeQM-H2O, MeQM-βME, and the 
internal standards were determined in the eluting buffer used in the HPLC analysis of 
the alkylation reaction to compensate for any pH or solvent effect on their 
absorbance.  Quantification of the amounts of MeQM-βME and MeQM-H2O 




coefficients for the two different internal standards used for HPLC analysis, phenol 
and meta-cresol, were also determined. 
For the βME trapping, three different elution buffers were used in the HPLC 
analysis.  Earlier work used 10 mM TEAA pH 5 as the aqueous phase and later work 
used either 0.1% aqueous TFA or 10 mM ammonium formate pH 6.9 as aqueous 
phase. The reasons for these adjustments will be discussed in the following section.   
The extinction coefficients at λ = 280 nm (ε280) of phenol and MeQM-H2O 
were determined in TEAA and TFA and ε280 values for m-cresol, MeQM-H2O, and 
MeQM-βME were determined in ammonium formate.  The wavelength at 280 nm 
was chosen for detection and ε determination because it is between the λmax of 
MeQM-H2O (279 nm) and MeQM-βME (283 nm).  This allows for maximum 
sensitivity to the detection of these compounds in the HPLC assay.  The molar 
extinction coefficient was calculated using the Beer-Lambert law (A = εcl) (Table 
5.1).  Stock solutions of each compound at 10 mM in H2O were prepared in triplicate.  
Aliquots were then diluted to a final concentration of 0.33 mM with the appropriate 
aqueous buffer.  With accurate ε280 values for each compound, MeQM-H2O and 
MeQM-βME can be directly compared to a known concentration of internal standard 
(phenol or m-cresol) and the HPLC peak area can be integrated and converted to the 






Table 5.1. Calculated molar extinction coefficients (ε) at λ280 nm of the compounds of 
interest in the βME trapping of MeQM. 
Compound 
(0.33 mM) 
ε280 (M-1cm-1) in 
9.7 mM TEAA pH 5 
ε280 (M-1cm-1) in 
0.097% aqueous TFA 
ε280 (M-1cm-1) in                                    
9.7 mM ammonium 
formate pH 6.9 
Phenol 560 ± 8 539 ± 30 572 ± 20 
m-Cresol n/a n/a 920 ± 30 
MeQM-H2O 2170 ± 40 1970 ± 30 1920 ± 60 
MeQM-βME 1420 ± 90 1460 ± 110 2170 ± 220 
 
 
5.2.3. Quantifying MeQM Released from Nucleoside Adducts by 
Trapping with β-Mercaptoethanol. 
Prior to conducting the βME trapping studies with both MeQM and a target 
nucleophile (dN or DNA), a series of control experiments confirmed the HPLC assay 
accurately measured the amount of MeQM-H2O, MeQM-βME, and the internal 
standard in the reaction mixture.  The goals of the control experiments were to 
confirm that MeQM-H2O and MeQM-βME are stable and to measure the persistence 
of MeQM and 4-MeBrQMP in solution in the absence of nucleophiles capable of 
forming labile adducts.  The rate of MeQM and 4-MeBrQMP persistence with and 
without the presence of DNA was measured by varying the aging time (Δt1) followed 
by addition of βME and a sufficient trapping time (Δt2) to allow for complete trapping 
of released MeQM by βME.  The aging time (Δt1) is necessary to allow MeQM to 
partition over time between irreversible reaction with water and reversible reaction 
with DNA prior to the addition of the βME trap.  The time needed for full transfer of 




constant and varying the trapping time (Δt2).  MeQM-H2O (5.2) and MeQM-βME 
(5.3) were quantified by HPLC analysis of each reaction (Scheme 5.5). 
Scheme 5.5. Scheme for the trapping of MeQM with βME.  Varying the aging time 
(Δt1) revealed the persistence of MeQM and 4-MeBrQMP while varying the trapping 
time (Δt2) allowed the release of MeQM from DNA to be measured. 
 
The first control reaction did not contain any nucleophiles that could 
potentially form reversible MeQM adducts (nucleosides or DNA) to measure the 
persistence of MeQM or 4-MeBrQMP in solution.  The initial reaction conditions 
consisted of 5% aqueous CH3CN with 50 mM 3-(N-morpholino)propanesulfonic acid 
(MOPS) pH 7 (buffer), 5 mM phenol (internal standard), 2 mM 4-MeBrQMP (MeQM 
source), and 500 mM KF (MeQM initiator) (Table 5.2).  This reaction was combined 
for a total of 100 µL in a 1.5 mL plastic Eppendorf vial and held at 37 °C for 1 hour 
(Δt1), after the addition of KF to allow MeQM to react with water.  After 1 hour, 20 
µL βME (600 mM in 50 mM MOPS pH 7) was added for a 60-fold excess compared 




to HPLC analysis to allow for complete trapping of any reversible MeQM.  The 
HPLC analysis utilized a gradient of 5 – 30% CH3CN in TEAA (10 mM, pH 5) over 
45 minutes with an analytical column (1 mL/min).  The one hour reaction time (Δt1) 
was expected to result in the maximum amount of MeQM-H2O and a lack of 
observable formation of MeQM-βME due to previous studies determining that the 
unsubstituted BrQMP (1.40) is fully converted to the QM intermediate within 30 
minutes under aqueous conditions.58 The inclusion of the electron-donating methyl 
group para to the phenolic oxygen in 4-MeBrQMP (2.6) stabilized the electron 
deficient MeQM intermediate (2.7).80 This was observed to lead to faster generation 
of MeQM from 4-MeBrQMP than QM from BrQMP allowing for more time for 
irreversible MeQM-H2O formation prior to the addition of βME in the absence of 
other nucleophiles.80 In the presence of DNA, this would also lead to faster formation 
of MeQM-DNA adducts.  Surprisingly, MeQM-βME was observed in higher yield 
than MeQM-H2O (46 nmol vs. 15 nmol), suggesting that MeQM or 4-MeBrQMP 
persisted for more than 1 hour under aqueous conditions, without a known 
nucleophile capable of forming a labile MeQM adduct and extending the lifetime of 








Table 5.2. Reaction conditions without a DNA nucleophile expected to produce a 
maximum amount of MeQM-H2O and a minimum amount of MeQM-βME. 





100 mM MOPS pH 7 25 50  
H2O 15   
50 mM Phenol 
in H2O 
10 5  
100 mM MOPS pH 7 25   
40 mM 4-MeBrQMP     
in CH3CN 
5 2  
2.5 M KF                      
in H2O 
20 500 100 
Trapping:       
600 mM βME               
in 50 mM MOPS pH 7 20 100 120 
 
 
Figure 5.4. HPLC chromatogram from the reaction detailed in Table 5.2.  The 
reaction was held for 1 hour at 37 °C after KF initiation of MeQM and for another 24 
hours at 37 °C after addition of βME.  HPLC analysis used a linear gradient of 5 – 




A series of control (lacking DNA related nucleophiles) experiments were then 
carried out with the goal of determining the amount of time necessary for MeQM to 
form from 4-MeBrQMP (Δt1) and for βME to react with and trap any free MeQM 
(Δt2).  The amount of time between KF initiation of MeQM and βME addition was 
varied between 0 minutes and 2 hours.  MeQM-βME formation was detected for each 
time point, suggesting that MeQM or 4-MeBrQMP persists for at least 2 hours in 
solution.  Furthermore, these experiments revealed that only a fraction of the expected 
200 nmol of MeQM-H2O and MeQM-βME was being detected.  The experiments 
averaged 63 nmol MeQM-H2O and MeQM-βME, combined, which is only a 31% 
yield based on 4-MeBrQMP.  Varying a number of reaction variables, including KF 
concentration, βME concentration, CH3CN concentration, and the presence of phenol, 
failed to affect the yield of the two MeQM adducts or the persistence of MeQM.   
 One possible explanation for the apparent persistence of MeQM was that one, 
or both, of MeQM-H2O and MeQM-βME formed reversibly.  Three experiments 
were conducted that demonstrated that both adducts were irreversible and stable 
under the βME trapping conditions.  The first experiment tested the stability of 
MeQM-H2O in the βME trapping conditions by including it at 2 mM as a replacement 
for an equal amount of 4-MeBrQMP.  The mixture was held at 37 °C for 66.5 hours 
prior to HPLC analysis (Figure 5.5).  There was no detected formation of MeQM-





Figure 5.5. HPLC chromatogram of the MeQM-H2O stability test.  MeQM-H2O was 
added at 2 mM (100% theoretical yield) to 4.2% aqueous CH3CN containing 50 mM 
MOPS pH 7, 5 mM phenol, 4 mM in nucleotides (nts) calf thymus DNA (ctDNA), 
500 mM KF, and 100 mM βME.  The reaction was held for 66.5 hours at 37 °C prior 
to HPLC analysis using a linear gradient of 5 – 30% CH3CN in TEAA (10 mM, pH 
5).  MeQM-H2O co-elutes with ctDNA, leading to the broad base of the peak at tr = 
23 minutes. 
 The second experiment tested the stability of MeQM-βME in the βME 
trapping conditions by including it at 2 mM as a replacement for an equal amount of 
4-MeBrQMP. The mixture was held at 37 °C for 68.5 hours prior to HPLC analysis 
(Figure 5.6).  Although a small amount of ctDNA did elute at the expected tr of 
MeQM-H2O, there was no significant formation of MeQM-H2O which would have 
been accompanied by a corresponding decrease in the amount of MeQM-βME from 
its regeneration of the active MeQM.  These two experiments also show that there is 
no interconversion between MeQM-H2O and MeQM-βME due to nucleophilic attack 





Figure 5.6. HPLC chromatogram of the MeQM-βME stability test.  MeQM-βME 
was added at 2 mM (100% theoretical yield) to 4.2% aqueous CH3CN containing 50 
mM MOPS pH 7, 5 mM phenol, 4 mM in nucleotides (nts) calf thymus DNA 
(ctDNA), and 500 mM KF.  The reaction was held for 68.5 hours at 37 °C prior to 
HPLC analysis using a linear gradient of 5 – 30% CH3CN in TEAA (10 mM, pH 5). 
 The third experiment removed any potential MeQM source (4-MeBrQMP, 
MeQM-H2O, or MeQM-βME) from the above stability tests.  This experiment tested 
if ctDNA impurities or βME side-products (such as thiol dimers) would obscure any 
of the compounds of interest (MeQM-βME, MeQM-H2O, or phenol).  After the 
mixture was incubated at 37 °C for 70 hours, there were no compounds detected by 
HPLC at the tr of MeQM-βME (40 min) or phenol (labeled).  Calf thymus DNA, 
however, eluted at the tr of MeQM-H2O (23 min), but this would increase the 
observed yield of MeQM-H2O and would not explain the low yields.  This result 




the reaction mixture or any side-reactions occurring with βME, as observed at tr = 10 
minutes (Figure 5.7). 
 
Figure 5.7. HPLC chromatogram of the stability test without a potential MeQM 
source. A 4.2% aqueous CH3CN solution containing 50 mM MOPS pH 7, 5 mM 
phenol, 4 mM in nucleotides (nts) calf thymus DNA (ctDNA), 500 mM KF, and 100 
mM βME was held for 70 hours at 37 °C prior to HPLC analysis using a linear 
gradient of 5 – 30% CH3CN in TEAA (10 mM, pH 5). 
 Next, the reaction vessel was varied to determine if this affected the 
persistence of MeQM or the yield of MeQM-H2O and MeQM-βME.  The previous 
experiments were carried out in polypropylene vials (1.5 mL).  The precursor 4-
MeBrQMP may interact more strongly with this plastic reaction vessel than a glass 
reaction vessel, sequestering it from reacting with the available H2O and βME.  To 
test glass reaction vessels, a 600 µL auto-sampler brown glass vial was fitted with a 
rubber septa.  Two identical reactions in which KF was added after βME to yield a 




adducts between the plastic and glass reaction vessels (Table 5.3).  The reaction in 
the glass vessel resulted in 51% increase in the amount of MeQM-H2O and MeQM-
βME formed (175 nmol vs. 74 nmol) and 87.5% of the maximum yield (200 nmol) 
based on 4-MeBrQMP.  It was also discovered that shaking the reaction, as opposed 
to floating in a water bath, had a more dramatic effect on the yield of both adducts 
when reaction conditions consisted of 4 hours in between KF initiation of MeQM and 
addition of βME (Δt1) (Table 5.4).  The combined total of MeQM-H2O and MeQM-
βME increased 20% from 79 nmol to 120 nmol.  Furthermore, shaking with the glass 
vessel increased the combined yield of MeQM-H2O and MeQM-βME by 12% over 
shaking the plastic reaction vessel (144 nmol vs. 120 nmol).  These results suggest 
that better mixing of the reaction solution is key to obtaining the maximum recovery 
of MeQM adducts.  A change of reaction temperature from 37 °C to room 














Table 5.3. Reaction conditions used to compare the effect of reaction vessel on the 
persistence of MeQM and subsequent formation of MeQM-βME.  The reactions were 
carried out in a polypropylene vial (1.5 mL) and a glass auto-sampler vial (600 µL) at 
37 °C for 24 hours with no agitation after the initial mixing. 





100 mM MOPS pH 7 10 8.3  
H2O 40   
CH3CN 15   
50 mM Phenol 
in H2O 
10 4.2  
40 mM 4-MeBrQMP 
in CH3CN 
5 1.7  
600 mM βME 
in 50 mM MOPS pH 7 20 100  
2.5 M KF 
in H2O 
20 416.7 120 
Table 5.4. Reaction conditions used to compare the effect of shaking the reaction 
vessel on the persistence of MeQM and subsequent formation of MeQM-βME.  The 
reactions were carried out in a polypropylene vial (1.5 mL) and a glass auto-sampler 
vial (600 µL) at room temperature for 4 hours after KF initiation (Δt1) followed by 
addition of βME and no agitation at 37 °C for 24 hours (Δt2). 





100 mM MOPS pH 7 10 10  
H2O 40   
CH3CN 15   
50 mM Phenol 
in H2O 
10 5  
40 mM 4-MeBrQMP 
in CH3CN 
5 2  
2.5 M KF 
in H2O 
20 500 100 
Trapping:       
600 mM βME 




Since the reaction conditions were changed significantly from the earlier 
studies (Table 5.2), a new control experiment was needed to measure the persistence 
of MeQM without the presence of DNA (Table 5.5).  Again, the aging time between 
KF initiation (Δt1) of MeQM and addition of the βME trap was varied between 0 – 24 
hours.  The subsequent formation of MeQM-βME was measured to quantify the 
persistence of MeQM or 4-MeBrQMP.  During this time, the reaction was shaken in 
the glass vessel at room temperature.  After βME addition, the reaction was kept in a 
water bath at 37 °C for 24 hours (Δt2) and subsequently analyzed by HPLC.  MeQM-
βME was observed to form after all reaction times (Δt1) of up to 2 hours, suggesting 
that MeQM or 4-MeBrQMP still persisted in solution as MeQM-βME has been 
shown to only form with MeQM.  
Table 5.5. Reaction conditions for the control experiment which measures the 
persistence of MeQM or 4-MeBrQMP in solution in the absence of DNA.  Reaction 
was shaken at room temperature after KF initiation of MeQM for 0 - 24 hours (Δt1) 
and was held at 37 °C for 24 hours after addition of βME (Δt2). 





100 mM MOPS pH 7 10 10  
H2O 30   
CH3CN 25   
50 mM Phenol 
in H2O 
10 5  
40 mM 4-MeBrQMP     
in CH3CN 
5 2  
2.5 M KF                      
in H2O 
20 500 100 
Trapping:       




Once it was determined that glass reaction vessels resulted in a higher yield of 
MeQM adducts, a more permanent solution than the septa capped auto-sampler vial 
was needed.  Glass Reacti-vials were the practical choice as they can use stir bars, can 
be stirred in the warm room at 37 °C, and they can accommodate a number of 
reaction volumes (0.3 mL and 5 mL vials).  All of the following reactions use Reacti-
vials as the reaction vessel. 
When ctDNA was introduced into the above reactions, HPLC analysis 
revealed that it co-elutes with MeQM-H2O, obscuring the actual amount of MeQM-
H2O in solution (Figure 5.8).  The broad peak at tr = 21 minutes was confirmed to be 
ctDNA by its λmax (259 nm) and it matches the tr of a prepared standard of only 







Figure 5.8. Example HPLC chromatogram of the βME trapping reaction detailed in 
Table 5.4, including ctDNA at 4 mM nts.  The reaction was stirred for 14 hours at r.t. 
after KF initiation of MeQM (Δt1) followed by stirring for 4 hours at 37 °C after βME 
addition (Δt2).  HPLC analysis used a linear gradient of 5 – 30% CH3CN in TEAA 
(10 mM, pH 5). 
As a simple solution to ctDNA co-eluting with MeQM-H2O, different aqueous 
phases were tested to observe any effect of the tr of ctDNA so that it would not 
overlap with any of the compounds of interest (phenol, MeQM-H2O, and MeQM-
βME).  The original aqueous phase was 10 mM TEAA pH 5 and the first new 
aqueous phase tested was 10 mM TEAA pH 4 since the elution of DNA is pH 
dependant.  This resulted in an increased tr (23 minutes) for ctDNA that still 
overlapped with MeQM-H2O.  The next aqueous phase tested was 10 mM ammonium 
formate pH 6.9.  The ctDNA now eluted earlier (17 minutes) and did not overlap with 
MeQM-H2O.  Unfortunately, the ctDNA now co-eluted with phenol.  The next 




expectation that the lower pH (~2) would increase the tr beyond MeQM-H2O, but not 
to MeQM-βME.  Using this aqueous phase, the ctDNA did not elute during the 
course of the gradient as it precipitated out of solution on the column prior to the UV-
Vis detector.  One last aqueous phase tested was 10 mM ammonium formate pH 3 to 
avoid precipitation of ctDNA, but the ctDNA once again co-eluted with MeQM-H2O.  
The only aqueous phase (in the pH range tolerated by the C18 silica) to clearly 
resolve the three compounds of interest was 0.1% TFA.  To avoid precipitating DNA 
on the HPLC column, a work-up of the reaction consisting of an addition of 100 µL 
0.1% TFA followed by filtration (syringe filter, 0.2 µm) and an addition of another 
aliquot of 0.1% TFA (50 µL) to push the remainder of the reaction through the filter 
was utilized when 0.1% TFA was the aqueous phase.  The drop in pH upon addition 
of 0.1% TFA caused the ctDNA to precipitate out of solution.  After filtration, the 
ctDNA was removed from the subsequent HPLC analysis allowing for a cleaner 
HPLC chromatogram. 
An attempt to determine the mechanism behind the surprising persistence of 
MeQM in aqueous conditions analyzed the reaction prior to the addition of βME.  
The hypothesis was that an intermediate was formed with the active MeQM that 
could then reverse to form MeQM or be substituted directly by βME to form MeQM-
βME.  Either option would give the impression of MeQM persisting for hours in 
solution.  The reaction from Table 5.5 was analyzed by HPLC after 1 – 2.5 hours 
after KF activation of MeQM (Δt1), prior to βME addition.  A new compound was 
observed (tr = 15 min) that does not co-elute with any previous compound and has a 




unobserved MeQM adduct.  Multiple reactions without ctDNA and βME were carried 
out to allow for the collection of this new compound.  The compound proved stable 
enough in CD3CN for 1H NMR (Figure 5.9) and ESI+-MS (Figure 5.10). 
 
Figure 5.9. 1H NMR of the proposed MeQM-MOPS adduct (5.10) in CD3CN at 500 
MHz.  The methylene protons from the MOPS fragment were observed between 2.5 – 
4 ppm, but the specific identification was ambiguous. 
1H NMR supports the claim that this is a MeQM adduct due to the 
characteristic three aromatic protons (H3, H5, H6 - 6.93 - 7.20 ppm), methylene 
bridge (H7 - 4.47 ppm), and a peak possibly corresponding to the 4-Me group (H4′ - 
2.28 ppm).  Due to H2O in the NMR sample, integration of the numerous aliphatic 
protons was not possible.  The chemical shifts of the aromatic protons and the 
methylene bridge do not match any of the previously mentioned MeQM adducts, such 




existed that the compound was the deprotected, but not debrominated, 4-MeBrQMP.  
This theory was disproved by ESI+-MS as there were no fragments characteristic of a 
bromine containing compound or of the deprotected and debrominated compound.  
There was, however, a fragment corresponding to a MeQM-MOPS adduct (m/z 
330.16 exp. vs. 330.14 calc.) and free MOPS (m/z 210.10 exp. vs. 210.08 calc.) 
(Figure 5.10).   
 
Figure 5.10. ESI+-MS of MeQM-MOPS (5.10).  The parent compound (5.10, M+) 
and the MOPS fragment are detected. 
Additional evidence supporting this structure was the disappearance of the 
compound at tr = 15 min when only MOPS is removed from the reaction.  
Unfortunately, attempts to recover the compound from the NMR solvent (CD3CN) 
were unsuccessful.  A majority of the compound eluted with the injection volume 




A portion of the NMR sample (30 µL in CD3CN) was subjected to the standard βME 
trapping conditions (70 µL water and 10 µL βME stirring for 4 hrs at 37 °C) to test 
the reversibility of the new MeQM adduct.  There was no observed MeQM-βME 
adduct, but due to the small amount of starting material in the NMR sample this result 
may be inconclusive.  Further testing of this adduct was not a priority, but provided 
enough reason to remove the MOPS buffer from the reaction and use a less 
nucleophilic buffer in its place.   
Upon the discovery that MOPS reacts with MeQM discovery, it was thought 
that this product was contributing to the persistence of MeQM. To investigate this 
claim, the βME trapping experiment was repeated by exchanging the MOPS buffer 
with H2O or potassium phosphate (50 mM, pH 7 stock solution).  Each reaction was 
incubated at room temperature for 2 hours after KF initiation of MeQM (Δt1) and 
another 4 hours at 37 °C after the βME addition to allow for the complete trapping of 
any reversible MeQM (Δt2). These conditions previously resulted in the formation of 
both MeQM-H2O and MeQM-βME to compare the three solvents (MOPS, H2O, and 
phosphate).  The reaction that included MOPS had the most MeQM-βME, accounting 
for 86% of the total adducts formed, while the reaction with H2O resulted in 17% 
MeQM-βME and the potassium phosphate reaction resulted in 10% MeQM-βME.  
Potassium phosphate was chosen to replace MOPS as the buffer in the following 
trapping studies based on this data. 
With the replacement of MOPS with potassium phosphate, the ability of 
ctDNA to extend the effective lifetime of MeQM was again investigated.  The 




a 30% aqueous CH3CN solution with phenol (internal standard), ctDNA (nucleophilic 
target), 4-MeBrQMP (MeQM source), and KF (MeQM initiator) (Table 5.6).  This 
solution was stirred at 37 °C for 30 minutes (Δt1) to allow for reaction with water or 
DNA prior to addition of βME (10 µL, 1.29 M final concentration).  The solution 
continued to stir at 37 °C for 4 hours (Δt2) to allow for full transfer of reversible 
MeQM from DNA to βME prior to 0.1% TFA work-up and HPLC analysis.  These 
conditions would allow for the capture of the initial MeQM by ctDNA and its 
subsequent release and trap by βME.  A blank reaction, without the ctDNA, was also 
analyzed by HPLC to quantify the effect of ctDNA on the persistence of MeQM, as 
measured by MeQM-βME.  The reaction containing ctDNA yielded a 2.5-fold 
increase in MeQM-βME over the blank reaction (35 nmol vs. 14 nmol) (Figure 5.11).  
In order to put this result in context, a number of DNA nucleophiles were also 
studied.  These included nucleosides, shorter dsDNA, and shorter ssDNA. 
Table 5.6. Reaction conditions for the comparison between the ability of various 
nucleoside based nucleophiles to extend the lifetime of MeQM in solution using 
potassium phosphate as a buffer.  ctDNA, OD1, OD2, OD1/OD3, and dNs were 
investigated at a final concentration of 4 mM in nucleotides. 





H2O 15   
CH3CN 25   
50 mM Phenol            
in H2O 
10 5  
16 mM nts DNA 
in 50 mM potassium 
phosphate pH 7 
25 4 (in nts)  25 (phosphate)  
40 mM 4-MeBrQMP      
in CH3CN 
5 2  
2.5 M KF                       
in H2O 
20 500 100 
Trapping:       






Figure 5.11. Comparing the formation of MeQM-βME in the presence of various 
nucleoside based nucleophiles.  Each reaction was stirred at 37 °C for 0.5 hr after KF 
initiation of MeQM (Δt1) and at 37 °C for 4 hr after βME addition (Δt2).  OD1 is an 
average of two reactions while the other data points are from single reactions.  The 
blank reaction does not contain nucleoside based nucleophiles. 
Previous studies have shown that dA will extend the effective lifetime of a 
bisQM in solution,61 and has been chosen as a positive control in place of ctDNA in 
the reaction above (Table 5.6).  The effect is observed due to the reversibility of the 
QM-dA N1 adduct and its ability to efficiently capture and release QM.  Formation of 
a reversible adduct, however, is not the only reason for success in this system as the 
reversible adducts of dG N7 and dC N3 failed to extend the lifetime of the bisQM 
under equivalent conditions that were successful with dA N1.101 Although dC N3 
forms a reversible adduct with o-QM, it is not as good of a nucleophile as dA N1 and 




N1 and dC N3 form adducts at high initial yields with o-QM, dC N3 reacted slower, 
reaching a maximum yield after 10 hours versus 30 minutes for dA N1.58 The o-QM 
is also released slower by dC N3, when measured by the half-life of QM-dC N3 
(approx. 50 hours), than by dA N1 (approx. 4 hours).  The adduct formed with dG N7 
only forms in low yields and the reverse reaction is in direct competition with 
deglycosylation leading to the irreversible guanine N7 adduct.58 As the other two dG 
adducts (N1 and N2) are irreversible, dG also does not effectively trap and release an 
o-QM under aqueous conditions.101  
Due to its ability to extend the lifetime of o-QM, dA was chosen as a positive 
control with βME trapping (Table 5.6).  For comparison to ctDNA, dA also utilized a 
concentration of 4 mM and the same reaction times as the ctDNA study.  The reaction 
with dA resulted in a 7.2-fold increase of MeQM-βME over the blank reaction (101 
nmol vs. 14 nmol) and a 2.9-fold increase of MeQM-βME over the ctDNA reaction 
(101 nmol vs. 35 nmol) (Figure 5.11).  This result confirmed that dA is a much more 
effective nucleophile for extending the lifetime of MeQM.  An eqimolar mixture of 
each nucleoside (dA, dG, dC, and dT) was studied also at a total nucleoside 
concentration of 4 mM.  This reaction was to test if dA was the major contributing 
nucleoside to the increase in effective lifetime of MeQM.  The equimolar mixture of 
dNs resulted in a 3.3-fold increase of MeQM-βME over the blank reaction (46 nmol 
vs. 14 nmol) and a 1.3-fold increase of MeQM-βME over the ctDNA reaction (46 
nmol vs. 35 nmol) (Figure 5.11).  The equimolar mixture of dNs was 46% as 
effective as just dA suggesting that dG and dC also increase the lifetime of MeQM in 




the equimolar mixture would be 25% effective as just dA.  For each of these 
reactions, most of the unaccounted MeQM was trapped as MeQM-H2O (Appendix 
D.9).  The remaining MeQM was most likely trapped by the irreversible dN 
nucleophiles (dA N6, dG N1, and dG N2) or polymerized into dimers or trimers.  
Denatured ctDNA was used as the source of ssDNA to directly compare the 
contribution of ssDNA versus dsDNA to extend the effective lifetime of MeQM.  The 
ctDNA was denatured by heating the ctDNA stock solution to 90 °C for 5 minutes 
followed by quick cooling in an ice bath.  The ssDNA is expected to more effectively 
increase the lifetime of MeQM by providing access to the dA N1 position 
unencumbered by hydrogen bonding found in dsDNA.  The denatured ctDNA, 
however, resulted in a 0.8-fold decrease in the formation of MeQM-βME when 
compared to the non-denatured (annealed) ctDNA (29 nmol vs. 35 nmol) (Figure 
5.11, Appendix D.9 for MeQM-H2O).  The most likely reason for similar results with 
annealed and denatured ctDNA is that the denaturing procedure was not effective, 
due to the length of ctDNA.  To test this hypothesis, a shorter (40 base pairs) 
oligonucleotide was studied in its ssDNA form and annealed with its complementary 
strand for its dsDNA form (Figure 5.12).  The new oligonucleotide, OD1, consisted 
of 40 nucleotides (17.5% A, 30.0% T, 37.5% G, 15.0% C).  The exact sequence had 
no significance, merely that there was not a lack of any one base, it did not form any 
stable secondary structures (hairpin) at 37 °C, and the melting temperature of its 
duplex DNA was above 37 °C (calculated at 69 °C as OD1/OD3) to limit the 
presence of ssDNA in future dsDNA studies.  OD1 met these criteria as the ssDNA 




unrelated project (as JA2-62 REV).  The reaction above (Table 5.6) used 4 mM nts 
OD1 and yielded a 5.6-fold increase in MeQM-βME compared to the reaction 
without nucleosides (79 nmol, vs. 14 nmol) and an increase of 2.7-fold compared to 
the denatured ctDNA (79 nmol vs. 29 nmol) (Figure 5.11, Appendix D.9 for MeQM-
H2O).  To test if the nucleotide composition of OD1 contributed to the increase in 
effective lifetime of MeQM, a second oligonucleotide (OD2) was purchased (Figure 
5.12).  OD2 also consisted of 40 nucleotides (5.0% A, 37.5% T, 40% G, 17.5% C) 
and featured 12.5% less dA than OD1, previously determined to be the major 
contributing nucleoside to extending the lifetime of MeQM (dA vs. dN).  Use of OD2 
did yield a 4.5-fold increase in MeQM-βME when compared to the reaction without 
nucleosides (63 nmol vs. 14 nmol), but a 0.8-fold decrease when compared to OD1 
(63 nmol vs. 79 nmol), suggesting that the composition of ssDNA does correlate to its 
ability to extend the lifetime of MeQM in solution (Figure 5.11).  OD2 was still 2.2-
fold more effective in extending the lifetime of MeQM than denatured ctDNA (63 
nmol vs. 29 nmol), despite the higher dA content of ctDNA (55% A:T).107 This 
further shows that denatured ctDNA is not an effective model of ssDNA. 
 
Figure 5.12. Synthesized oligonucleotide sequences used as model of dsDNA and 
ssDNA.  OD1 and OD3 are complementary. 
OD1 was annealed with its complementary strand OD3 to form OD1/OD3 for 




formation of MeQM-βME as a way to quantify the release of MeQM from DNA.  
The shorter OD1/OD3 is expected to have a greater effect on the lifetime of MeQM 
than ctDNA, based on the results of the ssDNA studies above.  The oligonucleotides 
OD1 and OD3 were annealed (OD1/OD3) in 50 mM potassium phosphate, pH 7 at 
90 °C for 5 minutes followed by slow cooling (overnight) to room temperature.  
OD1/OD3 was used in the reaction detailed in Table 5.9 at 4 mM nts and resulted in 
a 4.0-fold increase in the formation MeQM-βME compared to the reaction without 
nucleosides (56 nmol vs. 14 nmol) (Figure 5.11, Appendix D.9 for MeQM-H2O).  
OD1/OD3 was 0.7-fold less effective at extending the lifetime of MeQM than just 
OD1, which was expected as two of the positions capable of forming labile adducts 
with MeQM (dA N1 and dC N3) are occupied in OD1/OD3 due to hydrogen bond 
formation.  Most importantly, OD1/OD3 was 1.6-fold more effective at extending the 
lifetime of MeQM than ctDNA (56 nmol vs. 35 nmol of MeQM-βME).  Based on this 
result OD1/OD3 was used the standard dsDNA for the future experiments of MeQM 
trapping with βME, while OD3 will be the standard ssDNA for future experiments 
due to the increased percentage of dA compared to OD1 (30% vs. 17.5%). 
With a new standard dsDNA (OD1/OD3) and new reaction conditions 
(potassium phosphate in place of MOPS), the release of MeQM from dsDNA needed 
to be reexamined.  Previous studies determined that a trapping time of 4 hours after 
βME addition (Δt2) was sufficient to allow for the full transfer of reversible MeQM 
from ctDNA to βME.  The subsequent formation of MeQM-βME was measured 
while varying the time after βME addition (Δt2) from 0 – 24 hours.  Unfortunately, 




persistence of MeQM in solution.  The new experiment used the conditions detailed 
in Table 5.6 to quantify the release of MeQM from OD1/OD3 as measured by 
formation of MeQM-βME.  This information was necessary to determine the time 
needed after the addition of βME (Δt2) for the complete release of MeQM from 
dsDNA for use in future experiments that vary the aging time (Δt1).  Each reaction 
was stirred at 37 °C for 30 minutes after KF initiation of MeQM (Δt1) followed by 
βME addition.  The reaction was then stirred at 37 °C for 0 – 48 hours (Δt2) prior to 
work-up and HPLC analysis.  The maximum amount of MeQM-βME was observed at 
24 hours after βME addition, although the yield may have reached maximum as early 
as 1 hour, but it is difficult to tell because of the error in the measurements (Figure 
5.13).  Future experiments consistently used 24 hours between βME addition and 
work-up to ensure that all of the MeQM was released from the target DNA and for 






Figure 5.13. Measuring the release of MeQM from OD1/OD3 by quantifying the 
amount of MeQM-βME formed.  The data is best fit to a logarithmic trendline only to 
indicate product trends.  Data points prior to 16 hours are an average of three 
reactions.  Data points for 16, 24, and 48 hours are single reactions.  The error bars 
are based on the standard deviation of the data.  The amount of MeQM-H2O formed 
is shown in Appendix D.10. 
An issue with the new target dsDNA (OD1/OD3) was that, unlike ctDNA, it 
did not precipitate during the work-up prior to HPLC analysis.  While phenol 
(internal standard) and MeQM-βME were still well resolved by HPLC, OD1/OD3 
co-eluted with MeQM-H2O (Figure 5.14).  Previous attempts to alter the tr of ctDNA 
determined that higher pH elution buffers decreased the tr of DNA.  Specifically, use 
of ammonium formate (10 mM, pH 6.9) as the elution buffer resulted in both MeQM-
H2O and MeQM-βME to be well resolved.  Unfortunately, phenol was obscured by 
OD1/OD3.  The use of a new internal standard that did not co-elute with any other 
compound in the chromatogram was explored. The compound m-cresol differed from 
phenol only in the addition of a methyl group meta to the phenolic oxygen.  This 




elute with any other compound in the reaction when ammonium formate (10 mM, pH 
6.9) was used as the elution buffer.   Therefore, m-cresol was chosen as the internal 
standard for the following experiments with the βME trapping of MeQM (Figure 
5.15). 
  
Figure 5.14. HPLC chromatogram of the reaction detailed in Table 5.6 with 
OD1/OD3 as the DNA nucleophile.  The reaction was stirred at 37 °C for 30 minutes 
after KF initiation of MeQM (Δt1) and 4 hours after βME addition (Δt2).  HPLC 





Figure 5.15. HPLC chromatogram of the reaction detailed in Table 5.7 with 
OD1/OD3 as the DNA nucleophile.  The reaction was stirred at 37 °C for 30 minutes 
after KF initiation of MeQM (Δt1) and 24 hours after βME addition (Δt2).  
Unidentified peaks are mostly βME by-products. HPLC analysis used a linear 
gradient of 5 – 30% CH3CN in ammonium formate (10 mM, pH 6.9). 
With a new internal standard, experiments analyzing the release of MeQM 
from various nucleoside based nucleophiles by measuring MeQM-βME formation 
were undertaken.  The reaction conditions consisted of a 30% aqueous CH3CN 
solution with 5 mM m-cresol, 4 mM nts nucleophile (OD1/OD3 (dsDNA), OD3 
(ssDNA), dA (dN), or no DNA (blank)), 2 mM 4-MeBrQMP, and 500 mM KF 
(Table 5.7).  TFA was removed from the work-up as it was no longer needed to 
precipitate the DNA.  In its place 100 µL of 10 mM ammonium formate pH 6.9 was 
added to the reaction followed by filtration (0.2 µm) and HPLC analysis.  The new 




and in the blank reaction.  It is unknown what the precipitate is, but it does not appear 
to be any of the compounds of interest (m-cresol, MeQM-H2O, or MeQM-βME).   
Table 5.7. Comparison between the ability of various nucleoside based nucleophiles 
to extend the lifetime of MeQM in solution using m-cresol as the internal standard 
instead of the previously used phenol. OD1/OD3, OD3, and dA were investigated at 
a final concentration of 4 mM in nucleotides in 25 mM potassium phosphate. 





H2O 15   
CH3CN 25   
50 mM m-Cresol            
in H2O 
10 5  
16 mM nts DNA 
in 50 mM potassium 
phosphate pH 7 
25 4 (in nts) 25 (phosphate)  
40 mM 4-MeBrQMP      
in CH3CN 
5 2  
2.5 M KF                       
in H2O 
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The time points were chosen to give a profile of MeQM release from various 
nucleoside based nucleophiles by measuring the formation of MeQM-βME.  Each 
time point was an individual 110 µL reaction stirred in a 0.3 mL Reacti-vial at 37 °C. 
The time points after KF initiation of MeQM (aging, Δt1) were 0.5, 0.75, 1, 2, and 4 
hours, while the time after βME addition (trapping, Δt2) was a constant 24 hours.  The 
beginning Δt1 time point (0.5 hr) was chosen based on the length of time necessary 
for the BrQMP (1.40) to fully convert to the active QM intermediate.58 As MeQM is 




captured by DNA and not by βME.  The final Δt1 time point (4 hr) was chosen 
because a similar electron-rich QM-dA N1 adduct was observed to have a half-life of 
less than 4 hours.80 As this is the major source of released MeQM in the experiment, 
it was anticipated that MeQM release after 4 hours would be insignificant.  In 
addition to the reactions without nucleosides, dA, OD3, and OD1/OD3 were present 
in reactions at a concentration of 4 mM nts (Figure 5.16). 
 
Figure 5.16. Measuring the formation of MeQM-βME in the presence of various 
DNA based nucleophiles. Each reaction is stirred at 37 °C for the indicated time after 
KF initiation (Δt1) and stirred at 37 °C for 24 hours after addition of βME (Δt2).  The 
data is best fit to an exponential trendline only to indicate product trends.  Each data 







 For this assay, an increase in the formation of MeQM-βME can be correlated 
to an increase in the effective lifetime of MeQM in solution.  Immediately obvious is 
the drastic decrease in yield of MeQM-βME at 30 minutes after KF activation of 
MeQM (19 nmol) when compared to the previous assay conditions (128 nmol, 
Figure 5.13 – 24 hr after βME addition).  The cause of this discrepancy is unknown, 
but may be due to the new ammonium formate based work-up and eluting buffer (10 
mM ammonium formate pH 6.9) in combination with the new internal standard (m-
cresol) discussed earlier as these were the only conditions altered between the 
experiments shown in Figures 5.13 and 5.16.  It is also apparent that over shorter 
periods of KF initiation of MeQM (Δt1 < 1 hr), dA and OD3 more than double the 
amount of MeQM that persists in solution.  OD1/OD3, however, does not effect the 
lifetime of MeQM in solution when compared to the blank (no nucleoside based 
nucleophiles) reaction. At 2 hours after KF activation of MeQM (Δt1), only OD3 
shows increased formation of MeQM-βME, but not to the extent of the earlier time 
points. 
The ability of dA and OD3 to apparently extend the lifetime of MeQM can be 
attributed to their reversible nucleotide adducts dA N1, dC N3, and dG N7. 
Meanwhile, OD1/OD3 does not appear to extend the lifetime of MeQM. This can be 
attributed to the dA N1 and dC N3 positions participating in hydrogen bonding, 
leaving only dG N7 available in the major groove to form reversible adducts with 
MeQM.  The dG N7 position, as previously discussed, does not efficiently capture 
and release MeQM due in part to the reverse reaction being in direct competition with 




containing 83% of its bases capable of reversible alkylation (based on A, C, and G 
content), while OD1/OD3 only contains 26% of its bases capable of reversible 
alkylation (based on G content), but not the effective dA N1 position.  The threefold 
difference in available reversible alkylation positions should, at least partially, explain 
why OD3 is more effective at extending the lifetime of MeQM than OD1/OD3 
(Figure 5.16).  One problem with this reasoning is that dA should then be 
consistently better than OD3 at extending the lifetime of MeQM, but actually is 
equally effective after one hour.  More complex effects such as ssDNA secondary 
structures that sequester MeQM from the surrounding aqueous environment may 
provide a mechanism to increase the lifetime of MeQM.  The inability of dA to form 
these secondary structures could contribute to its decreased performance after one 
hour.  Additionally, proximate dA nucleotides in OD3 may better capture newly 
released MeQM while the monomeric dA nucleosides won’t have the same ability. 
 
5.3.  Summary. 
The goal of the previous studies was to, for the first time, quantify the release 
of MeQM from DNA.  The release of MeQM from nucleosides, ssDNA, and dsDNA 
was measured through the use of βME as a nucleophilic trap followed by HPLC 
analysis and quantification of the resulting βME and H2O adducts of MeQM.  The 
expectation was that the βME product would form in high yield initially and 
gradually decrease as MeQM was allowed more time to form irreversible adducts 




During the βME trapping studies a number of variables have been adjusted to 
allow for the unobstructed reaction of MeQM first with DNA and later with βME to 
quantify the release of MeQM from DNA.  These adjustments have resulted in the 
removal of competing compounds (MOPS), changed the reaction vessel 
(polypropylene to glass), and introduced constant stirring of the reactions.  All of 
these adjustments lead to the near complete consumption of MeQM by both H2O and 
βME.  This was necessary to isolate the contribution of various forms of DNA 
towards extending the effective lifetime of MeQM.  Furthermore, HPLC conditions 
were optimized to ensure that the three compounds of interest (MeQM-H2O, MeQM-
βME, and m-cresol) were eluted fully resolved from each other or any reaction by-
products. 
 The effective lifetime of MeQM under aqueous conditions can be extended by 
the presence of either dA or a short ssDNA (OD3) with dA providing a larger initial 
effect (< 1 hr).  Somewhat surprisingly, a short dsDNA (OD1/OD3) appears to have 
no effect on the effective lifetime of MeQM under aqueous conditions.  However, 
their does seem to be contradicting data on the total yield of MeQM adducts from the 
experiments shown in Figures 5.13 and 5.16.  Specifically, the experiments with m-
cresol as the internal standard and ammonium formate (10 mM, pH 6.9) as the 
aqueous HPLC phase yield 15% of MeQM adducts as the experiments with phenol as 
the internal standard and 0.1% TFA as the aqueous HPLC phase.  Further analysis of 
the assay conditions, including possibly selecting a new internal standard and aqueous 
HPLC phase, may be needed to identify the mechanism behind the apparent 





5.4.  Materials and Methods. 
Organic starting materials, reagents, and solvents were obtained commercially 
and used without further purification.  Silica gel used in the NaHSO4/SiO2 catalyst 
was grade 60 Å, <230 mesh and purchased from Fisher Scientific.  All CH3CN was 
HPLC grade purchased from Fisher Scientific.  UV-Vis spectroscopy was performed 
on a Hewlett Packard 8453 spectrophotometer.  OD1, OD2, and OD3 were purchased 
from Integrated DNA Technologies with “standard desalting” and were not further 
purified prior to use.  To form duplex DNA, OD1 and OD3 were dissolved in the 
indicated buffer, mixed, heated to 90 °C for 5 minutes and slowly cooled to room 
temperature over several hours. 
 
Synthesis of 2-(hydroxymethyl)-4-methylphenol (MeQM-H2O, 5.2).   
5-Methylsalicylaldehyde (0.809 g, 5.94 mmol) was dissolved in anhydrous THF (40.0 
mL), under N2 at 0 °C.  While stirring, a 1 M solution of BH3/THF (10.0 mL, 10.0 
mmol) was slowly added.  The reaction was stirred for 1.33 hr under N2 at 0 °C.  The 
reaction was slowly quenched by addition of 200 mL H2O and extracted with CH2Cl2 
(3 × 100 mL).  The organic layers were combined, washed with H2O (2 × 100 mL) 
and brine (3 × 100 mL), and dried with MgSO4.  The solvent was removed at reduced 
pressure and the remaining product was purified by chromatotron (1:1, hexanes: ethyl 
acetate) to yield a white crystalline solid (0.821 g, 100 % yield).  1H NMR (400 MHz, 
d4-methanol) δ 7.06 (d, J=2 Hz, 1H), 6.89 (dd, J=8, 2 Hz, 1H), 6.65 (d, J=8 Hz, 1H), 




129.7, 128.4, 116.0, 61.4, 20.7. ESI+-MS: m/z 121.0627 (M + H – H2O)+.  Calcd for 
C8H9O+ (M + H – H2O)+: 121.0648.  m/z 241.1197 (2M + H – 2H2O)+.  Calcd for 
C16H17O2+ (2M + H – 2H2O)+: 241.1223. m/z 361.1604 (3M + H – 3H2O)+.  Calcd for 
C24H25O3+ (3M + H – 3H2O)+: 361.1798.  λmax = 223, 279 nm (diode array detector, 
17% CH3CN in ammonium formate, 8 mM, pH 6.9). 
 
 
Preparation of NaHSO4/SiO2 catalyst.104 NaHSO4 (6.9 g, 50 mmol) was dissolved 
in nanopure water (100 mL) at room temperature.  While stirring, <230 mesh silica 
gel (15 g) was added and the solution stirred at room temperature for 30 minutes.  
The water was evaporated under reduced pressure to yield a white powder.  The white 
powder was further dried in an oven at 120 °C for 2.5 hr and stored in a sealed 250 
mL round bottom flask at room temperature.   
 
Synthesis of 4-methyl-2-[bis[(2-hydroxyethyl)thio]methyl]phenol (5.9).104  
5-Methylsalicylaldehyde (1.37 g, 10.0 mmol) and β-mercaptoethanol (2.80 mL, 40.0 
mmol) were combined in a 50 mL round bottom flask with a magnetic stirrer.  
NaHSO4/SiO2 (2.01g, w/w 23 %) was added slowly over several minutes while 
stirring at room temperature.  As the reaction became more viscous an additional 1.00 
mL β-mercaptoethanol was added.  Once all of the NaHSO4/SiO2 was added, an 
additional 1.00 mL β-mercaptoethanol was added.  The reaction was immediately 
washed with petroleum ether (20 mL) and the organic layer was checked by TLC 




removed by pipette once the solid settled to the bottom of the flask and CHCl3 (10 
mL) was added to the reaction producing an opaque solution upon stirring.  TLC (3:1, 
hexanes:ethyl acetate) of the reaction mixture showed complete consumption of the 
starting material (5-methylsalicylaldehyde).  The reaction mixture was extracted by 
petroleum ether (3 × 20 mL) and the CHCl3 layer was saved.  An additional 20 mL 
CHCl3 was added to the CHCl3 layer and the combined solution was washed with 
H2O (2 × 20 mL), dried with Na2SO4, and evaporated under reduced pressure to yield 
a clear oil (1.73 g, 63.0 % crude yield).  The clear oil began to crystallize over several 
hours and the remaining solvent was removed overnight under vacuum.  1H NMR 
(400 MHz, CDCl3) δ 7.79 (s, 1H), 7.30 (d, J=1.4 Hz, 1H), 6.92 (dd, J= 1.4, 8.2 Hz, 
1H), 6.70 (d, J= 8.2 Hz, 1H), 5.50 (s, 1H), 3.76 (s, 2H), 3.70 (m, 4H), 2.81 (m, 2H), 
2.66 (m, 2H), 2.25 (s, 3H).  ESI+-MS: m/z 197.09 (M + H - βME)+.  Calcd for 
C10H13O2S+ (M + H - βME)+: 197.06.  m/z 257.10 (M - OH)+.  Calcd for C12H17O2S2+ 
(M - H2O)+: 257.07.  m/z 297.09 (M + Na)+.  Calcd for C12H18NaO3S2+ (M + Na)+: 
297.06. 
 
Synthesis of 4-methyl-2-[(2-hydroxyethylthio)methyl]phenol (MeQM-βME, 
5.3).105 The crude product generated above (5.9) (0.27 g, 0.98 mmol) was combined 
with 1,4-cyclohexadiene (0.09 mL, 0.95 mmol) in 1,2-dichloroethane (7 mL).  A 
suspension of AlCl3 in hexanes (0.10 mL, 0.96 M, 0.096 mmol) was added dropwise 
to the reaction solution while stirring under N2 at room temperature.  A color change 
in the reaction mixture from colorless to red/orange was observed, along with a 




reaction solution changed from red/orange to yellow.  The reaction was monitored by 
TLC (2:1, hexanes:ethyl acetate) and 1H NMR (CD3CN) after a quick workup in 
which a 100 µL aliquot of the reaction solution was quenched slowly in a 1.5 mL 
Eppendorf with 200 µL H2O.  Additional CHCl3 (100 µL) was added and, after 
shaking, the organic phase was removed for analysis.  A second addition of AlCl3 in 
hexanes (0.90 mL, 0.96 M, 0.86 mmol) was added dropwise to the reaction after 5 
hours.  A color change from yellow to cloudy red was observed and the reaction was 
stirred under N2 at room temperature overnight.  A third addition of AlCl3 in hexanes 
(1.0 mL, 0.96 M, 0.96 mmol) was added dropwise to the reaction after 25.5 hours and 
a color change from yellow to dark red was observed.  The solution became a cloudy, 
dark brown color within 45 minutes.  The reaction was slowly quenched with H2O 
(20 mL) after 28 hours.  The quenched reaction was extracted with CHCl3 (3 × 20 
mL), washed with brine (3 × 20 mL), dried with MgSO4, and evaporated under 
reduced pressure to yield a yellow/brown oil, which changed color to a brown/black 
oil while stored at 0 °C.  The brown/black oil was purified by silica gel radial 
chromatography (chromatotron) using hexanes, then 2:1 hexanes:ethyl acetate with 
<1 % methanol, and finally ethyl acetate with <1 % methanol.  The second band 
contained the product, but was not pure by 1H NMR (CD3CN) (32 mg, 16 % crude 
yield).  The product was further purified by analytical reverse-phase C18 HPLC using 
a 3 - 25% gradient of CH3CN in 0.1% aqueous TFA over 76 minutes (1 mL/min).  
The product 5.3 was collected (tr = 50 - 60 minutes) and lyophilized to yield a clear 
oil (13 mg, 6.7 % yield).  1H NMR (400 MHz, d3-acetonitrile) δ 6.99 (s, 1H), 6.92 (d, 




J=6.4 Hz, 2H), 2.22 (s, 3H).  13C NMR (500 MHz, d3-acetonitrile) δ 154.2, 132.3, 
130.1, 130.0, 126.1, 116.9, 62.6, 35.2, 31.6, 20.9.  ESI+-MS: m/z 199.0838 (M + H)+.  
Calcd for C10H15O2S+ (M + H)+: 199.0787.  m/z 121.0689 (M – βME)+.  Calcd for 
C8H9O+ (M – βME)+: 121.0648.  m/z 221.0669 (M + Na)+.  Calcd for C10H14NaO2S+: 
221.0607.  m/z 237.0584 (M + K)+.  Calcd for C10H14KO2S+: 237.0346.  λmax = 219, 






Chapter 6: Conclusions 
 
A variety of exogenously generated electrophiles have proven to be capable of 
alkylating DNA.  If not repaired, these DNA adducts can lead to mutations and either 
cancer or cell death.  Prediction of the toxicity of any DNA alkylating agent utilizing 
this mechanism of action would require the determination of its reactivity towards 
DNA under biologically relevant conditions.  An added complication to the 
determination of the reactivity of an alkylating agent with DNA is that some of these 
electrophiles can alkylate DNA reversibly, effectively extending their lifetime in vivo 
while making their detection more difficult than that for irreversible alkylating agents.  
The ability to predict toxicity of a DNA alkylating agent is important because a 
number of these compounds have found success as chemotherapeutic agents whose 
mechanism of action is the targeted alkylation of DNA contained in tumor cells.  
While effective, any non-specific alkylation outside of the tumor can lead to 
genotoxicity and the devastating side-effects experienced with chemotherapy.  The 
development of a trapping system allowing for the detection and quantification of the 
reversible DNA adducts would greatly enhance understanding of the reactivity of the 
reversible DNA alkylating agent and help to guide the synthesis of more selective 
agents. 
 Electrophilic ortho-quinone methides (o-QM) can alkylate DNA and are 
generated during xenobiotic metabolism of a variety of compounds.  From model 
studies based on nucleosides, o-QMs react most readily, but reversibly with strong 




The hour time-scale of the reverse reactions complicates analysis of their products in 
DNA, which requires enzymatic digestion and chromatographic separation.  The 
alkylation profile of DNA can change drastically from the beginning of the digestion 
to the chromatographic separation.  Instead, a chemical trap utilizing 
bis[(trifluoroacetoxy)iodo]benzene (BTI) has been developed to transform the 
reversible MeQM-DNA adducts into irreversible derivatives capable of surviving 
such analysis, allowing the intrinsic selectivity of MeQM alkylation of DNA to be 
determined for the first time.  The goal of this dissertation was to synthesize and 
characterize the oxidation products of each individual MeQM-dN adduct and then use 
these products as analytical standards to determine the MeQM alkylation profile of 
DNA at short time points. 
 Oxidative trapping studies with the unsubstituted o-QM and dC highlight the 
necessity of an alkyl substituent para to the phenolic oxygen to block over-oxidation 
and the subsequent rearrangement and reincorporation of bromine to the final 
product.  The novel precursor 4-MeBrQMP (2.6) included a methyl group para to the 
phenolic oxygen to block the over-oxidation.  Initial studies with dC resulted in the 
formation of MeQM-dC N3 (2.8) which was subsequently oxidized to a single stable 
product (2.15).  The oxidized MeQM-dC N3 adduct (2.15) was fully characterized by 
1D NMR, 2D NMR, and ESI+-MS. 
 Oxidation of the four MeQM-dG adducts (dG N7, dG N1, dG N2, and guanine 
N7) yielded four unique products.  Due to the deglycosylation of MeQM-dG N7 to 
MeQM-guanine N7, only three of the oxidation products were fully characterized by 




survive the enzymatic digestion of DNA.  Interestingly, BTI oxidation of the MeQM-
dG adducts resulted in the transformation of the QM phenol to a p-quinol, unlike the 
oxidation of MeQM-dC N3 that resulted in the transformation of the QM phenol to a 
spiro-cyclized product.  The result of both transformations is the formation of stable 
products capable of surviving the enzymatic digestion conditions.  
 Initial studies involving duplex DNA were begun as my undergraduate mentee 
Omer Ad carried out the synthesis and characterization of the oxidized products of 
MeQM-dA N1 and MeQM-dA N6.  The enzymatic digestion of DNA was observed to 
be sensitive to the quality of enzyme used, specifically phosphodiesterase I.  The 
enzyme supplier has therefore become an important variable to in the digestion of 
DNA.  With suitably high quality enzymes, both from Sigma-Aldrich, enzymatic 
digestion was determined to be effective after both alkylation and oxidation 
conditions are applied to a target DNA.  It was also observed that the efficiency of 
alkylation of target DNA by MeQM decreases as the target is changed from 
monomeric nucleosides to a short duplex DNA (OD1/OD3) and decreases further as 
the target DNA is changed to a long duplex DNA (salDNA).  The result is that 
amount of MeQM-DNA adducts formed is near the level of detection of the HPLC 
analysis.  This leads to conditions that are not sufficient to quantify the products of 
oxidation of MeQM alkylated DNA.  One possible solution is to use a method of 
analysis that is more sensitive than HPLC/UV-Vis, such as LC/MS or ultra high 
performance liquid chromatography (UHPLC).  The increased sensitivity of either 
method would lower the limit of detection for the products of oxidation of MeQM-




materials in the MeQM alkylation of DNA, either 4-MeBrQMP or target DNA, to 
increase the amount of MeQM-DNA adducts formed.  The subsequent oxidation 
would lead to a larger amount of oxidized MeQM-DNA adducts formed for analysis.  
Similar to this solution, increasing the maximum injection volume on the HPLC 
would allow the alkylation and oxidation reactions to be scaled-up and increase the 
amount of product analyzed.  Another method to increase the amount of MeQM-
DNA adducts that are formed would be the use of a shorter duplex DNA as the target 
DNA. 
 Experiments were also performed to study a different aspect, but with the 
same goal, of reversible MeQM alkylation of DNA by analyzing the release of 
MeQM from alkylated DNA.  Oxidative dearomatization of the QM phenol with BTI 
can trap the reversible MeQM-DNA adducts by transforming these adducts into 
irreversible DNA adducts while β-mercaptoethanol (βME) can irreversibly trap 
MeQM released from DNA to form MeQM-βME.  HPLC quantification of MeQM-
βME can be used to measure the amount of reversible MeQM-DNA adducts still 
present in a specific target DNA at a specific time.  Alkylations of target DNA 
(dsDNA, ssDNA, and dN) by MeQM for less than 4 hours were subsequently reacted 
with βME.  These studies showed that the nucleoside dA and the ssDNA OD3 
successfully extended the lifetime of MeQM in solution.  The dsDNA OD1/OD3, 
however, had no effect on the lifetime of MeQM when compared to the reaction 
without a nucleoside based nucleophile.  The ability of single stranded OD3 to 
effectively capture and release MeQM while double stranded OD1/OD3 did not 




DNA adducts formed initially and, therefore, may be a better target DNA for the 
oxidative trapping studies than OD1/OD3.  The presence of reversible MeQM-DNA 
adducts should allow for a higher yield of oxidized products at short reaction times, 
increasing the amount of oxidized MeQM-DNA adducts available for HPLC analysis. 
 The analytical standards necessary for the quantification of the oxidative 
trapping of reversible MeQM-DNA adducts have been synthesized and characterized.  
Unfortunately, the alkylation yield of duplex DNA is insufficient for analysis by 
HPLC.  A number of solutions including increasing the concentration of reagents, 
substituting ssDNA for dsDNA, and utilizing a more sensitive analytical method for 
the detection of MeQM-DNA adducts have been proposed and will be pursued in the 
future.  Once the oxidative trapping of MeQM-DNA adducts can be accomplished, 
the alkylation time can be varied to obtain an alkylation profile of MeQM towards 
DNA.  It can also be determined if MeQM alkylates DNA at the most nucleophilic 
and accessible position (dG N7) or if there is a sequence specificity that influences 
the reactivity of MeQM towards DNA.  If, as predicted, dG N7 is preferentially 
alkylated initially, MeQM may be useful also as a molecular probe of duplex DNA 
structure.  For example, if there are portions of duplex DNA that are not base paired, 
the presence of MeQM-dC N3 and MeQM-dA N1 would be detected.   
 The goal of the studies presented in this dissertation is to develop a method of 
trapping the reversible QM-DNA adducts to determine the intrinsic selectivity of o-
QM towards DNA.  With the BTI based oxidative trapping system and the 
synthesized analytical standards, this intrinsic selectivity can be determined.  




be used to assess the potential toxicity of QM-based DNA alkylating agents.  
Furthermore, a targeted QM-based DNA alkylating agent can be developed with the 
hope of finding use as an anti-cancer chemotherapeutic agent with the information 









Appendix A. Supporting Information for Chapter 2 
 
Table A.1. 13C and 1H NMR data for the product (2.2) formed by oxidation of QM-
dC adduct 1.42 (DMSO-d6). 
Position 13C shift (ppm) 1H shift (ppm) HMBC Connectivity 
1' 85.6 6.39 (t, J=6.6 Hz) 2', 3', 4', 6 
2' 40.2 2.23 (m) 4' 
3' 70.2 4.30 (m) 2', 4', 5' 
4' 87.9 3.87 (m) 2', 3', 5' 
5' 61.1 3.62 (m) 2', 3', 4' 
2, 4 145.2, 145.2   1', 5, 6, 7 
5 98.1 6.78 (d, J=8.0 Hz) 6 
6 129.9 7.85 (d, J=8.0 Hz) 1', 5 
7 116.6 8.63 (s) 10 
8 138.7   7, 10 
10 143.2 8.39 (s)   
11 124.4   10, 12 










Table A.2. 13C and 1H NMR data for the product (2.15) formed by oxidation of 
MeQM-dC adduct 2.8 (DMSO-d6). 
Position 13C shift (ppm) 1H shift (ppm) HMBC Connectivity 
1' 83.8 6.16 (t, J=7.0 Hz) 2', 3', 4', 6 
2' 39.5 2.04 (m)   
3' 70.5 4.22 (m) 2', 4', 5' 
4' 87.1 3.75 (m) 2', 5' 
5' 61.4 3.53 (m) 3' 
2 147.5   1', 6 
4 154.9   5, 6, 7 
5 96 5.78 (d, J=8.2 Hz) 6 
6 137 7.50 (d, 8.2 Hz) 1', 5 
7 51.5 3.70 (d, J=11.2 Hz), 3.92 (d, J=11.2 Hz)    
8 73.1   7, 10 
9 199.7   7 
10 123.5 5.97 (d, J=9.9 Hz)   
11 146.3 7.03 (dd, J=9.9, 2.2 Hz) 14 
12 128.8   11, 14 
13 136.6 6.06 (bd, J=6.4 Hz) 7, 10, 11, 14 








Figure A.1. Reverse-phase C18 chromatography was used to detect and isolate 
formation and oxidation of the QM-dC N3 adduct (1.42).  (A) Separation of the QM-
dC adduct 1.42 used a gradient of 3 - 25% CH3CN in triethylammonium acetate pH 5 
over 76 min (analytical, 1 mL/min).  (B) Separation of the adduct 2.2 after oxidation 
by BTI used a gradient of 3 - 25% CH3CN in water over 66 min (preparative, 5 
mL/min).  
 
Figure A.2. HPLC analysis of the BTI oxidation of MeQM-dC N3.  Oxidized product 
2 was the initial focus of the structure elucidation efforts.  Unfortunately, oxidized 
product 1 appears to have been the eventually isolated and characterized MeQM-dC 





Figure A.3. Reverse-phase C18 chromatography was used to detect and isolate 
formation and oxidation of the MeQM-dC N3 adduct (2.8).  (A) Separation of the 
MeQM-dC adduct 2.8 and (B) its oxidation product 2.15 used a gradient of 3 - 25% 
CH3CN in ammonium formate pH 6.8 over 76 min (analytical, 1 mL/min).  
 
Figure A.4. 1H NMR of the combined isolated product from the Sep-Pak solvent 





Figure A.5. 1H NMR of 2.2 in DMSO-d6 at 600 MHz. 
 







Figure A.7. 1H – 13C HSQC of 2.2 in DMSO-d6 at 600 MHz. 
 





Figure A.9. 1H – 15N HMBC of 2.2 in DMSO-d6 at 600 MHz. 
 





Figure A.11. ESI+-MS/MS of 2.2 (m/z 384). 
 





Figure A.13. 1H NMR of 2.8 in DMSO-d6 at 500 MHz. 
 






Figure A.15. 1H NMR of 2.15 in DMSO-d6 at 400 MHz. 
 






Figure A.17. 1H – 1H COSY of 2.15 in DMSO-d6 at 400 MHz. 
 





Figure A.19. 1H – 13C HMBC of 2.15 in DMSO-d6 at 400 MHz. 
 




Appendix B. Supporting Information for Chapter 3 
 
Table B.1. 13C and 1H NMR data for the product (3.7) formed by oxidation of 
MeQM-dG N1 (DMSO-d6). 
Position 13C shift (ppm) 1H shift (ppm) HMBC Connectivity 
1' 82.2 6.15 (t, J=6.9 Hz) 2', 3' 
2' 39.5 2.54 (m), 2.22 (m)   
3' 70.8 4.34 (m) 2', 4', 5' 
4' 87.6 3.81 (m) 2', 5' 
5' 61.7 3.53 (m)   
2 153.9   10 
4 149.4   1', 8 
5 115.6   8 
6 156.2   10 
8 135.7 7.97 (s) 1' 
10 39.4 4.88 (t, J=15.7 Hz),       4.62 (t, J=15.7 Hz) 16 
11 129.5   10, 13 
12 184.8   13, 14, 16 
13 125.5 6.09 (d, J=10.0 Hz)   
14 154.3 6.95 (dd, J=2.9, 10.0 Hz) 16, 17 
15 66.5   13, 17 
16 146.3 6.13 (m) 10, 14, 17 










Table B.2. 13C and 1H NMR data for the product (3.8) formed by oxidation of 
MeQM-dG N2 (DMSO-d6). 
Position 13C shift (ppm) 1H shift (ppm) HMBC Connectivity 
1' 82.8 6.14 (t, J=6.9 Hz) 2' 
2' 39.3 2.58 (m), 2.19 (m)   
3' 70.8 4.32 (m) 2', 4', 5' 
4' 87.6 3.80 (m) 2', 5' 
5' 61.8 3.50 (m)   
2 152.4   10 
4 150.3   1', 8 
5 117.0   8 
6 156.6     
8 135.7 7.91 (d, J=2.5 Hz) 1' 
10 38.9 4.11 (d, J=5.3 Hz) NH 
11 131.7   10, 13 
12 185.1   10, 14, 16 
13 125.5 6.06 (d, J=10.0 Hz)   
14 154.5 6.96 (dd, J=2.9, 10.0 Hz) 16, 17 
15 66.4   13, 17 
16 149.4 6.80 (m) 10, 14, 17 
















Table B.3. 13C and 1H NMR data for the product (3.9) formed by oxidation of 
MeQM-guanine N7 (DMSO-d6). 
Position 13C shift (ppm) 1H shift (ppm) HMBC Connectivity 
2 154.4     
4 159.7   8 
5 107.9   8, 10 
6 152.9     
8 143.4 7.84 (s) 10 
10 43.8 4.99 (d, J=15.7 Hz, 1H),  5.04 (d, J=15.7 Hz, 1H) 8, 13, 16 
11 131.3   10, 13, 16 
12 184.1   10, 13, 14, 16 
13 125.2 6.06 (d, J=10.1 Hz)   
14 154.6 6.95 (dd, J=2.8, 10.1 Hz) 16, 17 
15 66.3   13, 17 
16 150.6 6.51 (s) 10, 14, 17 

























Table B.4. 13C and 1H NMR data for the p-quinol model compound 4-hydroxy-2,4-
dimethyl-2,5-cyclohexadien-1-one (3.9) (CDCl3).68 
Position 13C shift (ppm) 1H shift (ppm) 
1 186.3   
2 126.6 6.01 (d, J=9.9 Hz, 1H) 
3 152.3 6.81 (d, J=2.9, 9.9 Hz, 1H) 
4 67.3   
5 148 6.63-6.60 (m, 1H) 
6 133.3   
7 26.8 1.40 (s, 3H) 














Figure B.1. HPLC analysis of MeQM-dG N7 after overnight lyophilization.  The dry 
product was dissolved in 1:1 H2O:CH3CN prior to Gradient 1 using the analytical 
column (1 mL/min). 
 
Figure B.2. HPLC analysis of the product formed by oxidation of MeQM-dG N1.  
The 1H NMR sample (Figure 3.12) was diluted with H2O to make a 50% aqueous 
DMSO-d6 solution prior to re-injection into the HPLC.  The peak at approximately 30 






Figure B.3. 1H NMR of MeQM-dG N7 (3.4) in DMSO-d6 at 600 MHz. 
 





Figure B.5. 1H NMR of MeQM-dG N1 (3.2) in DMSO-d6 at 400 MHz. 
 





Figure B.7. 1H NMR of 3.7 in DMSO-d6 at 600 MHz. 
 
 






Figure B.9. 1H – 13C HSQC of 3.7 in DMSO-d6 at 600 MHz. 
 





Figure B.11. 1H NMR of 3.8 in DMSO-d6 at 600 MHz. 
 
 






Figure B.13. 1H – 13C HSQC of 3.8 in DMSO-d6 at 600 MHz. 
 





Figure B.15. 1H NMR of 3.10 in DMSO-d6 at 600 MHz. 
 
 






Figure B.17. 1H – 13C HSQC of 3.10 in DMSO-d6 at 600 MHz. 
 




Appendix C. Supporting Information for Chapter 4 
 
 
Figure C.1. HPLC analysis of an alkylation reaction consisting of 2 mM each dN, 25 
mM sodium phosphate (pH 7), 200 mM NaF, and 160 mM 4-MeBrQMP in an 80:20 
solution of H2O:CH3CN.  The reaction was carried out in a 1.5 mL plastic Eppendorf 
tube for 30 minutes at 37 °C. 
 
Figure C.2. HPLC analysis of an alkylation reaction consisting of 2 mM each dN, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 240 mM 4-MeBrQMP in an 70:30 
solution of H2O:CH3CN.  The reaction was carried out in a 1.5 mL plastic Eppendorf 





Figure C.3. HPLC analysis of an alkylation reaction consisting of 2 mM each dN, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 240 mM 4-MeBrQMP in an 70:30 
solution of H2O:CH3CN.  The reaction was carried out in a 1.5 mL plastic Eppendorf 
tube for 1 hour at 37 °C. 
 
Figure C.4. HPLC analysis of an alkylation reaction consisting of 2 mM each dN, 25 
mM sodium phosphate (pH 7), 500 mM KF, and 240 mM 4-MeBrQMP in an 70:30 
solution of H2O:CH3CN.  The reaction was carried out in a 0.3 mL glass Reacti-vial 





Figure C.5. Overlay of 3 HPLC chromatograms showing the MeQM alkylation of 
monomeric nucleosides (dC in black, dG in red, and dA in green).  Each reaction 
consisted of 4-MeBrQMP (25 mM), dN (25 mM), and KF (250 mM) in a 1:1 solution 
of DMF:H2O.  Each reaction was stirred in a 0.3 mL Reacti-vial for 1 hour at 37 °C 
prior to analysis by HPLC using an analytical column (1 mL/min).  The HPLC 





Figure C.6. HPLC analysis of undigested salDNA.  A mixture consisting of salDNA 
(8 mM nts), sodium phosphate (25 mM, pH 7), and NaF (200 mM) in an 80:20 
solution of H2O:CH3CN was subjected to work-up and digestion conditions (Method 
2) without the presence of alkaline phosphatase or phosphodiesterase I. 
 
Figure C.7. HPLC analysis of undigested OD1/OD3.  An aqueous mixture consisting 
of OD1/OD3 (16 mM nts) and potassium phosphate (25 mM, pH 7) was subjected to 
work-up and digestion conditions (Method 2) without the presence of alkaline 




Appendix D. Supporting Information for Chapter 5 
 
Figure D.1. 1H NMR of MeQM-H2O (5.2) in d4-methanol at 400 MHz. 
 





Figure D.3. High resolution ESI+-MS of MeQM-H2O (5.2) calibrated with CsI.  Mass 
error is 22.1 ppm (M + H – H2O)+. 
 
Figure D.4. ESI+-MS of the dithioacetal intermediate (5.9).  Compound 2.3 is 





Figure D.5. 1H NMR of MeQM-βME (5.3) in CD3CN at 400 MHz after purification 
by chromatotron. 
 






Figure D.7. 13C 1D (top) and DEPT135-SP (bottom) NMR of MeQM-βME (5.3) in 
CH3CN at 500 MHz.  For DEPT135-SP positive signals are CH and CH3 carbons, 
negative signals are CH2 carbons.  Quaternary carbons are not observed. 
 
Figure D.8. High resolution ESI+-MS of MeQM-βME (5.3) calibrated with CsI.  





Figure D.9. Comparing the formation of MeQM-H2O in the presence of various 
nucleoside based nucleophiles.  Each reaction was stirred at 37 °C for 0.5 hr after KF 
initiation of MeQM (Δt1) and at 37 °C for 4 hr after βME addition (Δt2).  OD1 is an 
average of two reactions while the other data points are from single reactions.  The 
blank reaction does not contain nucleoside based nucleophiles. 
 
Figure D.10. Measuring the capture of MeQM by H2O by quantifying the amount of 
MeQM-H2O formed.  The data is best fit to a logarithmic trendline.  Data points prior 







Figure D.11. Measuring the formation of MeQM-H2O in the presence of various 
DNA based nucleophiles. Each reaction is stirred at 37 °C for the indicated time and 
stirred at 37 °C for 24 hours after addition of βME.  The data is best fit to an 
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